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Abstract 
The role of bone morphogenetic protein signalling in the control of skin repair 
after wounding. 
Christopher John LEWIS 
Keywords: Wound healing, bone morphogenetic protein, BMP, skin, 
keratinocyte, Noggin, Smad 
 
Bone morphogenetic proteins (BMPs) and their receptors (BMPRs) coordinate 
tissue development and postnatal remodelling by regulating proliferation, 
differentiation and apoptosis. However, their role in wound healing remains 
unclear. To study this, transgenic mice overexpressing Smad1 (K14-caSmad1) 
or the BMP antagonist Noggin (K14-Noggin) were utilised, together with human 
and mouse ex vivo wound healing models and in vitro keratinocyte culture.  
In wild-type mice, transcripts for Bmpr-1A, Bmpr-II, Bmp ligands and Smad 
proteins were decreased following tissue injury, whilst Bmpr-1B expression was 
up-regulated. Furthermore, immunohistochemistry revealed a down-regulation 
of BMPR-1A in hair follicles adjacent to the wound in murine skin, whilst in 
murine and human wounds, BMPR-1B and phospho-Smad-1/5/8 expression 
was pronounced in the wound epithelial tongue.  
K14-caSmad1 mice displayed retarded wound healing, associated with reduced 
keratinocyte proliferation and increased apoptosis, whilst K14-Noggin mice 
exhibited accelerated wound healing. Furthermore, microarray analysis of K14-
caSmad1 epidermis revealed decreased expression of distinct cytoskeletal and 
iii 
 
cell motility-associated genes including wound-associated keratins (Krt16, 
Krt17) and Myo5a versus controls.  
Human and mouse keratinocyte proliferation and migration were suppressed by 
BMP-4/7 both in vitro and ex vivo, whilst they were stimulated by Noggin. 
Additionally, K14-caSmad1 keratinocytes showed retarded migration compared 
to controls when studied in vitro. Furthermore, Bmpr-1B silencing accelerated 
migration and was associated with increased expression of Krt16, Krt17 and 
Myo5a versus controls.  
Thus, this study demonstrates that BMPs inhibit proliferation, migration and 
cytoskeletal re-organization in epidermal keratinocytes during wound healing, 
and raises a possibility that BMP antagonists may be used for the future 
management of chronic wounds. 
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1.1 The skin: a multifunctional organ 
The skin is the largest organ in the body, and is essential for the survival of all 
vertebrates. As well as keeping vital tissues within our bodies, skin provides an 
anatomical barrier to pathogens, and limits interaction between the hostile 
external environment and internal organs. The presence of specialised Merkel 
cells allows us to perceive our environment through tactile sensation, and aids 
in our withdrawal from noxious stimulants, including heat, trauma, ultraviolet 
radiation and cold. The skin is vital in thermoregulation and water control, 
controlling evaporation and constricting blood vessels to reduce heat loss 
(Johnson and Kellogg, 2010). Skin is also able to perform an endocrine 
function, synthesising vitamin D3 through the reaction of sunlight with 
cholesterol derivatives (Lips, 2006). From an aesthetic perspective, skin and 
personal appearance play a key role in human social behaviour (Morrison et al., 
2010). Not only can skin perform this wide variety of functions, but it is also able 
to heal itself when injured, illustrating its self-reparative properties. It can quickly 
be appreciated that the skin is a remarkable and highly complex organ in order 
to perform all of these roles. An array of different cell types including 
keratinocytes, fibroblasts, immune cells, Langerhans cells, hair follicles (HFs), 
sebocytes and melanocytes interact via an orchestra of signalling cascades in 
order to maintain skin homeostasis (Fuchs, 1993; Millar, 2002; van Genderen et 
al., 1994).  
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1.2 Anatomy of the skin 
The skin is broadly divided into the epidermis and dermis, developing from the 
ectoderm and mesoderm respectively, together with contributions from the 
neural crest to aid craniofacial development (Brenner and Hearing, 2008; Chai 
et al., 2000; Chang and Hemmati-Brivanlou, 1998; Smith and Holbrook, 1986). 
The epidermis is stratified into four distinct layers (Figure 1.1), whilst the dermis 
consists of two layers.  
 
1.2.1 Epidermis 
The epidermis is composed of a stratified squamous epithelium (interfollicular 
epidermis, IFE), varying in thickness from 0.007 to 1.15mm dependent on body 
site. It consists of four or five distinct cellular layers, which are structurally and 
functionally distinct (Figure 1.1), together with appendages such as HFs, 
sebaceous glands and sweat glands. Keratins are a group of proteins produced 
by epithelial cells, and are central to the formation of the intermediate filament 
system (Moll et al., 1982). Within the skin, they are fundamental to the durability 
and water-resistant properties, and are produced by keratinocytes.  
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Figure 1.1 - Epidermal anatomy. The epidermis is divided into four or five 
distinct sub-layers. The stratum basale consists of a monolayer of mitotically 
active cuboidal cells, which replenish the suprabasal layers. The stratum 
spinosum lies immediately above and consists of several stratified layers of 
polygonal-shaped cells. The stratum granulosum consists of only three or four 
flattened layers of anucleate cells. This layer contains keratohyalin and lamellar 
granules, comprising keratohyalin, filaggrin and lipids. The stratum corneum is 
composed of 25 to 30 layers of flattened scale-like anucleate cells. This layer is 
characterised by cornification, involving drying and flattening of the surface 
corneocytes. If present, the stratum lucidum would be found between the 
stratum granulosum and stratum corneum (Lippens et al., 2009). 
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The innermost layer of keratinocytes in the epidermis forms the stratum basale. 
This consists of a monolayer of cuboidal cells attached to the basement 
membrane via hemidesmosomes. The stratum basale cells are mitotically 
active, and contain a pool of epidermal stem cells and transit-amplifying cells 
(Fuchs, 2009). The daughter cells created move outwards to replenish the 
suprabasal layers in a process which typically takes 4 to 6 weeks in human 
skin. As keratinocytes migrate upwards in the epidermis, they lose contact with 
the nutrient and vascular-rich dermis, resulting in nuclear degradation and 
increased cellular keratin expression. This path of terminal differentiation is 
highly complex, and is regulated by changes in epidermal calcium, cytokine and 
cyclic adenosine monophosphate levels (Proksch et al., 2008). Basal 
keratinocytes chiefly express keratin-5 (Krt5) and keratin-14 (Krt14) (Moll et al., 
2008; Rao et al., 1996). However, these keratins are subsequently down-
regulated in the suprabasal layers as the basal cells divide (Fuchs and Green, 
1980). Both of these keratins are important for structural integrity of the skin to 
be maintained; absence of Krt5 and Krt14 is associated with epidermolysis 
bullosa and skin blistering (Jerabkova et al., 2010).  
The stratum spinosum (spinous layer) lies immediately above the stratum 
basale and consists of several stratified layers of cells. These are polygonal in 
shape rather than cuboidal.  Keratinocytes in this layer express keratin-1 (Krt1) 
and keratin-10 (Krt10) (Fuchs and Green, 1980; Moll et al., 2008; Moll et al., 
1982), which form dense bundles to increase skin strength. Krt1 and Krt10 
expression inhibits keratinocyte proliferation and cell cycle progression, 
indicating the terminal differentiation of these cells (Moll et al., 2008).  
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The stratum granulosum (granular layer) consists of only three or four flattened 
layers of anucleate cells. This layer contains keratohyalin and lamellar granules, 
comprising keratohyalin, filaggrin and lipids respectively (Matoltsy and Matoltsy, 
1970; Odland and Holbrook, 1981). The contents of these granules promote 
skin durability, as the proteins cause thickening of the cell membrane and lipids 
coat the cell surface.  As keratinocytes differentiate, a cornified cell envelope 
develops to protect keratinocytes from the external environment, consisting of 
lipids and proteins including involucrin, loricrin and filaggrin (Nemes and 
Steinert, 1999). 
The stratum lucidum (clear layer) is found only in the thick skin of the palms and 
soles (Kanitakis, 2002) and was so named after the translucency of the layer 
upon microscopic examination. It consists of three to five layers of thin, 
transparent dead cells (Lippens et al., 2009), and is characterised by the 
presence of eleidin, a product of keratohyalin and precursor of keratin (Alcamo 
IE, 2004). 
The stratum corneum (horny layer) is composed of 25 to 30 layers of flattened 
scale-like cells. This layer is characterised by cornification, involving drying and 
flattening of the surface corneocytes. These cells are anucleate and dead, and 
account for three-quarters of the epidermal thickness. The corneocytes are 
shed over time, and are replaced by new cells from the layers below.  
In addition to the functional layers of keratinocytes and corneocytes, the 
epidermis contains specialised cells including melanocytes, Merkel cells and 
Langerhans cells. Melanocytes are cells of neural crest origin, and produce 
melanin, the function of which is to pigment the skin and hair, and protect 
against ultra-violet radiation (Brenner and Hearing, 2008). Pigmentation 
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involves production and dispersion of melanin by epidermal melanocytes to 
neighbouring keratinocytes, with up to 36 keratinocytes surrounding each 
melanin-producing cell (Schallreuter et al., 2008). Melanin synthesis or 
melanogenesis occurs within the specialized organelle termed melanosomes 
where the amino acid L-tyrosine serves as the starting precursor (Lerner and 
Fitzpatrick, 1950; Schallreuter et al., 1998).  
Merkel cells are somatosensory cells which enable fine touch discrimination, 
through sensory afferent nerves. The origin of these cells has remained 
contentious until recently (Boulais and Misery, 2007) and they are now 
established to be epidermal in origin (Van Keymeulen et al., 2009). They are 
located in the stratum basale and are particularly concentrated in areas of high 
tactile sensibility, such as the fingertips (Boulais and Misery, 2007).  
Langerhans cells are local dendritic cells of the epidermis, and serve an 
immunological function. When presented with a local skin infection, these cells 
take up microbial antigen, therefore making them one of the subgroup of 
antigen-presenting cells (APCs). They are characterised by the presence of 
Birbeck granules (Breathnach et al., 1962) containing langerin (Valladeau et al., 
2000), the function of which is to internalize antigen into the cell, in preparation 
to initiate an immune response.  
 
1.2.2 Dermis 
The dermis is composed of four constituent cell types: fibroblasts, adipocytes, 
mast cells and macrophages (Brown, 2004). The major structural components 
responsible for the durability of skin include collagen (Meigel et al., 1977), 
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elastin (Weinstein and Boucek, 1960) and glycosaminoglycans (Gillard et al., 
1977). The dermis is divided into two layers; the upper papillary (stratum 
papillare) and lower reticular (stratum reticulare) dermis (Figure 1.2).  
The superficial portion of the stratum papillare is arranged into ridge-like 
structures, the dermal papillae, which contain blood vessels and Meissner’s 
corpuscles (Cormack, 1987; Sorrell and Caplan, 2004). The rete subpapillare 
demarcates the lower limit of the papillary dermis, forming a rich vascular 
network. The stratum reticulare extends from this superficial vascular plexus to 
a deeper vascular plexus, the rete arteriosum cutaneum, which serves as the 
boundary between the dermis and hypodermis. HFs and their associated 
dermal cells extend into and often through the reticular dermis to terminate in 
the hypodermis, a tissue rich in adipocytes (Sorrell and Caplan, 2004). 
The stratum papillare and reticulare differ in both the composition and 
organisation of their extracellular matrices; the stratum papillare is characterised 
by thin, poorly organised collagen fibre bundles, consisting primarily of type I 
and type III collagens, which contrast with the thick, well-organized fibre 
bundles in the stratum reticulare (Cormack, 1987; Sorrell and Caplan, 2004) 
Collagen fibres in the stratum papillare contain more type III collagen than do 
those in the reticular dermis (Meigel et al., 1977; Sorrell and Caplan, 2004). 
Collagen in the dermis functions to provide elasticity, retain water and provide 
resistance to penetrating skin injuries.   
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Figure 1.2 – Dermal layers and vasculature. The dermis is divided into two 
layers; the upper papillary layer (stratum papillare) and lower reticular layer 
(stratum reticulare). The superficial papillary layer is arranged into ridge-like 
structures, the dermal papillae, which contain blood vessels and Meissner’s 
corpuscles. The subpapillary network (rete subpapillare) demarcates the lower 
limit of the papillary dermis, forming a rich vascular network. The reticular layer 
extends from this superficial vascular plexus to a deeper vascular plexus, the 
rete arteriosum cutaneum (Adapted from Gray’s Anatomy). 
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1.3 Molecular regulation of keratinocyte proliferation, 
differentiation and apoptosis in postnatal epidermis 
Newborn mouse epidermis consists of a basal layer, one or two layers of 
spinous cells, three or four layers of granular cells and around twenty layers of 
cornified cells (Weiss and Zelickson, 1975). However, this epidermal structure 
and thickness is only maintained in postnatal life in foot-pads, whilst hairy skin 
epidermal thickness is progressively decreased starting from postnatal day 10. 
During the telogen stage of the hair cycle in adult mice, the epidermis consists 
of only a few keratinocyte layers (Peters et al., 2002; Weiss and Zelickson, 
1975). Several mechanisms contribute to this postnatal decrease in epidermal 
thickness in hairy skin, including decreased epidermal proliferation, keratinocyte 
apoptosis, and phagocytosis of cell fragments by neighbouring keratinocytes 
(Botchkarev et al., 1999; Magerl et al., 2001; Weiss and Zelickson, 1975).     
 
 1.3.1 p63 transcription factor 
p63 is a transcription factor that acts as a master regulator of the epidermal 
differentiation programme, which induces the expression of several groups of 
genes encoding the cytoskeleton (Krt5 and Krt14) (Romano et al., 2009), cell 
adhesion molecules (P-cadherin, integrin-α3, Perp (p53 apoptosis effector 
related to PMP-22), dystonin), cell matrix regulators (Fraser Syndrome-1), 
transcription factors (activating enhancer binding protein 2-ϒ (AP-2ϒ), inhibitor 
of nuclear factor kappa-B kinase subunit alpha-α (IKK-α), interferon regulatory 
factor 6 (IRF6)) and epigenetic regulators (Satb1 (special AT-rich sequence-
binding protein-1), Brg1) in epidermal progenitor cells (Botchkarev et al., 2012; 
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Ihrie et al., 2005; Koster and Roop, 2007; Vanbokhoven et al., 2011). Ablation 
of the p63 gene in mice results in the failure of epidermal stratification and other 
squamous epithelia, failure of  formation of epidermal appendages (HFs, glands 
and teeth) and severe abnormalities in the development of limbs and external 
genitalia (Ince et al., 2002; Mills et al., 1999; Yang et al., 1999). Furthermore, 
heterozygous mutations in the human p63 gene have been shown to be 
responsible for several ectodermal dysplasia syndromes, also characterized by 
abnormalities in the development of digits, teeth, hair, nails and sweat glands 
(Koster, 2010; Rinne et al., 2007).  
The p63 gene has multiple isoforms, including TAp63 and ΔNp63, which show 
distinct, but partially overlapping roles in the control of epidermal differentiation 
and stratification (Koster and Roop, 2007; Vanbokhoven et al., 2011). The TP63 
gene is transcribed from two alternative promoters, producing either a TAp63 
isoform with an N-terminal transactivation (TA) domain, a core DNA-binding 
domain and a C-terminal oligomerization domain, or a ΔNp63 isoform that lacks 
the TA domain (Petitjean et al., 2008). The ΔNp63 isoform is more abundant in 
the epidermis compared to TAp63, is strongly expressed in basal epidermal 
keratinocytes and is markedly down-regulated in the stratum spinosum 
(Romano et al., 2012). ΔNp63 plays a major role in mediating the effects of p63 
on epidermal development, whereas TAp63 protects keratinocytes from 
senescence and suppresses neoplastic development in postnatal epidermis 
(Guo et al., 2009; Romano et al., 2012). 
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1.3.2 Regulation of keratinocyte proliferation in the epidermis 
Cell proliferation in the epidermis is essential to maintain its self-renewing 
capacity and is typically restricted to basal epidermal keratinocytes (Magerl et 
al., 2001). In newborn mice, proliferating cells account for approximately 35-
45% of keratinocytes in the basal epidermis, but this figure falls to 20-25% of 
basal epidermal cells in adult epidermis (Botchkarev et al., 1999; Fessing et al., 
2011).  
Keratinocytes produce and secrete a large number of growth factors, including 
epidermal growth factor (EGF) (Pastore et al., 2008), nerve growth factor (NGF) 
(Paus et al., 1994), granulocyte-macrophage colony stimulating factor (GM-
CSF) (Braunstein et al., 1994) and endothelins (Tsuboi et al., 1994), which 
interact with the corresponding cell membrane receptors and stimulate cell 
proliferation in an autocrine manner (Pastore et al., 2008). Keratinocyte 
proliferation is also stimulated in a paracrine manner by fibroblast growth factor 
(FGF) (Gospodarowicz et al., 1990), hepatocyte growth factor (HGF) (Gurtner et 
al., 2008; Sato et al., 1995) and insulin-like growth factor (IGF) (Eming et al., 
1996), predominantly secreted in the skin by mesenchymal cells (Botchkarev et 
al., 2006; Braun et al., 2004; Shirakata, 2010). In addition, neuropeptides 
including substance P (Tanaka et al., 1988), calcitonin gene related peptide 
(Takahashi et al., 1993), and vasoactive intestinal polypeptide (Haegerstrand et 
al., 1989) released from sensory nerve endings in the epidermis or dermis, as 
well as pro-opiomelanocortin-derived peptides, such as beta-endorphin, 
released from melanocytes, also stimulate keratinocyte proliferation (Paus et 
al., 1997; Scholzen et al., 1998). 
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Cell proliferation in the basal epidermal cells is also positively regulated by a 
number of transcription factors including c-myc and ΔNp63 (Blanpain and 
Fuchs, 2009; Watt et al., 2008). c-myc stimulates keratinocyte proliferation by 
controlling the expression of cell cycle regulators cyclin-dependent kinase-4 
(Cdk4) and CdkN2B, whilst ΔNp63 maintains the progenitor status of basal 
epidermal keratinocytes by stimulating expression of FGF receptors Fgfr2/3, as 
well as by directly supressing the expression of anti-proliferative target genes, 
including 14-3-3s, p16/Ink4a, p19/Arf and p21 (Ferone et al., 2012; Su et al., 
2009; Watt et al., 2008; Westfall et al., 2003). These cell cycle inhibitors are 
also targeted by a number of epigenetic regulators (DNA methyltransferase-1 
(DNMT1), histone deacetylases-1/2 (HDAC1/2), polycomb components Cbx4, 
Bmi1, Ezh1/2), which stimulate proliferation of basal epidermal progenitors via 
repression of these genes (Botchkarev et al., 2012). 
However, stimulatory effects on epidermal proliferation are also counter-
balanced by numerous inhibitory mechanisms under the control of a variety of 
signalling molecules, transcriptional and epigenetic regulators. Signalling 
molecules that inhibit keratinocyte proliferation include transforming growth 
factor-β (TGF-β), bone morphogenetic proteins (BMPs), Notch ligands, vitamin 
D3 and interferon-ϒ, which interact with their corresponding receptors on 
keratinocytes (Shirakata, 2010). TGF-β, BMP and Notch pathways exert their 
inhibitory activities by stimulating the expression of Cdk inhibitor p21, which 
mediates keratinocyte exit from the cell cycle and inhibits the expression of cell 
cycle-associated genes (Dotto, 2000, 2009; Ferrandiz et al., 2012; Watt et al., 
2008). Indeed, a number of studies have illustrated the inhibitory effect of BMPs 
on both human and mouse keratinocyte proliferation (Ahmed et al., 2011; 
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Botchkarev, 2003; Botchkarev et al., 1999; Sharov et al., 2009; Sharov et al., 
2006). 
Transcription factors inhibit proliferation in basal epidermal layer via a number 
of different mechanisms including negative regulation of the distinct stimulators 
of cell proliferation. AP-2α transcription factor inhibits keratinocyte proliferation 
via repression of EGFRs (Wang et al., 2006b), whereas ΔNp63α stimulates 
expression of IKKα, an important component of NF-ΚB (nuclear factor Κ-light-
chain-enhancer of activated B cells) signalling, which is required for cell cycle 
withdrawal (Marinari et al., 2009). Furthermore, ΔNp63α positively regulates 
expression of IRF6 transcription factor, which in turn, induces proteasome-
mediated ΔNp63α degradation and keratinocyte exit from the cell cycle (Moretti 
et al., 2010).  
 
1.3.3 Regulation of postnatal epidermal differentiation 
Terminal keratinocyte differentiation begins following the asymmetric cell 
division of basal epidermal cells and their subsequent movement into the 
suprabasal epidermal layers (Blanpain and Fuchs, 2009; Simpson et al., 2011). 
Asymmetric cell division in the epidermis is controlled by G-protein-signalling 
modulator 2 (also known as LGN), NuMA (nuclear mitotic access protein) and 
dynactin (Dctn1) proteins, which are concentrated in the apices of keratinocytes 
during mitosis (Lechler and Fuchs, 2005; Williams et al., 2011). Notch signalling 
operates downstream of these proteins (Williams et al., 2011) and interacts with 
mitotic spindle machinery to align the spindle orientation along the apico-basal 
axis (Goulas et al., 2012). 
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Notch signalling in suprabasal epidermal keratinocytes is induced by Notch 
ligand expression in basal cells, and triggers the beginning of suprabasal 
differentiation through the expression of Krt1, a marker of the stratum spinosum 
(Blanpain and Fuchs, 2006; Wang et al., 2008). Furthermore, Notch signalling 
operates in synergy with AP-2α/ϒ transcription factors, which, by stimulating the 
expression of CCAAT/enhancer-binding protein-α/β (C/EBP-α/β) transcription 
factors, also mediate the switch in expression between the basal (Krt5/Krt14) 
and suprabasal (Krt1/Krt10) keratins (Byrne et al., 1994; Wang et al., 2008). 
This process is also promoted by Forkhead box protein N1 (Foxn1) transcription 
factor (Baxter and Brissette, 2002), and by p63, which contributes to this 
process indirectly via TAp63α-mediated induction of AP-2ϒ expression (Koster 
et al., 2006). 
Transition from the stratum spinousum to the stratum granulosum is associated 
with the expression of genes that contribute to the formation of the cornified cell 
envelope (epidermal differentiation complex (EDC) and transglutaminase 
genes), as well as regulate lipid synthesis and promote formation of lipid-
containing lamellar bodies (Kalinin et al., 2002). Expression of the EDC genes 
encoding filaggrin, involucrin, loricirin, trychohyalin, small proline-rich and late 
cornified cell envelope proteins is controlled by numerous transcription factors 
including AP-1, AP-2, aryl hydrocarbon receptor nuclear translocator (Arnt), 
Foxn1 and Gata binding protein 3 (Brown et al., 2007; Kypriotou et al., 2012).  
p63 transcription factor also contributes to the control of terminal keratinocyte 
differentiation indirectly, by modulating the expression of zinc finger protein 750 
(ZNF750) transcription factor, which, in turn, positively regulates expression of 
Kruppel-like factor 4 (Klf4) and some of its target genes (Sen et al., 2012). 
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Furthermore, p63 regulates the expression of higher-order chromatin remodeller 
Satb1, which promotes the establishment of specific three-dimensional 
chromatin structure at the central EDC domain, which is required for 
coordinated regulation of gene expression (Fessing et al., 2011).  
It is important to note that epigenetic regulators, including DNMT1, HDAC1/2 
and Polycomb complex components Cbx4, Ezh1/2 and Bmi1, are able to 
modulate premature activation of terminal differentiation-associated genes 
(Ezhkova et al., 2011; Ezhkova et al., 2009; Luis et al., 2011; Mejetta et al., 
2011; Sen et al., 2010) by forming active or repressive local chromatin structure 
at differentiation gene promoter regions.  
 
1.3.4 Regulation of keratinocyte apoptosis in the epidermis 
Apoptosis is an important mechanism of maintenance of epidermal homeostasis 
and contributes to the reduction of epidermal layers in postnatal hairy skin (Raj 
et al., 2006; Weiss and Zelickson, 1975). Condensed chromatin in apoptotic 
cells shows evidence of DNA breaks, which is recognized by terminal 
deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining (Ishida-
Yamamoto et al., 1999). Apoptotic TUNEL-positive cells are continuously 
present in suprabasal epidermal layers during murine embryonic development 
and also in postnatal skin (Magerl et al., 2001). In human embryonic epidermis, 
TUNEL-positive cells are more numerous in the stratum spinousum and stratum 
granulosum compared to the stratum basale, and their number is decreased in 
neonatal and adult skin (Polakowska et al., 1994).   
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Apoptotic cell death in epidermal keratinocytes is regulated by a number of 
extrinsic (signalling receptor-mediated) and intrinsic (mitochondrial) pathways, 
whose activity is counter-balanced by anti-apoptotic factors, such as B-cell 
lymphoma 2 (Bcl2) (Raj et al., 2006). The balance between pro- and anti-
apoptotic regulators in different epidermal layers is vital in regulating the 
susceptibility of keratinocytes to programmed cell death. Basal keratinocytes 
express higher levels of Bcl2 and are therefore more resistant to apoptosis 
compared to differentiated keratinocytes (Polakowska et al., 1994; Raj et al., 
2006). p53 and its target genes play a central role in the control of apoptosis 
induced in epidermal keratinocytes by UV- and ionizing radiation (Raj et al., 
2006), whilst p63 contributes to the control of apoptosis in normal epidermis by 
regulating expression of caspase-8 and its inhibitor FLICE-like inhibitory protein 
(FLIP) (Borrelli et al., 2009). 
 
1.4 The hair follicle 
The HF is a complex mini-organ that is found all over the skin, with the 
exception of the glabrous skin of the palms and soles, and the lips. Hair is a 
primary characteristic of mammals and exerts a wide range of functions 
including thermoregulation, physical protection, sensory activity, and social 
interactions (Stenn and Paus, 2001). Hair is composed of terminally 
differentiated, dead keratinocytes, which are compacted to form the hair shaft. 
Hair shafts are made by the HF, which constitutes the pilosebaceous unit 
together with its associated structures, the sebaceous gland and the arrector pili 
muscle (Stenn and Paus, 2001).  
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The mature HF can be divided into a ‘permanent’ upper part, which does not 
cycle visibly, and a lower part, which is continuously remodelled in each hair 
cycle (Figure 1.3). The upper pole of the HF consists of the infundibulum, which 
is the opening of the hair canal to the skin surface, and the isthmus. The lower, 
cycling part represents the hair bulb. The lower end of the infundibulum is 
marked by the insertion of the sebaceous gland duct (Cotsarelis G, 2008; 
Schneider et al., 2009). Proximally, the infundibulum joins the isthmus region of 
the outer root sheath (ORS), where the arrector pili muscle is inserted. 
The lower isthmus harbours epithelial and melanocytic HF stem cells in the 
bulge region. The bulge is the end of the permanent, non-cycling region. The 
hair bulb contains the matrix keratinocytes and the HF pigmentary unit (Tobin, 
2008). Nestled within the matrix lies the dermal papilla, which contains 
specialised fibroblasts. These are thought to control the number of matrix cells, 
and therefore the hair size (Paus and Cotsarelis, 1999). The matrix 
keratinocytes cyclically differentiate into trichocytes and inner root sheath (IRS) 
cells, forming the Henle, Huxley and cuticle layers of the IRS, and the cuticle, 
cortex and medulla layers of the hair shaft as they move upwards (Alonso and 
Fuchs, 2006). Pigment in the hair shaft is produced by melanocytes 
interspersed among the matrix cells. As the matrix cells differentiate and move 
upward, they are compressed and funnelled into their final shape by the rigid 
IRS, whose dimensions and curvature largely determine the shape of the hair 
(Alonso and Fuchs, 2006; Paus and Cotsarelis, 1999). As hair shaft cells 
terminally differentiate, they extrude their organelles and become tightly packed 
with bundles of 10nm filaments assembled from cysteine-rich hair keratins, 
which become physically cross-linked to give the hair shaft high tensile strength 
and flexibility. The IRS also keratinizes so that it can rigidly support and guide 
19 
 
the hair shaft during its differentiation process, but its dead cells degenerate as 
they reach the upper HF, thereby releasing the hair shaft that continues through 
the skin surface (Alonso and Fuchs, 2006). 
 
Figure 1.3 - Structure of a human anagen hair follicle. (A) Sagittal section 
through an anagen human scalp hair follicle showing the permanent 
(infundibulum, isthmus) and growth-associated (suprabulbar and bulbar area) 
components; (B) High magnification image of the isthmus - dashed area 
indicates approximate location of the bulge; (C) High magnification image of the 
bulb; (D) Schematic illustration of the concentric layers of the ORS, IRS and 
shaft in the bulb. Abbreviations - BM: basal membrane; APM: arrector pili 
muscle; CTS: connective tissue sheath; DP: dermal papilla; M: matrix; HS: hair 
shaft, IRS: inner root sheath; ORS: outer root sheath; SG: sebaceous gland) 
(Schneider et al., 2009). 
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1.5 Hair follicle development and hair cycling 
Follicular development takes place between weeks 9 and 12 in humans, and 
involves a complex series of inductive signals (Figure 1.4). The initial signal for 
HF induction is produced in the dermis (Millar, 2002) and is thought to be 
mediated via β-catenin (Fuchs and Raghavan, 2002; Millar, 2002; Noramly et 
al., 1999) and the Wnt signalling cascade (MacDonald et al., 2009; Millar, 
2002), resulting in the altered transcription of a wide variety of Wnt-specific 
target genes, including keratins (DasGupta and Fuchs, 1999), Gremlin 
(Klapholz-Brown et al., 2007) and SOX-9 (Yano et al., 2005).   
A second signal cascade involved in follicular development is Sonic hedgehog 
(Shh) (Callahan and Oro, 2001; Dlugosz, 1999; Millar, 2002; St-Jacques et al., 
1998). This pathway forms a key signalling cascade in embryogenesis that is 
responsible for the development of organs including the skin and hair (Bitgood 
and McMahon, 1995). Shh signalling appears to be required for down-growth of 
the follicular epithelium and dermal papilla (Millar, 2002; St-Jacques et al., 
1998), and is absent from the HFs of mice lacking epithelial β-catenin, indicating 
that Shh lies downstream of Wnt signalling in HF development (Huelsken et al., 
2001; Millar, 2002). In addition, HFs in Shh–null mice fail to down-grow 
significantly (St-Jacques et al., 1998).  
As the hair peg grows downwards, it envelops the mesodermal papilla, and 
epithelial cell proliferation and differentiation result in the formation of at least 
seven distinct epithelial layers (Figure 1.3), making up the IRS and ORS (Millar, 
2002). Several signalling cascades are thought to be involved in this process of 
hair shaft differentiation, including Notch (Kopan and Weintraub, 1993; Millar, 
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2002), BMPs (Blessing et al., 1993; Botchkarev et al., 2001; Kulessa et al., 
2000; Millar, 2002) and Wnt (DasGupta and Fuchs, 1999; Millar, 2002). 
 
Figure 1.4 - The development of the hair follicle.  The first sign of impending 
HF growth is a crowding of nuclei in the basal keratinocytes to form the hair 
placode. An epithelial signal from the placode induces the dermal condensate to 
form beneath. Subsequently, the dermal condensate stimulates the hair placode 
to proliferate and invade the dermis. The basal cells elongate and the structure 
begins to grow downwards as the hair germ and peg, under the control of 
signals from the expanding epithelial cells. As the hair peg grows downwards, it 
envelops the mesodermal papilla, and epithelial cell proliferation and 
differentiation result in the formation of at least seven distinct epithelial layers, 
making up the IRS and ORS (Fuchs, 2008). 
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Mature HFs undergo a cycle of programmed growth (anagen), regression 
(catagen), rest (telogen) and shedding (exogen) (Alonso and Fuchs, 2006; Paus 
and Cotsarelis, 1999; Schneider et al., 2009) (Figure 1.5). Anagen represents a 
period of growth, and histologically, anagen HFs elongate. The proliferating 
matrix cells have a cell-cycle length of approximately 18 hours (Alonso and 
Fuchs, 2006); during which time daughter cells terminally differentiate to form 
the hair shaft or IRS. The duration of anagen determines the length of the hair 
and is dependent upon continued proliferation and differentiation of matrix cells 
at the HF base, and lasts approximately 2 to 6 years in human HFs (Alonso and 
Fuchs, 2006).  
Matrix keratinocytes are transit-amplifying cells and can divide a finite number 
of times before terminally differentiating. As the supply of matrix cells declines, 
hair shaft and IRS differentiation slows and the HF enters an apoptotic phase 
called catagen (Alonso and Fuchs, 2006). The transition to catagen is controlled 
by molecular regulators including fibroblast growth factor 5, epidermal growth 
factor, p53 and members of the TGF-β superfamily, including TGF-β1 and BMP 
receptors (BMPRs) (Andl et al., 2004; Hansen et al., 1997; Paus and Cotsarelis, 
1999; Rosenquist and Martin, 1996). Catagen is a highly controlled process of 
involution, reflecting programmed apoptosis in follicular keratinocytes (Lindner 
et al., 1997; Paus and Cotsarelis, 1999) and melanocytes (Slominski et al., 
1994). The dermal papilla condenses and moves upward, coming to rest 
underneath the HF bulge. As the lower HF recedes, a temporary structure 
known as the epithelial strand forms, which is unique to catagen. This connects 
the dermal papilla to the upper part of the HF (Alonso and Fuchs, 2006). 
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Figure 1.5 – The hair cycle. The hair cycle starts from the first postnatal 
anagen, when the hair shaft is growing and protruding through the skin surface. 
Follicles progress synchronously to the destructive (catagen) phase, during 
which the lower two-thirds of the follicle undergo apoptosis and regress. The 
dermal papilla is brought to rest below the bulge-stem-cell compartment, and 
after the resting (telogen) phase, a critical threshold of activating factors is 
reached and the stem cells become activated to regrow the hair (Fuchs, 2007). 
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Following catagen, HFs lie dormant in a relative resting phase known as 
telogen. During this stage, the hair shaft matures into a club hair, which is 
eventually shed from the HF (Paus and Cotsarelis, 1999). The telogen stage 
typically lasts for two to three months before the scalp HFs re-enter the anagen 
stage and the cycle is repeated. The percentage of HFs in the telogen stage 
varies substantially according to the region of the body (e.g., 5 to 15 percent of 
scalp HFs are in the telogen stage at any one time, as compared with 40 to 50 
percent of HFs on the trunk) (Dawber, 1997; Paus and Cotsarelis, 1999).  
The transition from telogen to anagen involves activation of stem cells in the HF 
bulge (Taylor et al., 2000). These cells proliferate to form daughter transit-
amplifying cells, which form the new HF (Alonso and Fuchs, 2006; Blanpain et 
al., 2004). The induction of the anagen phase involves a series of complex 
signalling cascades, including Wnt (Huelsken et al., 2001; Van Mater et al., 
2003), Shh (St-Jacques et al., 1998), BMPs and the BMP receptor antagonist 
Noggin (Botchkarev et al., 1999; Kulessa et al., 2000). 
 
1.6 The pathophysiology of wound healing 
A wound is a breach in the structural integrity of the skin, and may be 
accompanied by disruption of the structure and function of the underlying 
normal tissue (Hodges, 2008). The continuity of the skin must be re-established 
expeditiously, as it plays a crucial role in the maintenance of homeostasis (Lau 
et al., 2009; Martin and Parkhurst, 2004; Singer and Clark, 1999). A healed 
wound is one in which the connective tissues have been repaired and the 
wound completely re-epithelialized.  
25 
 
Acute wounds refer to those wounds, such as burns, traumatic injuries and 
surgically-created wounds, which heal in a timely fashion. Wound healing may 
be sub-classified into primary, delayed primary (tertiary) and secondary healing 
(Figure 1.6) (Hodges, 2008). Primary healing occurs when a wound is closed 
within 12 to 24 hours of its creation, for example a surgical incision (Brown, 
2004); the incision causes only focal disruption of the continuity of the epithelial 
basement membrane, and the death of relatively few epithelial and connective 
tissue cells. As a result, epithelial regeneration predominates over fibrosis 
(Enoch, 2008). Delayed primary healing refers to a contaminated or poorly 
delineated wound that is closed after several days (Brown, 2004); these include 
animal bites. Closure is performed once the immune response has helped to 
debride the wound. Collagen metabolism is relatively unaffected and the wound 
retains its tensile strength as if closure had been immediate. Secondary healing 
occurs in wounds with extensive soft tissue loss (Brown, 2004). Regeneration of 
epithelial tissue alone cannot restore the original architecture, and granulation 
tissue grows from the wound edges, together with extracellular matrix and 
collagen deposition. These large wounds close by a combination of wound 
contraction and epithelialization. Myofibroblasts are the key to the success of 
secondary healing (Singer and Clark, 1999; Werner and Grose, 2003).  
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Figure 1.6 – Sub-types of acute wound healing. Primary healing occurs 
when a wound is closed within 12 to 24 hours of its creation. Tertiary healing 
occurs in contaminated wounds that are closed after several days once the 
immune response debrided the wound. Secondary healing occurs in wounds 
with extensive soft tissue loss (Adapted from biology-forums.com) 
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Wound healing is a complex process that can be divided into four distinct 
phases (Figure 1.7); haemostasis, inflammation, proliferation and remodelling. 
These phases are however, not simple linear events, but rather overlapping in 
time (Enoch, 2008; Li et al., 2007).  
 
Figure 1.7 – The four phases of wound healing. Note how each phase is 
overlapping with another and they are not simply linear in their timescale. ECM: 
Extracellular matrix; MMP: Metalloproteinases; TIMP: Tissue inhibitors of 
metalloproteinases (Enoch, 2008). 
 
1.6.1 The haemostatic phase 
Skin injury is characterised by cell rupture at the wound edge, microvascular 
damage and extravasation of blood into the wound (Kirsner and Eaglstein, 
1993; Shaw and Martin, 2009), all of which herald the beginning of the 
haemostasis phase (Figure 1.8). Following transection of blood vessels, 
platelets are exposed to extracellular matrix (ECM) proteins (Lau et al., 2009), 
resulting in the activation of the coagulation cascade, vessel vasoconstriction, 
platelet aggregation and the formation of a clot within the wound bed to limit 
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further blood loss (Shaw and Martin, 2009). The clot is comprised of fibrin, 
fibronectin, vitronectin, von-Willebrand factor and thrombospondin (Li et al., 
2007). This provides the initial matrix for cellular migration and serves as a 
reservoir of growth factors (Enoch, 2008; Li et al., 2007; Nurden et al., 2008; 
Shaw and Martin, 2009). 
Platelets and mast cells degranulate to release an orchestra of growth factors 
including histamine (Riley, 1953), platelet-derived growth factor (PDGF) 
(Szpaderska et al., 2003), bFGF (Brunner et al., 1993), IGF-1 (Kim et al., 2007), 
tumour necrosis factor-α (TNF-α) (Malaviya et al., 1996), EGF (Ben-Ezra et al., 
1990), TGF-β (Grainger et al., 1995), platelet-factor-IV (Enoch, 2008; Shaw and 
Martin, 2009) and vascular endothelial growth factor (VEGF) (Salgado et al., 
2001). These proteins initiate the wound healing cascade by attracting and 
activating fibroblasts, neutrophils, macrophages and endothelial cells (Grinnell 
et al., 1981). Additionally, platelets secrete vasodilators including serotonin, 
which increase local vascular permeability, resulting in fluid exudate in the 
wound (Enoch, 2008).  
Cells within the wound bed are also exposed to a number of serum-derived 
interleukins (Shaw and Martin, 2009), including GM-CSF (Lim et al., 2013) and 
interferon-γ (Ishida et al., 2004), which stimulate the induction of serum 
response factor (SRF) (Shaw and Martin, 2009; Zhao et al., 2005). SRF induces 
transcription of genes responsible for proliferation and differentiation (Chai and 
Tarnawski, 2002; Shaw and Martin, 2009), and it has been shown that 
wounding results in altered transcription of many genes within an hour of injury 
(Cole et al., 2001; Cooper et al., 2005; Deonarine et al., 2007; Roy et al., 2008; 
Shaw and Martin, 2009). 
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Beyond haemostasis, damage to cells along the wound margin can lead to the 
activation of stress pathways (Shaw and Martin, 2009), including the stress-
activated protein kinase/Jun amino-terminal kinases (SAPK/JNK) and p38 
pathways (Kobayashi et al., 2003; Shaw and Martin, 2009; Yano et al., 2004), 
together with the release of endogenous proteins such as damage-associated 
molecular pattern molecules (DAMPs) (Bianchi, 2007; Hirsiger et al., 2012; 
Shaw and Martin, 2009; Zhang et al., 2010). Combined, these pathways and 
molecules may act chemotactic factors and modify gene expression patterns, 
which have been shown to be transiently altered in response to tissue injury.   
 
Figure 1.8 – The haemostatic phase. Following injury, platelets are exposed 
to ECM proteins, resulting in the activation of the coagulation cascade, vessel 
vasoconstriction, platelet aggregation and the formation of a clot. Platelets and 
mast cells degranulate to release growth factors, which activate fibroblasts, 
neutrophils, macrophages and endothelial cells. Damage to cells along the 
wound margin can lead to the activation of stress pathways, together with the 
release of endogenous proteins such as DAMPs. Photomicrograph illustrates 
activation of JNK pathway (green) in mouse skin 24 hours following wounding 
(Shaw and Martin, 2009).  
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1.6.2 The inflammatory phase 
The inflammatory phase (Figure 1.9) can be divided into early and late, 
depending on the time and the type of inflammatory cell present. The early 
inflammatory phase occurs during the first 48 hours post-injury, and begins with 
the activation of the classical and alternative complement cascades (Enoch, 
2008).  
 
Figure 1.9 – The inflammatory phase. The wound is initially infiltrated by 
polymorphonuclear neutrophils, whilst T-lymphocytes and Langerhans cells are 
activated. Endothelial cells in the vicinity of the wound begin to express 
selectins, which regulate diapedesis (inset).  Once in the wound, neutrophils 
phagocytose invading bacteria. The late inflammatory phase is heralded by the 
arrival of monocytes. Once arrived, these cells undergo a phenotypic change to 
become macrophages, removing bacteria, debriding the wound and secreting 
growth factors. Photomicrograph illustrates macrophage ingress to day 3 mouse 
wound (F4/80 stain) (Shaw and Martin, 2009). 
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The wound is initially infiltrated by polymorphonuclear neutrophils (PMNs) (Kim 
et al., 2008; Shaw and Martin, 2009), which are attracted to by ECM proteins, 
TGF-β, complement components, bacterial by-products (Enoch, 2008) and 
foreign bacterial lipopolysaccharide epitopes (Eming et al., 2007; Shaw and 
Martin, 2009), whilst resident immune cells including T-lymphocytes (Efron et 
al., 1990) and Langerhans cells (Cumberbatch et al., 2000; Shaw and Martin, 
2009) are activated.  
The extravasation of lymphocytes into regions of inflammation is a multistep 
process known as diapedesis (Lau et al., 2009).  Initially, PMNs tether to an 
endothelial cell surface using a selectin molecule, such as L-selectin (Lau et al., 
2009). This induces chemokine and integrin expression, resulting in PMN 
transmigration across the endothelial wall (Lau et al., 2009; Shaw and Martin, 
2009). This movement is enhanced by blood vessel dilatation and the increased 
vascular permeability that is triggered by nitric oxide, histamine, tissue 
plasminogen activator and other factors (Eming et al., 2007; Shaw and Martin, 
2009). Once in the wound, PMNs phagocytose invading bacteria (Simpson and 
Ross, 1972) and release oxygen-free radicals (Shaw and Martin, 2009). During 
this time, basal keratinocytes at the margins of the cut epidermis begin to 
exhibit increased mitotic activity, and begin to migrate and proliferate along the 
dermal edge (Enoch, 2008).  
The late inflammatory phase is heralded by the arrival of monocytes (Mori et al., 
2008), which are attracted to the wound bed by monocyte-specific 
chemoattractants including monocyte chemoattractant protein 1 (Kunkel et al., 
1991), macrophage inflammatory protein 1 (Sherry et al., 1988), collagen and 
fibronectin fragments and thrombin (Postlethwaite and Kang, 1976). Once 
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arrived, these cells undergo a phenotypic change to become macrophages 
(Diegelmann and Evans, 2004; Li et al., 2007) and have a triple function, acting 
to remove bacteria, debride the wound and secrete growth factors including 
PDGF (Shimokado et al., 1985), bFGF (Henke et al., 1993), VEGF (Cho et al., 
2001) and TGF-α and β (Falanga, 1993; Li et al., 2007). In addition, 
macrophages secrete fibronectin (Rennard et al., 1981), attracting fibroblasts to 
the wound bed, and start to induce angiogenesis via the secretion of angiogenic 
factors (Li et al., 2007). 
 
 1.6.3 The proliferative phase  
The proliferative phase begins at 72 hours and typically lasts for approximately 
two to four weeks, though this is dependent on the wound size and location 
(Shaw and Martin, 2009). Fibroblasts are attracted to the wound from the 
adjacent unwounded dermis (Hinz, 2007; Hinz et al., 2007; Shaw and Martin, 
2009), circulating fibrocytes (Abe et al., 2001) and bone marrow progenitor cells 
(Fathke et al., 2004; Shaw and Martin, 2009; Wu et al., 2007b; Wu et al., 2010). 
Once within the wound, they proliferate and produce the matrix components 
fibronectin (Bitterman et al., 1983), hyaluronan (Sampson et al., 1992), collagen 
(Min et al., 2004) and proteoglycans (Tiedemann et al., 1997). The proliferative 
phase is characterised by neoangiogenesis (Shaw and Martin, 2009; Tonnesen 
et al., 2000), under the regulation of VEGF (Byrne et al., 2005), PDGF 
(Battegay et al., 1994), bFGF (Cross and Claesson-Welsh, 2001) and TGF-β 
(Bielefeld et al., 2013; Douglas, 2010; Enoch, 2008; Li et al., 2007; Myers et al., 
2007). Angiogenic capillary buds grow into the fibrin-rich wound clot to become 
a microvascular network within the granulation tissue (Enoch, 2008; Shaw and 
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Martin, 2009). This combination of capillary buds, proliferating fibroblasts and 
type III collagen forms granulation tissue (Gabbiani et al., 1976) (Figure 1.10), 
which acts as a provisional wound matrix and is usually indicative of optimal 
healing (Enoch, 2008; Li et al., 2007).  
 
Figure 1.10 – The appearance of granulation tissue. Note the raw, pink 
appearance of the provisional matrix (Maria and Rajnikanth, 2010). 
 
Epithelialisation, having begun within 24 hours of the injury, continues during 
the proliferative phase (Figure 1.11). In a process known as epiboly (Falanga et 
al., 2007), basal keratinocytes proliferate at the wound margin and migrate as a 
sheet across the provisional matrix made from granulation tissue (Hell and 
Lawrence, 1979; Kondo and Ishida, 2010). The hair follicle forms an important 
source for stem cells and keratinocytes in skin repair and is extensively 
discussed in Section 1.8. Other stem cell sources include the interfollicular 
epidermis (Ghazizadeh and Taichman, 2001; Levy et al., 2005; Page et al., 
2013), adipose tissue (Natesan et al., 2011; Sultan et al., 2012; Sung et al., 
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2012) and bone marrow (Brittan et al., 2005; Fan et al., 2006; Wu et al., 2007a; 
Wu et al., 2007b; Wu et al., 2010), all of which may supply progenitor cells that 
become involved in skin repair. Migrating keratinocytes produce matrix 
metalloproteinases (MMPs) including MMP-9 (Li et al., 2007; Pilcher et al., 
1999), which specifically degrades type-IV collagen in the basement membrane, 
allowing cells to migrate. MMP-1 disrupts keratinocyte attachment to fibrillar 
collagen, and facilitates the continued migration of cells across the wound (Li et 
al., 2007; Parks, 1999). Additionally, migrating keratinocytes secrete laminin V 
onto exposed dermal collagen, which helps to re-establish the basement 
membrane and aid their own movement (Nguyen et al., 2000). A number of 
other protein groups are also vital for keratinocyte migration, including focal 
adhesion proteins such as paxillin (Huang et al., 2004; Huang et al., 2003; 
Kimura et al., 2008) and Ras-related C3 botulinum toxin substrate 1 (Rac1) 
(Chen et al., 2004; Tscharntke et al., 2007), claudin tight junction proteins 
(Webb et al., 2013), gap junction proteins (Scott and Kelsell, 2011; Xu and 
Nicholson, 2013), microtubule components (Leandro-Garcia et al., 2010) and 
actin-binding proteins such as Myosin VA (Myo5a) (Cao et al., 2004; Lan et al., 
2010; Sloane and Vartanian, 2007) and actin binding LIM protein family 
member 2 (Ablim2) (Barrientos et al., 2007).  
At the front of the migrating wound ‘tongue’, keratinocytes proliferate to provide 
a sufficient supply of cells to cover the wound (Li et al., 2007). The hallmarks of 
these activated keratinocytes include cell hypertrophy, generation of actin-rich 
lamellar processes (Allard and Mogilner, 2013; Mitchison and Cramer, 1996; 
Shaw and Martin, 2009) in the direction of migration and reorganization of the 
keratin intermediate filament network (Coulombe, 1997; Wawersik et al., 2001). 
In particular, the type I keratin Krt6 and type II keratins Krt16 and Krt17 are up-
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regulated in activated keratinocytes (Myers et al., 2007; Wawersik et al., 2001), 
whilst the major differentiation-specific keratins Krt1 and Krt10 are down-
regulated (Wawersik et al., 2001). There is, however, a delicate balance 
between Krt6, Krt16 and Krt17 in wound-activated keratinocytes, as constitutive 
overexpression of Krt16 results in the development of skin lesions, including 
acanthosis and hyperkeratosis (Coulombe et al., 1995). Once advancing 
epithelial cells meet, further movement is halted by ‘contact inhibition’, and a 
new basement membrane is established. Further keratinocyte differentiation re-
establishes a stratified epithelial surface (Enoch, 2008), which begins at the 
wound margin and gradually progresses to the wound centre (Laplante et al., 
2001; Li et al., 2007).  
The dermis is re-established in a process known as fibroplasia (Li et al., 2007), 
which involves fibroblast recruitment from nearby unwounded dermis (Hinz, 
2007; Hinz et al., 2007; Shaw and Martin, 2009), circulating fibrocytes (Abe et 
al., 2001) or bone marrow progenitor cells (Fathke et al., 2004; Wu et al., 
2007b; Wu et al., 2010). Subpopulations of fibroblasts undergo phenotypic 
change to become α-smooth muscle actin-expressing myofibroblasts, which aid 
wound contraction (Hinz, 2007; Li et al., 2007; Welch et al., 1990). Additionally, 
fibroblasts produce vimentin, a type III intermediate filament, which contributes 
to dermal-mediated wound contraction (Eckes et al., 1998). Both fibroblast 
migration and wound closure are impaired in the absence of vimentin, 
highlighting its importance (Eckes et al., 1998). 
 
 
 
36 
 
 
Figure 1.11 – The proliferative phase. The proliferative phase begins at 72 
hours and is characterised by capillary bud growth into the wound clot. The 
combination of proliferating fibroblasts, extracellular matrix and capillary buds 
forms granulation tissue. Basal keratinocytes proliferate at the wound margin 
and migrate as a sheet across this provisional matrix. Fibroblasts produce 
fibronectin, hyaluronan, collagen and proteoglycans. Subpopulations undergo 
phenotypic change to become myofibroblasts, which aid wound contraction. 
Photomicrograph illustrates endothelial cell staining (CD-31 – green 
immunofluorescence) and keratin-14 (red immunofluorescence) in a day 5 
mouse wound (Shaw and Martin, 2009).  
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1.6.4 The remodelling phase 
The remodelling phase is characterised by the change of ECM composition 
(Figure 1.12). Type III collagen forms the predominant collagen synthesised by 
fibroblasts during early wound healing (Kondo and Ishida, 2010). This is 
gradually replaced by type I collagen over a period of 12 months, and re-
establishes to a level of approximately 70% (Abercrombie et al., 1960; Li et al., 
2007). This process of degradation and synthesis is performed by MMPs (Li et 
al., 2007). Further remodelling of the wound causes a decrease in MMPs and 
an increase in tissue inhibitors of MMPs (TIMPs) (Gill and Parks, 2008). There 
is a reduction in myofibroblasts (Hinz, 2007) and macrophages (Ma et al., 
2003), whilst blood flow to the area is reduced (Enoch, 2008) and matures to a 
functional vascular network (Shaw and Martin, 2009). As the scar matures, 
fibronectin (Kischer and Hendrix, 1983) and hyaluronan (Messadi and 
Bertolami, 1993) are degraded and collagen bundles increase in diameter, 
resulting in increased tensile strength; a maximum of 80% pre-injury strength 
can be achieved (Enoch, 2008). 
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Figure 1.12 – The remodelling phase. The remodelling phase is characterised 
by the change of extracellular matrix composition. Type III collagen is gradually 
converted to type I collagen by MMPs. There is a reduction in myofibroblasts 
and macrophages, whilst blood flow to the area is reduced and matures to a 
functional vascular network. Fibronectin and hyaluronan are degraded whilst 
collagen bundles increase in diameter, resulting in increased tensile strength to 
a maximum of 80% pre-injury strength. Photomicrograph illustrates collagen 
(stained with Masson’s trichrome stain) (Shaw and Martin, 2009). 
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1.7 The molecular regulation of wound healing 
Beyond the classical staged description of wound healing, it is now widely 
appreciated that there are a wide variety of transcriptional regulators and genes 
that orchestra the healing process through its various sequential phases (Cole 
et al., 2001; Cooper et al., 2005; Schafer and Werner, 2007; Thorey et al., 
2001). 
 
 1.7.1 Transcriptional regulation of re-epithelialization  
A multitude of transcription factors have been shown to modulate the wound 
healing process through effects on keratinocyte proliferation and migration, 
including c-Fos, c-Jun, c-Myc, Smads (discussed in section 1.9.7) and 
peroxisome proliferator-activated receptors. Components of the activating 
enhancer binding protein-1 (AP-1) group of transcription factors, including c-Fos 
and c-Jun have been shown to be up-regulated in the wound margin following 
skin injury in both murine (Martin and Nobes, 1992; Schafer and Werner, 2007; 
Tsuboi et al., 1990) and human wounds (Kondo et al., 2000), with subsequent 
effects on MMP, integrin, and growth factor production (Angel et al., 2001; 
Gangnuss et al., 2004; Schafer and Werner, 2007). This increased expression 
is thought to play roles in keratinocyte migration, as the expression of both c-
Jun and c-Fos is increased during dorsal closure of Drosophilia embryos (Martin 
and Parkhurst, 2004; Schafer and Werner, 2007). Furthermore, knock-out of c-
Jun in mice leads to retardation of wound healing (Li et al., 2003), whilst knock-
out of a co-activator that is associated with c-Fos and c-Jun leads to the 
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development of chronic wounds (Mahajan et al., 2004; Schafer and Werner, 
2007).   
c-Myc is a transcription factor involved in the control of cell proliferation and 
apoptosis (Luscher, 2001). Levels of this transcription factor are up-regulated 
following wounding (Tsuboi et al., 1990), where it is thought to play roles in 
modulating keratinocyte proliferation and migration (Waikel et al., 2001; Zanet 
et al., 2005). Indeed, constitutive over-expression of c-Myc in the epidermis led 
to a depletion of epidermal stem cells. In contrast, the c-Myc antagonist Mad1 is 
strongly up-regulated in suprabasal keratinocytes following skin injury, where it 
is thought to promote re-differentiation of newly repaired epidermis (Schafer and 
Werner, 2007; Werner et al., 2001). 
Peroxisome proliferator–activated receptors (PPARs) are a group of 
transcription factors, which act as downstream targets of AP-1 signalling 
(Schafer and Werner, 2007; Tan et al., 2001). They are restricted to HF 
keratinocytes in adult skin (Michalik et al., 2001), but their expression is strongly 
up-regulated in keratinocytes after skin injury, an effect induced by TNF-α (Tan 
et al., 2001). Knock-out of PPARβ impairs wound healing due to defective 
keratinocyte migration (Gurtner et al., 2008; Icre et al., 2006; Michalik et al., 
2001; Tan et al., 2005), whilst proliferation was increased, potentially due to 
effects on MMP-9 expression (Tan et al., 2005; Schafer and Werner, 2007).  
Other transcription factor groups noted to be important include members of the 
E2F family, which regulate cell cycle progression (Fang and Han, 2006). Levels 
of E2F-1 and E2F-2 have been found to be much higher in the margin of human 
wounds than in adjacent unwounded epidermis (D'Souza et al., 2002; Schafer 
and Werner, 2007). Additionally, knock-out of signal transducer and activator of 
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transcription 3 (Stat3) impairs wound closure due to impaired keratinocyte 
migration (Gurtner et al., 2008; Sano et al., 2005; Schafer and Werner, 2007).  
 
1.7.2 Transcriptional regulation of acute inflammation 
Many transcriptional regulators have been demonstrated to regulate the 
inflammatory phase of acute wound healing. Deletion of Smad3 has been 
shown to reduce inflammatory cells in the wound (Ashcroft et al., 1999), 
suggesting that it is vital in regulating the inflammatory response. In addition, 
both Smad2 and Smad4 have been shown to epigenetically regulate IL-9 
expression, which plays roles in regulating T-cell proliferation, immunoglobulin 
production and cytokine secretion (Wang et al., 2013). Furthermore, PPARα 
has been demonstrated to regulate inflammation, as knockout of this gene 
delays wound healing due to an exaggerated inflammatory response (Michalik 
et al., 2001).  
NF-E2-related factor 2 (Nrf2) is a transcription factor involved in the regulation 
of oxygen-free radical degradation through the stimulation of superoxide 
dismutase (Kwak et al., 2001; Schafer and Werner, 2007). This gene has been 
shown to be up-regulated in response to cutaneous injury (Braun et al., 2002; 
Pedersen et al., 2003), and when deleted, macrophage presence in the wound 
is prolonged (Braun et al., 2002). NF-KB represents an important transcriptional 
regulator of chronic inflammation, as it increases the expression of the genes 
for many cytokines, enzymes, and adhesion molecules including inducible nitric 
oxide synthase, intercellular adhesion molecule 1, vascular-cell adhesion 
molecule 1, and E-selectin (Barnes, 1997).  
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 1.7.3 Transcriptional regulation of skin remodelling 
Healing wounds undergo drastic histological changes during the remodelling 
phase and there is a corresponding variety of transcription factors that are 
involved in this process. c-Myb is a transcriptional activator (Oh and Reddy, 
1999) that is up-regulated following skin injury (Kopecki et al., 2007), where it 
plays roles in modulating fibroblast proliferation and collagen synthesis (Kopecki 
et al., 2007).  HoxB13, a homeobox gene family member, is also thought to play 
roles in regulating collagen and hyaluronan synthesis (Stelnicki et al., 1998a), 
leading to increased scar tissue formation (Mack et al., 2003).  
β-catenin is a transcriptional co-activator that associates with other transcription 
co-factors (T cell factors (TCF)/lymphoid enhancer factors (LEF) to modulate 
gene expression through the Wnt signalling cascade (Bielefeld et al., 2013; 
Fuchs and Raghavan, 2002; MacDonald et al., 2009; Millar, 2002; Noramly et 
al., 1999). Analogous to their importance in epidermal and hair development, 
Wnt and β-catenin also play key roles in dermal reconstitution (Bielefeld et al., 
2013). Wnts 1, 3, 4, 5a and 10b are expressed in the wound margin, whilst Wnt 
10b is expressed in migrating keratinocytes (Okuse et al., 2005). However, Wnt 
4 is expressed in the healing dermis (Okuse et al., 2005). β-catenin is an 
important regulator of fibroblast activity, and elevated levels have been found in 
both murine and human wounds, together with their target genes (Cheon et al., 
2005; Cheon et al., 2002). Constitutively-activating mutations in β-catenin have 
been shown to induce massive fibroblast proliferation, migration and 
fibromatosis (Alman et al., 1997). Wounds in transgenic (TG) mice over-
expressing β-catenin were histologically similar to hypertrophic and keloid 
scars, with increased collagen and fibroplasia (Cheon et al., 2002; Schafer and 
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Werner, 2007). Furthermore, levels of β-catenin and TCF transcription factors 
were found to be elevated in fibroblasts during the proliferative phase of wound 
repair (Cheon et al., 2002), suggesting that β-catenin is an important regulator 
of scarring.  
The Notch pathway is involved in determining cell fate through cell-cell 
interactions using its ligands Serrate1 and Serrate2, particularly of the HF IRS 
and ORS (Kopan and Weintraub, 1993; Lin et al., 2000; Millar, 2002). The 
genes encoding Notch1, a membrane protein involved in determining cell fate 
through cell-cell interactions and intracellular signal transduction, and its ligands 
Serrate1 and Serrate2, are expressed in matrix cells destined to form the IRS 
and hair shaft (Kopan and Weintraub, 1993). It is also important in skin healing 
as Notch ligands are expressed in wounds (Thelu et al., 2002), whilst TG over-
expression impairs would closure through effects on fibroblast migration, 
angiogenesis and macrophage recruitment (Chigurupati et al., 2007; Outtz et 
al., 2010).  
The Shh pathway forms a key signalling cascade in embryogenesis that is 
responsible for the development of organs including the skin and hair follicle 
(Bitgood and McMahon, 1995; Callahan and Oro, 2001; Dlugosz, 1999; Millar, 
2002; St-Jacques et al., 1998). Two transmembrane proteins mediate the Shh 
signal: Patched 1 and 2 (PTCH1 and 2) and Smoothened (SMO). In the 
absence of a signal, PTCH1 and PTCH2 inhibit the SMO signal transducer 
(Ingham and McMahon, 2001; Oro and Higgins, 2003). SMO inactivation leads 
to formation of the cytoplasmic Gli degradation complex. Phosphorylated Gli is 
mediated for ubiquination (Bhatia et al., 2006; Dlugosz, 1999). Shh binds to 
PTCH1 and PTCH2, which releases the SMO signal transducer from PTCH-
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mediated suppression, and inhibits assembly of the Gli degradation complex, 
resulting in the transcription of target genes (Osterlund et al., 2004).  
During wound repair, Shh has been shown to increase fibroblast activity, 
vascularity, collagen deposition and nitric oxide activity when topically 
administered to diabetic mouse wounds (Asai et al., 2006; Luo et al., 2009). 
Furthermore, cyclopamine, a Shh inhibitor, has been shown to delay wound 
healing by reducing granulation tissue formation, vascularity and proliferation 
(Le et al., 2008). 
 
1.8 Hair follicles and wound healing 
It is well established that wounds created in hair-bearing regions heal faster 
than in those devoid of HFs (Brown and McDowell, 1942; Ito and Cotsarelis, 
2008; Martinot et al., 1994; Stojadinovic et al., 2011), whilst healing in murine 
models is maximal if created during the anagen phase of hair growth (Ansell et 
al., 2011; Jaks et al., 2010; Zawacki and Jones, 1967). Epidermal loss with 
preservation of evenly-spaced HFs results in rapid epithelialization and healing, 
as seen in superficial dermal burn injuries (Papini, 2004). This phenomenon 
also underpins split thickness skin-grafting where, after removal of the 
epidermis and a variable depth of dermis from healthy skin, the donor region 
repairs epidermis from sweat glands and hair follicle remnants  (Figure 1.13) 
(Jahoda and Reynolds, 2001).  
Skin injury results in the activation of follicular epithelial cells, which 
subsequently migrate to the epidermal defect to assist in skin regeneration (Ito 
and Cotsarelis, 2008). In this situation, intact HFs provide islands for epidermal 
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proliferation and recovery within the wound, as opposed to marginal healing 
alone (Langton et al., 2008). However, full-thickness dermal injury and loss of 
HF integrity, as seen in full-thickness burns, results in delayed wound healing 
from the skin margins.  
 
Figure 1.13 – Split-thickness skin graft donor site healing illustrating 
epithelialization from hair follicle islands. (a) Day 1 post-graft harvest 
illustrating inflammation; (b) Day 6 post-graft harvest with evidence of 
granulation; (c) Day 14 post-graft harvest with re-epithelialization visible from 
intact hair follicle remnants. Scale bar 400µm (Schreml et al., 2010).   
 
Epidermal replenishment following injury is controlled by stem cell populations 
resident in the IFE and HF bulge, the deepest permanent portion of the follicle 
(Cotsarelis, 2006; Cotsarelis et al., 1990; Ito and Cotsarelis, 2008; Ito et al., 
2005; Myers et al., 2007). The bulge is seen as a thickening of the ORS in 
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human HFs, below the opening of the sebaceous gland at the attachment site of 
the arrector pili muscle (Cotsarelis, 2006; Kasper et al., 2011). It is identified by 
a variety of markers, including cluster of differentiation-34 (CD34) in mouse skin 
(Kloepper et al., 2008; Trempus et al., 2003), CD200 in human skin (Kloepper 
et al., 2008), transcription factor-3 (tcf-3) (Nguyen et al., 2006), LIM/homeobox 
protein 2 (Lhx2) (Kloepper et al., 2008; Rhee et al., 2006), Leucine-rich repeat-
containing G-protein coupled receptor 6 (Lgr6) (Snippert et al., 2010) and 
Krt15/19 (Jaks et al., 2010; Kloepper et al., 2008; Lyle et al., 1998; Plikus et al., 
2012; Waters et al., 2007) (Figure 1.14). The anatomical architecture of the 
follicle aids this regeneration process; the ORS is continuous with the IFE, 
facilitating migration of stem cell progeny to the epidermal defect (Cotsarelis, 
2006). These stem cells are characterised by the property of quiescence 
(Waters et al., 2007) and high proliferative potential (Lavker and Sun, 2000; 
Ohyama, 2007; Rochat et al., 1994; Wong and Reiter, 2011), and have been 
shown to remain dormant for several months (Lyle et al., 1998; Morris and 
Potten, 1999) in both mouse and human HFs.  
Within adult skin, the bulge is regarded as the major site for epithelial stem cells 
(Lau et al., 2009). However, in embryonic skin the IFE contains a higher 
proliferative potential, and there is a shift in stem cell location from embryonic 
epidermal cells to adult follicular bulge cells (Lau et al., 2009). The number of 
colony-forming units within the IFE decreases following birth, whilst that of the 
HF increases (Lau et al., 2009). This change has been correlated with the 
expression of Krt15, which is initially expressed in the IFE and subsequently 
moves to the HF bulge (Lau et al., 2009; Liu et al., 2003).  
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Figure 1.14 - Schematic illustration of stem cell locations in the telogen 
adult HF. Skin epithelia feature distinct stem cell populations both in epidermis 
and in hair follicles. The isthmus and junctional zone contain Lrig1+ (yellow), 
Gli1+ and Lgr6+ stem cells (green), all of which physiologically maintain the 
isthmus and contribute to sebaceous gland, infundibulum and in some instance 
to inter-follicular epidermis. Blimp1 identifies unipotent sebaceous gland 
progenitors (orange). The bulge stem cells (blue) normally contribute to all hair 
follicle lineages and can be identified based on the expression of Krt15, CD200, 
Lgr5, CD34, Sox9, Lhx2, Tcf3 and Nfatc1. The secondary germ of telogen hair 
follicles (purple) contains committed hair follicle-fated progenitors that express 
CD200, Gli1 and Lgr5 (Plikus et al., 2012). 
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Within the IFE, basal stem cells produce a transit-amplifying population of 
keratinocytes with limited proliferative capacity, forming an architectural division 
known as an epidermal proliferative unit (EPU) (Cotsarelis, 2006; Fuchs, 2008; 
Potten, 1974). This is architecturally defined as a bed of 10 tightly packed basal 
cells yielding a stack of increasingly larger and flatter cells that culminate with a 
single hexagonal surface cell (Figure 1.15) (Potten, 1974; Fuchs, 2008). These 
stem cells give rise to daughter cells that undergo several divisions before 
migrating to the superficial layers of the epidermis, and undergoing terminal 
differentiation via Notch/p63 cross-talk (Lau et al., 2009; Levy et al., 2007; 
Nguyen et al., 2006). The IFE stem cell population is principally concerned with 
the maintenance of epidermal homeostasis (Ito et al., 2005). Their ability to 
exhibit phenotypic plasticity, however, has been demonstrated (Yu et al., 2006; 
Yu et al., 2010a).  
 
Figure 1.15 - Relationship between epidermal and hair follicle stem cells 
during homeostasis. During normal conditions, epidermal renewal is 
dependent on cell proliferation within epidermal proliferative units (EPUs), which 
are clonal populations of cells roughly arranged in hexagonally shaped columns 
that  culminate with a single hexagonal surface cell (Cotsarelis, 2006).  
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Conversely, bulge stem cells do not contribute to epidermal homeostasis, but 
become inherently involved in the processes of epithelial regeneration following 
injury (Cotsarelis, 2006; Ito and Cotsarelis, 2008; Ito et al., 2005; Wong and 
Reiter, 2011), principally due to their proliferative capacity and strategic location 
(Figure 1.16). Cell labelling has illustrated migration of stem cell progeny from 
the follicular bulge to the infindibulum (Taylor et al., 2000), epidermis (Tumbar 
et al., 2004) and epidermal defect (Ito et al., 2005).  
There does, however, appear to be a differential contribution to epithelial 
healing from different sub-populations within the HF (Cotsarelis, 2006; Ito and 
Cotsarelis, 2008). Using an inducible Krt15 promoter to drive Cre recombinase 
to the bulge cells, Ito et al. (2005) demonstrated that HF bulge cells migrated to 
the epidermis following wounding. Approximately one quarter of cells seen in 
the re-epithelialized wound originated from the HF bulge (Ito et al., 2005; Ito and 
Cotsarelis, 2008), acting as transient-amplifiers for a short period following 
injury. In contrast, non-bulge derived follicular keratinocytes from the IFE persist 
within the healed epidermis for several months, donating a permanent 
keratinocyte population and forming EPUs following injury (Cotsarelis, 2006; 
Levy et al., 2007; Ito and Cotsarelis, 2008). 
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Figure 1.16 - Relationship between epidermal and hair follicle stem cells 
after wounding. Upon wounding, Lrig1 positive (yellow), Lgr6 positive (green) 
and Krt15 positive bulge stem cells (blue) in nearby hair follicles become 
activated and generate progeny that migrate out of the follicles and participate 
in rapid wound re-epithelialization (Plikus et al., 2012). 
 
An absence of HFs has been shown to be detrimental to wound healing but not 
to epidermal integrity and homeostatic maintenance. Split-thickness skin grafts 
harvested from the scalp, containing both epidermis and a variable thickness of 
dermis, heal at a faster rate than those harvested from sparse hair-bearing 
areas (Mimoun et al., 2006; Waters et al., 2007; Weyandt et al., 2009).  
Targeted destruction of bulge cells does not affect epidermal viability and 
integrity (Ito et al., 2005). However, studies of mutant Edaradd mice which lack 
tail skin adnexae revealed impaired wound healing; an absence of HFs results 
in an extended epidermal response time (Langton et al., 2008), and enhanced 
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keratinocyte recruitment from the interfollicular epidermis. Knock-out of c-myc, a 
transcription regulator of epidermal stem cell fate, delays re-epithelialization, 
due to the inability of IFE stem cells to produce daughter keratinocytes (Lau et 
al., 2009; Schafer and Werner, 2007). In addition, it is worth noting that follicular 
epidermal cells accelerate wound repair by other mechanisms, and have been 
shown to remove clotted blood and damaged stroma following epidermal injury 
through alteration in connexin expression (Goliger and Paul, 1995; Lau et al., 
2009). 
Clinical evidence is now emerging of the potential role that bulge-derived stem 
cells may play in the management of both acute and chronic wounds.  Murine 
models have illustrated that transplantation of stem cells from the HF bulge can 
repopulate the epidermis, sebaceous glands, and the epithelial layers of the HF 
(Oshima et al., 2001). Kurata et al. (1994) cultured human HF ORS cells and 
applied to murine and human burn wounds, resulting in epithelial differentiation 
and the formation of a multi-layered neo-epidermis. EpiDex™ (Renner et al., 
2009; Tausche et al., 2003) is an autologous epidermal equivalent produced by 
culturing the ORS cells of the patients own hair. Small tissue discs are 
produced, which can be used to provide wound coverage. This method is, 
however, limited by a prolonged culture time of four weeks, making this an 
unfeasible option for early wound cover.  
Navsaria et al. (2004) conducted a study whereby whole HFs were implanted in 
Integra™ (dermal matrix composed of bovine type 1 collagen and shark 
chondroitin-6-sulphate); this composite was subsequently used to reconstruct a 
full-thickness scalp injury. Re-epithelialization in this case was attributed to HF 
stem cell activity, though full epithelial closure required skin graft application. 
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Whilst the contribution of bulge stem cells in this paper is contentious, it does 
highlight the potential clinical role for HF autografts to be used in conjunction 
with a dermal matrix in burn reconstruction. Spector and Glat (2007) conducted 
a similar study, attempting to reconstruct a scalp defect using Integra™ and hair 
micrografts. Hair grew successfully, but the contribution of bulge-derived stem 
cells once again cannot be distinguished in this case due to the early 
application of a skin graft. However, these studies do highlight the possibility of 
using HFs and cultured HF stem cells to treat skin injuries and some groups are 
already ascertaining which hair-bearing areas will provide the highest yield of 
stem cells when this area expands in the future (Lavoie et al., 2011).   
 
1.9 Bone morphogenetic proteins 
BMPs are members of TGF-β superfamily and are involved in the regulation of 
proliferation, differentiation and apoptosis (Botchkarev, 2003; Hay et al., 2004), 
as well as acting as potent tumour suppressors (Sharov et al., 2009). There are 
over 20 different BMP ligands belonging to the TGF-β superfamily, each of 
which plays a key role in embryonic development and postnatal remodelling of 
structures including the skin (Botchkarev, 2003; Botchkarev and Sharov, 2004; 
Massague, 1998) and bone (Kinsella et al., 2011). Dysfunction of BMP 
signalling is associated with a variety of conditions, including diabetes 
(Caperuto et al., 2008), vascular calcification (Son et al., 2011) and pulmonary 
hypertension (Kim and Choe, 2011).  
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1.9.1 BMP structure and subgroups 
The different BMPs can be sub-grouped according to the homology in their 
sequence and functions (Miyazono et al., 2010). The first group includes BMP-2 
and BMP-4 (BMP-2/4 group). BMP-5, BMP-6, BMP-7 (also known as 
osteogenic protein-1, OP-1) and BMP-8 (OP-2) form the OP-1 group. Growth-
differentiation factor-5 (GDF-5), GDF-6 and GDF-7 (BMP-12) form the GDF-5 
group (Miyazono et al., 2010). Differing BMPs vary both in their spatiotemporal 
expression and biological activity, as they can bind to receptors with differing 
affinity.    
BMPs are expressed as large precursor proteins; the raw molecule carries an 
N-terminal signal peptide, which directs the protein to the secretory pathway, a 
pro-domain that ensures correct folding, and the C-terminal mature peptide 
(Sieber et al., 2009). Each monomer, consisting of approximately 100-140 
amino acids (Botchkarev, 2003; Celeste et al., 1990) is stabilised by three intra-
molecular disulphide bonds formed between six highly conserved cysteines, a 
structure known as the cysteine knot motif (Sieber et al., 2009). The active 
signalling molecule is typically formed through homodimerization. Dimers are 
covalently linked via a disulphide bond, requiring a seventh conserved cysteine 
within each monomer. Exceptions include GDF-9, BMP-15 and GDF-3, which 
lack the seventh cysteine but are biologically active. Heterodimerization has 
been observed in BMP-2/5, BMP-4/7, BMP-2/6 and BMP-2/7 (Sieber et al., 
2009); these heterodimers are more effective than when homodimers are 
formed (Butler and Dodd, 2003; Israel et al., 1996). 
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1.9.2 BMP receptors and signalling cascades 
BMPs bind to heterodimeric receptor complexes composed of type I and type II 
transmembrane serine/threonine kinase receptors (Sieber et al, 2009). Six 
different receptors have been identified to bind BMPs. Type I receptors include 
Activin receptor type Ia (ActRIa or Alk2), BMP receptor 1A (BMPR-1A or Alk3) 
and BMP receptor 1B (BMPR-1B or Alk6). They form heterodimeric complexes 
with type II receptors; BMP receptor II (BMPR-II) and Activin receptors type IIA 
and IIb (ActRIIA and ActRIIB) (Miyazono et al., 2010). BMPR-1A, BMPR-1B and 
BMPR-II are specific for BMP signalling, and within the skin, are found 
distributed through the suprabasal epithelial cell layers and HF bulge; however 
expression is limited to developing follicles in fetal skin (Hwang et al., 2001). 
BMP ligands bind type I and II receptors with differing affinity, with BMP-2 and 
BMP-4 preferentially binding to BMPR-1A and BMPR-1B, whilst BMP-7 
preferentially binds to type II receptors (Knaus and Sebald, 2001; Koenig et al., 
1994; Sieber et al., 2009).  
The receptors contain an extracellular ligand binding domain and an 
intracellular serine/threonine kinase domain. The type I receptors carry a 
glycine/serine-rich region preceding the kinase domain (GS-box) and a short 
region of eight amino acids, termed the L45 loop, within its kinase domain. The 
type II receptors are constitutively active, whilst activation of the type I receptors 
requires ligand binding, ligand-receptor oligomerization and 
transphosphorylation of the GS-box by the type II receptor (Shimasaki et al., 
2004). Phosphorylation of the intracellular domain of type I receptors by type II 
receptor kinases leads to the transmission of the intracellular signal through 
canonical and non-canonical BMP pathways (Botchkarev, 2003) (Figure 1.17). 
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Following binding of BMP to cell surface receptors, two different signal 
transduction pathways may be activated; the ‘canonical’ pathway that includes 
Smad proteins, or the ‘non-canonical’ BMP-mitogen-activated protein kinase 
(BMP-MAPK) pathway (Botchkarev, 2003). Binding to preformed receptor 
complexes induces signal transduction via the BMP-Smad pathway, whilst 
binding to BMPR-I with subsequent recruitment of BMPR-II results in BMP-
MAPK pathway activation (Botchkarev, 2003; Hassel et al., 2003; Nohe et al., 
2002).  
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Figure 1.17 – The ‘canonical’ BMP-Smad and ‘non-canonical’ BMP-MAPK 
pathways of BMP activation. Binding of free BMP to BMPRs activates either 
the BMP–Smad (left) or BMP–MAPK (right) signalling pathway. The BMP–
Smad pathway includes recruitment and phosphorylation of R-Smad followed 
by the formation of their complexes with Co-Smad and translocation into the 
nucleus to regulate gene transcription.  The BMP–MAPK pathway focuses on 
recruitment of XIAP, TAB1 and TAK1 kinase, which in turn may activate 
apoptosis via the p38/Jnk pathway. XIAP - X-linked inhibitor of apoptosis 
protein; TAK1 - TGF-β Activated Kinase 1; TAB1 - TAK1-binding protein 1; 
BRAM1 - BMP receptor-associated molecule 1 (Botchkarev and Sharov, 2004).  
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The BMP-Smad ‘canonical’ pathway is activated following BMP binding to the 
heteromeric BMPR complex. BMPR-II phosphorylates the glycine/serine-rich 
domain of the type I receptors, which results in phosphorylation of specific 
Smad proteins (Smad1, Smad5, and Smad8) (Botchkarev, 2003). Three 
subclasses of Smad proteins have been identified; receptor-regulated Smads 
(R-Smads), common mediator-Smads (co-Smad) and inhibitory Smads (I-
Smads) (Sieber et al., 2009). Smad1/5/8, the R-Smad group, are 
phosphorylated by BMPR-I kinases and then form heteromeric complexes with 
Smad4 (Co-Smad). The R-Smad/Co-Smad complex subsequently translocates 
to the nucleus to regulate transcription of BMP-responsive genes, including 
MMPs and Wnt signalling components (Fessing et al., 2010; Massague et al., 
2005; Sieber et al., 2009). R-Smads contain two preserved domains, the N-
terminal MH1 and C-terminal MH2 domain (Sieber et al., 2009), which are 
connected by a proline-rich link. The MH1 domain regulates DNA binding, whilst 
the MH2 domain is principally concerned with R-Smad specificity and Smad 
oligomerization (Massague, 2003; Sieber et al., 2009). Smad6 and Smad7 (I-
Smad) antagonise the phosphorylation of R-Smads (Botchkarev, 2003). 
Endogenous levels of R-Smad are controlled by Smad ubiquitination regulatory 
factor-1 (Smurf1), which interacts with Smad1 and Smad5 to promote their 
degradation (Botchkarev, 2003; Zhu et al., 1999). 
The BMP-MAPK ‘non-canonical’ signalling pathway is activated when BMPs 
bind to one of the BMPR-I types, followed by the subsequent recruitment of 
BMPR-II (Botchkarev and Sharov, 2004; Nohe et al., 2002).The activated 
BMPR complex may interact with intracellular adaptor proteins XIAP and 
BRAM1, which link BMP receptors with TAB1 (TAK1 binding protein), which 
activates TAK1 (TGF-β activated kinase 1) (Botchkarev and Sharov, 2004; 
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Morita et al., 2001; Sieber et al., 2009; Yamaguchi et al., 1999). TAK1 is a 
member of the MAPK family, whose activity is also stimulated by TGF-β1. TAK1 
activates the p38 and JNK pathways, which are involved in BMP-induced 
apoptosis (Kimura et al., 2000; Zhang et al., 2006).     
 
1.9.3 BMP antagonists  
The interaction of BMP ligands with BMPRs is controlled by the presence of 
circulating endogenous antagonists. These include Noggin, chordin, follistatin 
and the Cerberus/DAN family of proteins, all of which belong to distinct protein 
groups (Botchkarev, 2003; Massague and Chen, 2000). However, these 
antagonists display a higher affinity for BMP ligands than the BMPRs, acting as 
competitive antagonists and restricting ligand-receptor interaction (Botchkarev, 
2003). Chemical compounds mimicking the action of BMP antagonists, 
including dorsomorphin (Boergermann et al., 2010) have been developed, and 
have been shown to attenuate both the Smad and MAPK-mediated signalling 
pathways.  
Noggin is a secreted homodimeric glycoprotein BMPR antagonist consisting of 
222 amino acids, encoded by the NOG gene (Botchkarev, 2003; Krause et al., 
2011). It plays important roles in development and postnatal tissue remodelling, 
acting as a pleiotropic factor (Krause et al., 2011). The structure of Noggin is 
that of an acidic amino-terminal and a cysteine rich carboxy-terminal region 
(Krause et al., 2011). The presence of cysteine knots allows Noggin to assume 
a structure, which can bind to BMP ligands; this prevents BMP binding to both 
type I and type II BMPRs (Groppe et al., 2002; Krause et al., 2011). However, 
Noggin binds with varying affinities to the various BMP ligands, preferentially 
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inhibiting BMP-2, -4, -5, -7, -13 and -14 (Botchkarev, 2003; Gamer et al., 2005; 
Krause et al., 2011; Song et al., 2010), whereas BMP-3, -6, -9, -10 and -15 
remain unaffected.  
Noggin is essential for the development of ectoderm-derived structures, 
including the neural tube (McMahon et al., 1998), tooth (Tucker et al., 1998), HF 
(Botchkarev et al., 1999) and eye (Gerhart et al., 2009; Sharov et al., 2003). 
Within the mesoderm, Noggin expression is critical in the mediation of 
embryonic chondrogenesis, osteogenesis and joint formation (Gong et al., 
1999; Krause et al., 2011; Tylzanowski et al., 2006). Noggin-null mice exhibit 
neural tube defects, HF retardation and skeletal dysmorphogenesis (Krause et 
al., 2011; McMahon et al., 1998; Plikus et al., 2004). Indeed, mutations of the 
NOG gene have been implicated in human skeletal dysplastic conditions, 
including proximal symphalangism and multiple synostosis syndrome 1 (Krause 
et al., 2011; Marcelino et al., 2001; Potti et al., 2011).  
Chordin is a 120 kDa protein, which binds to BMP-2 and BMP-4, though with a 
lower affinity than that seen with Noggin (Botchkarev, 2003; Piccolo et al., 
1997). The chordin-BMP complex can be cleaved by BMP-1 metalloprotease, 
with subsequent release of active BMP (Botchkarev, 2003; Kessler et al., 1996; 
Piccolo et al., 1997). However, the Noggin-BMP complex cannot be 
deconstructed in the same manner (Botchkarev, 2003; Wardle et al., 1999).  
Follistatin is a 35 kDa dimeric protein that preferentially binds activin, a member 
of the TGF-β family (Patel, 1998; Wankell et al., 2001). However, it also binds 
BMP-2, -4, -7 and -15 with lower affinity, preventing their interaction with 
BMPRs (Botchkarev, 2003). BMP signalling may also be blocked by BAMBI 
(BMP and activin membrane bound inhibitor), a pseudo-receptor with an extra-
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cellular domain similar to that found in type I BMPRs (Botchkarev, 2003; 
Onichtchouk et al., 1999). 
 
1.9.4 BMPs in skin development & postnatal remodelling 
BMP ligands and signalling cascades are essential for early embryonic 
development and further postnatal remodelling (Botchkarev, 2003), 
demonstrated by their extensive presence in the mesoderm and ectoderm. 
Such is their importance in early development that targeted deletion of BMP-2 
(Zhang and Bradley, 1996), BMP-4 (Winnier et al., 1995), BMP-7 (Dudley et al., 
1995), BMPR-1A/1B (Mishina et al., 1995; Yi et al., 2000) and Smad1/4/5 
(Chang et al., 1999; Lechleider et al., 2001; Sirard et al., 1998) results in 
embryonic lethality due to varying organ dysfunction.   
BMP ligands and receptors are differentially expressed within developing 
human and murine skin, with BMPR-1A seen in the basal epidermis, whilst 
BMPR-1B expression is restricted to suprabasal keratinocytes (Botchkarev, 
2003; Botchkarev et al., 1999). BMP-6 mRNA expression is seen in the 
suprabasal layers of mouse epidermis at E15.5 (Botchkarev, 2003; Wall et al., 
1993), whilst BMP-7 mRNA is seen in basal epidermal layers (Takahashi and 
Ikeda, 1996); this suggests that both BMPR-1B and BMP-6 facilitate 
keratinocyte differentiation, whilst BMPR-1A and BMP-7 play roles in 
proliferation within the epidermis (Panchision et al., 2001). The expression of 
BMP-2 is limited to the HF epithelium, whilst BMP-4 is seen within the 
mesenchyme (Bitgood and McMahon, 1995). In addition, components of the 
BMP-Smad pathway (Smad1/5/6) are expressed in developing skin, further 
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supporting the role of BMP in epidermal development (Botchkarev, 2003; Dick 
et al., 1998; Flanders et al., 2001). 
There does, however, appear to be a delicately balanced mediation of BMP-
induced epidermal development, based on their levels of expression 
(Botchkarev, 2003). Targeted over-expression of BMP-6 in murine skin 
(Blessing et al., 1996) results in marked inhibition of epidermal proliferation. 
Moderate BMP-6 expression stimulates proliferation of basal keratinocytes and 
leads to ectopic cellular proliferation, a paucity of Krt1 and Krt10 differentiation 
markers, abnormal expression of Krt6, Krt14 and Krt16 in the suprabasal layers 
(Blessing et al., 1996; Botchkarev, 2003), and  impeded cutaneous wound 
healing (Kaiser et al., 1998). The constitutive over-expression of the BMP 
antagonist Noggin confirms this data. Krt14 promoter-mediated Noggin over-
expression in the epidermis results in epidermal hyperplasia, due to increased 
basal keratinocyte proliferation (Plikus et al., 2004; Sharov et al., 2009). In 
addition, Noggin knock-out mice demonstrate epidermal proliferation and 
ectopic Krt14 expression in the suprabasal epidermis (Botchkarev, 2003; 
Botchkarev et al., 1999); thus, it appears that the effects of BMP in epidermal 
regulation are dose dependent.     
In postnatal human and murine skin, expression of BMPR-1B and BMPR-II is 
strictly limited to the suprabasal epidermal layers (Botchkarev, 2003; Hwang et 
al., 2001), and appears to stimulate differentiation and attenuate proliferation. 
Chemical-induced differentiation of mouse primary keratinocytes is 
accompanied by increased BMP-2 (Park and Morasso, 2002) and BMP-6 
expression (Wach et al., 2001). However, treatment of mouse keratinocytes 
with BMP-6 inhibits cell growth and DNA synthesis (Botchkarev, 2003; Drozdoff 
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et al., 1994; Fessing et al., 2010). In addition, treatment of cancer cell lines with 
BMP-2 and BMP-4 attenuates cell proliferation and migration (Ahmed et al., 
2011; Jiang et al., 2011). Thus, BMPs stimulate the differentiation of postnatal 
skin, but suppress keratinocyte proliferation.  
 
 1.9.5 The role of BMPs in hair follicle embryogenesis 
BMP ligands and signalling pathways play critical roles in the development of 
ectodermal derivatives including feathers and HFs (Botchkarev, 2003; Fuchs et 
al., 2001; Millar, 2002). The varied phenotype of TG mice either over-
expressing or inhibiting BMP signalling illustrates this fact. Noggin knock-out 
mice lack approximately 90% of HFs (Botchkarev et al., 1999); over-expression 
of the BMP antagonist within the epidermis results in increased HF density, 
smaller eyelids, ectopic cilia, claw hyperpigmentation, interdigital webbing, 
transdifferentiation of sweat glands into HFs and increased genitalia size 
(Botchkarev and Sharov, 2004; Plikus et al., 2004).    
HF development is based on eight consecutive stages (Paus and Cotsarelis, 
1999), which in mice, results in the formation of four distinct hair types; guard, 
awl, auchene and zig-zag (Botchkarev and Sharov, 2004). Of these 
developmental stages, BMP signalling is essential for the processes of initiation, 
cell lineage commitment and cell differentiation (Botchkarev and Sharov, 2004).  
During the induction stage of follicular development, BMP-2 and BMPR-1A are 
expressed in the hair placode (Botchkarev and Sharov, 2004; Lyons et al., 
1989, 1990), whereas BMP-4 and Noggin are expressed in the dermal 
condensate (Botchkarev et al., 1999; Botchkarev and Sharov, 2004). Noggin 
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acts as a mesenchymally-derived stimulator of HF induction, evidenced by an 
increased HF density in TG mice over-expressing Noggin (Plikus et al., 2004). 
In comparison, Noggin knock-out mice display a lack of induction of all 
secondary (non-tylotrich) HFs, whereas primary (tylotrich) follicles exhibit 
increased apoptosis (Botchkarev et al., 1999; Guha et al., 2004), illustrating the 
important stimulatory effect this glycoprotein has. Downstream components of 
complementary signalling cascades are found to be altered in Noggin TG 
models. Furthermore, BMP-6 contributes to HF induction and growth through 
stimulatory actions on dermal papilla cells (Rendl et al., 2008).  
Lymphoid enhancer binding factor 1 (LEF-1) is an important component of the 
Wnt/β catenin pathway and plays critical roles in HF development (Fuchs and 
Raghavan, 2002; Millar, 2002). LEF-1 is decreased in the hair placodes of 
Noggin knock-out mice (Botchkarev et al., 1999). LEF-1 knock-out mice are 
characterised by reduced HF density and retardation of HF development (van 
Genderen et al., 1994), whilst over-expression of LEF-1 results in ectopic follicle 
formation in the oral epithelium (Botchkarev, 2003; Zhou et al., 1995). In 
addition, N-CAM, a neural cell adhesion molecule, is decreased in Noggin 
knock-out hair placodes (Botchkarev et al., 1999). Adhesion molecules are 
crucial for follicular development (Muller-Rover et al., 1998), and since LEF-1 
stimulates N-CAM expression (Boras and Hamel, 2002) and negatively 
regulates E-cadherin expression (Jamora et al., 2003); BMP ligands may 
negatively regulate hair placode formation by mediating adhesion molecule 
expression (Botchkarev and Sharov, 2004). Invasion of the developing follicle 
into the dermis requires degradation of the integument by MMPs (Botchkarev 
and Sharov, 2004). It has been shown that BMP-2 inhibits the production of 
MMP-13, thereby impeding follicular dermal invasion (Varghese and Canalis, 
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1997). In addition, MMP-7 is co-expressed with Smad1 in hair placodes 
(Botchkarev and Sharov, 2004), further supporting a relationship.  
Cell lineage commitment and differentiation appear to be inherently associated 
with BMP signalling. Within the developing follicle, BMP-2, BMP-4, Noggin and 
BMPR-1A are expressed throughout the epithelial and mesenchymal cells of 
the bulb, whilst BMPR-1B is limited to the dermal papilla, follicular connective 
tissue sheath cell and melanocytes (Botchkarev, 2003; Botchkarev and Sharov, 
2004; Kobielak et al., 2003; Kulessa et al., 2000). Kulessa et al. (2000) 
demonstrated that over-expression of Noggin in the hair matrix keratinocytes 
resulted in impaired hair growth and attenuated differentiation of hair matrix 
keratinocytes. Transplantation of skin allograft from Noggin knock-out mice to 
immunodeficient mice results in failure of follicular development, due to a loss of 
Noggin-mediated placode development (Botchkarev et al., 2002; Botchkarev 
and Sharov, 2004). Of course, it is not just the varying ligands and antagonists 
that are required for this differentiation; the presence of BMPRs is also vital. 
Targeted ablation of BMPR-1A in developing epithelium illustrated a failure of 
IRS and hair shaft differentiation, and an absence of differentiation-specific 
keratins (Kobielak et al., 2003; Kobielak et al., 2007). Transplantation of BMPR-
1A null skin allograft onto immunocompromised nude mice displayed a failure of 
IRS development, with preservation of the ORS (Andl et al., 2004; Kobielak et 
al., 2003). In addition, sebocyte differentiation and sebaceous gland 
development appears to be under BMP-mediated control (Botchkarev and 
Sharov, 2004). Over-expression of Noggin results in ectopic sebocyte growth 
(Guha et al., 2004). This suggests that BMP signalling is required for the 
differentiation of HF progenitors.    
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 1.9.6 The role of BMPs in hair cycle regulation 
Several important studies have implicated BMP signalling as being important in 
the control of postnatal hair cycling. During induced hair cycling, BMP-4, BMPR-
1A and Noggin display spatiotemporal expression changes, and are involved in 
the transition from telogen to anagen (Botchkarev et al., 2001). In particular, 
BMP-6 and BMPR-1A are expressed in the HF bulge-containing epithelial stem 
cells (Blanpain et al., 2004; Fuchs, 2008; Kandyba et al., 2013; Sharov et al., 
2009), suggesting that BMPs play a role in maintaining stem cell quiescence. 
This quiescent state is regulated through Wnt inhibition (Fuchs, 2008; Kandya 
et al., 2013) under the control of BMPRs. Conditional loss of BMPR-1A in 
telogen HFs results in the precocious entry of follicles into anagen and the 
stabilization of β catenin, leading to increased stem cell activity (Fuchs, 2008; 
Kandya et al., 2013). Conversely, constitutive BMPR-1A activation maintains 
stem cells in a quiescent state (Kandya et al., 2013). During the telogen resting 
phase, BMP-4 produced by dermal fibroblasts and keratinocytes binds to 
BMPR-1A and prevents the follicular transition to anagen (Botchkarev and 
Sharov, 2004). Furthermore, the administration of BMP-4 inhibits HF growth 
(Botchkarev et al., 2002). Therefore, it appears that BMP-mediated suppression 
of the Wnt pathway and β catenin inhibits stem cell activation and follicular 
growth (Fuchs, 2008; Kandyba et al., 2013; Zhang et al., 2006).  
Entry into anagen is accompanied by down-regulation of both BMP-4 and 
BMPR-1A (Wilson et al., 1994). Up-regulation of Noggin induces active hair 
growth in postnatal telogen mouse skin (Botchkarev et al., 2001; Botchkarev, 
2003; Zhang et al., 2006), through antagonism of BMP-4; indeed, over-
expression of Noggin results in markedly enlarged anagen follicles (Sharov et 
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al., 2006), further supporting this argument. The Noggin-mediated transition into 
anagen is thought to be mediated by Shh signalling (Botchkarev, 2003) Shh is 
up-regulated in the follicle following Noggin treatment, whilst BMP-4 treatment 
down-regulates Shh expression (Botchkarev et al., 2001; Botchkarev, 2003).  
Transition to the catagen phase of the hair cycle is accompanied by controlled 
apoptosis within the HF. Deletion of BMPR-1A results in a delayed catagen 
transition, suggesting a role for BMPR-1A in this shift (Andl et al., 2004; 
Botchkarev and Sharov, 2004). Over-expression of Noggin, however, results in 
accelerated catagen re-entry in secondary follicles, and delayed catagen onset 
in primary follicles (Guha et al., 2004; Botchkarev and Sharov, 2004).  
 
 1.9.7 The role of BMPs in wound healing 
Research obtained over the last decade suggests an important role for BMPs 
during the processes of cutaneous wound repair, therefore highlighting the 
possibility of therapeutic modulation of these growth factors to aid skin healing. 
Yet, the precise mechanisms involved remain elusive. The TGF-β family as a 
whole is well known to be involved in skin repair, and exhibits both a spatial and 
temporal expression pattern during healing (Kane et al., 1991) with profound 
effects on inflammatory cell and fibroblast chemotaxis, angiogenesis and 
collagen deposition (Douglas, 2010; Pierce et al., 1989). TGF-β signalling 
inhibits skin repair, at least in part by supressing keratinocyte migration, 
whereas activin signalling stimulates the wound healing response and promotes 
keratinocyte proliferation (Ashcroft et al., 1999; Hosokawa et al., 2005; Munz et 
al., 1999; Wankell et al., 2001); conversely, over-expression inhibits wound re-
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epithelialization (Yang et al., 2001). These data all point towards a functional 
role of TGF-β family members in the regulation of skin repair.  
Much of the research looking at the role of BMP on healing has focused on their 
role in fracture repair. In bone, BMPs are produced by osteoprogenitor cells, 
osteoblasts, chondrocytes and platelets (Lissenberg-Thunnissen et al., 2011; 
Pecina and Vukicevic, 2007; Sipe et al., 2004). Following their release, they are 
able to induce a sequential cascade of events leading to chondrogenesis, 
osteogenesis, angiogenesis and controlled synthesis of ECM proteins 
(Lissenberg-Thunnissen et al., 2011; Tsiridis et al., 2007; Tsuji et al., 2006; 
Urist, 1965; Vukicevic et al., 1995). Many clinical studies are now available 
supporting the role of exogenous BMPs in the fields of orthopaedic (Blokhuis et 
al., 2013; Garrison et al., 2010; Tsuji et al., 2006; Wei et al., 2012), maxillofacial 
(Huang et al., 2005a; King et al., 1997) and craniofacial (Huang et al., 2005b; 
Kinsella et al., 2011; Sato and Urist, 1985) reconstruction. This has led to the 
development of a number of synthetic BMP ligand compounds, which are 
applied to fracture sites to promote bone growth (Govender et al., 2002; 
Lissenberg-Thunnissen et al., 2011; White et al., 2007). But what evidence is 
there to support a role for BMP involvement in skin repair?  
Previous studies have illustrated that components of the TGF-β signalling 
pathway, including Smad2 (Hosokawa et al., 2005; Tomikawa et al., 2012), 
2012) Smad3 (Ashcroft et al., 1999; Flanders et al., 2003) and Smad4 (Yang et 
al., 2012) negatively regulate skin repair through attenuation of keratinocyte 
proliferation and altered wound inflammatory cell infiltrate (Moura et al., 2013). 
Overexpression of Smad7 (I-Smad), however, accelerates skin repair (Han et 
al., 2011). Furthermore, BMP ligands have been shown to be both up and 
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down-regulated following injury. Following wounding, BMP-6 mRNA and protein 
expression is up-regulated in both keratinocytes and dermal fibroblasts as early 
as 48 hours following injury (Kaiser et al., 1998; Botchkarev, 2003; Moura et al., 
2013), as well as being found to be significantly up-regulated in chronic wounds 
(Kaiser et al., 1998); these are often characterised by an excess of granulation 
tissue. In addition, healing in TG mice over-expressing BMP-6 is delayed due to 
excess granulation and delayed keratinocyte migration (Kaiser et al., 1998). In 
contrast, both BMP-2 and -4 have been shown to be down-regulated in retinal 
epithelium in response to hypoxia-induced ischaemic retinopathy (Mathura et 
al., 2000), with a significant decrease detected within six hours of injury.  
Exogenous treatment of in vitro retinal epithelial cells with BMP ligands results 
in reduced proliferation (Mathura et al., 2000), whilst keratinocyte treatment with 
BMP-2 and BMP-4 suppresses proliferation (Ahmed et al., 2011; Sharov et al., 
2006). Furthermore, knock-out of BMP-5 results in a phenotype characterised 
by skin tumours, due to a loss of stem cell regulation (Kangsamaksin and 
Morris, 2011), and it is well established that over-expression of Noggin results in 
skin tumours (Sharov et al., 2009). Taken together, this research suggests that 
BMPs act as negative growth regulators in the presence of injury, serving to 
control and counteract hyperproliferation (Blessing et al., 1996; Drozdoff et al., 
1994; Kaiser et al., 1998).  
Studies have also demonstrated the inhibitory effects of the TGF-β family on 
cell migration during skin repair (Ashcroft et al., 1999; Hosokawa et al., 2005), 
as well as demonstrating that Smad2 (Hosokawa et al., 2005), Smad3 (Ashcroft 
et al., 1999; Flanders et al., 2003) and Smad4 (Yang et al., 2012) inhibit cell 
movement in other models. Additionally, keratinocyte migration has been shown 
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to be slowed following exogenous BMP-2 and BMP-4 treatment (Ahmed et al., 
2011).  
BMPs influence angiogenesis, clearly a vital facet of cutaneous wound healing. 
It is suggested that differing BMP ligands act as either pro or anti-angiogenic; 
BMP-2 and -7 are pro-angiogenic, whilst BMP-6, -9 and -10 inhibit sprouting 
angiogenesis (David et al., 2009; Ramoshebi and Ripamonti, 2000; Sieber et 
al., 2009). Down-stream components of the BMP-Smad pathway are also 
important in blood vessel formation; TG mice lacking the Smad5 gene die in 
utero due to defects in angiogenesis of the yolk sac (Yang et al., 1999). 
Furthermore, knock-out of BMPR-1A and BMPR-II impairs vascular remodelling 
(David et al., 2009). BMP defects are also implicated in human vascular 
diseases, most notably mutations of ALK-1 receptors and Smad4 in hereditary 
haemorrhagic telangiectasia (Gallione et al., 2006) and defects of BMPR-II and 
Smad8 in pulmonary arterial hypertension (David et al., 2009; Huang et al., 
2009; Morrell, 2006; Shintani et al., 2009).  
A further facet of wound repair in which BMPs play a role is inflammation. The 
TGF-β family as a whole is well established to play roles in immune suppression 
and T-cell regulation (Bierie and Moses, 2010; Douglas, 2010). Indeed, 
variations in TGF-β1 levels leads to a propensity to develop autoimmune 
diseases such as systemic lupus erythematosus and vitiligo due to T-cell over-
activity (Gorelik and Flavell, 2000; Kulkarni et al., 1993; Kulkarni and Karlsson, 
1993; Tu et al., 2011; Xing et al., 2012), potentially due to the loss of p21Cip1 
and p27Kip1 cell cycle regulators (Wolfraim et al., 2004). Furthermore, BMP 
signalling has been illustrated to stimulate both IL-2 and T-cell activity, whilst 
antagonism of the BMP axis using dorsomorphin (a small molecule selective 
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inhibitor of BMP signalling) and Noggin suppress interleukin secretion and T-cell 
function (Boergermann et al., 2010; Cejalvo et al., 2007; Yoshioka et al., 2012). 
Thus, local antagonism of BMPs using Noggin may reduce local inflammatory 
cell infiltrate and could increase the propensity to develop subsequent wound 
infections.   
Studies have also demonstrated the presence of dose-dependent 
subcutaneous and intramuscular soft tissue swelling secondary to BMP-2 and 
BMP-7 treatment, further supporting an argument that BMPs play key roles in 
the inflammatory process (Lee et al., 2012). Here, BMP treatment stimulated IL-
6 and TNF-α and led to the formation of granulomas composed of histiocytes, 
fibrocytes and granulation tissue (Lee et al., 2012). These effects of BMPs on 
inflammation, however appear to be tissue-specific as topical administration of 
BMP-2 onto bone induces local inflammatory suppression and reduced 
expression of IL-6 and IL-10 (Ratanavaraporn et al., 2012). 
Scarring is an inevitable caveat of cutaneous wounding, and at its extreme, may 
develop into a hypertrophic or even a keloid scar. The TGF-β family (Cowin et 
al., 2001), and in particular, BMPs are involved in the processes of late wound 
repair and cutaneous remodelling (Botchkarev, 2003). Pathologically, TGF-β, 
specifically the β1 isoform, has been implicated in the development of 
hypertrophic scarring, as fibroblasts from these scars exhibit increased TGF-β1 
production and TGF-β receptor expression (Penn et al., 2012; Wang et al., 
2000). Foetal mammals heal wounds through the second trimester with no 
evidence of scarring (Stelnicki et al., 1998b), but when BMP-2 is applied to 
foetal wound beds, there is marked dermal and epidermal thickening, together 
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with the deposition of irregular collagen bundles due to enhanced fibroblast 
activity (Stelnicki et al., 1998b).  
Similar results are found in the cornea; up-regulation of BMP-6 is associated 
with increased conjunctival scar tissue (Andreev et al., 2006), whilst over-
expression of the weak BMP antagonist follistatin results in abnormal wound 
healing (Wankell et al., 2001). In particular, TG mice over-expressing this 
protein exhibit a reduced volume of granulation tissue, delayed re-
epithelialization, weakened tensile strength and reduced scarring (Wankell et 
al., 2001). In contrast, inhibition of follistatin under the control of a Krt5 promoter 
results in earlier keratinocyte hyperproliferation at the wound margin 
(Antsiferova et al., 2009). Thus, this suggests that antagonism of BMP ligands 
impedes scar tissue formation (Wankell et al., 2001). Indeed, BMP-2-induced 
chondrogenic differentiation of dermal fibroblasts has been demonstrated, 
accompanied by enhanced subsequent collagen synthesis (Singh et al., 2011), 
which has led to some postulation that these cytokines may be used for 
cartilage and tendon reconstruction in the future (Obert et al., 2009).     
Together, these data suggest that BMPs are required for cell proliferation, 
differentiation and collagen deposition within the epidermis and dermis. But 
despite these insights, the expression of distinct BMP signalling components 
and the effects of BMPs and their antagonist Noggin in skin healing after injury 
remain to be explored. 
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Research Aims 
 
Whilst the role of the TGF-β family in cutaneous wound repair is well 
documented, the exact mechanisms and role of BMPs in this complex process 
remains elusive. In the UK, chronic wounds represent a significant burden to 
patients and the NHS; approximately 200,000 patients in the UK have a chronic 
wound (Posnett and Franks, 2008), impacting on a person’s quality of life; 
symptoms include pain, exudate and odour, and these symptoms are frequently 
associated with poor sleep, loss of mobility and social isolation. The 
understanding of the molecular mechanisms of skin repair is therefore of vital 
importance. To address this area, we aim to:  
i) Examine the dynamic expression profile of BMP-Smad pathway components 
in skin during wound healing on mRNA and protein levels using quantitative 
PCR analysis and immunohistochemistry respectively.  
ii) Determine the effects of constitutive over-expression of the canonical down-
stream signalling component Smad1 or BMP antagonist Noggin on wound 
healing using in vivo TG mouse models. Dynamic changes in keratinocyte 
proliferation, apoptosis and migration will be compared between mouse strains 
using wound morphometric analysis, immunohistochemistry and quantitative 
PCR. 
iii) Investigate the effects of BMP pathway potentiation and antagonism on in 
vitro and ex vivo human and mouse keratinocyte migration, proliferation and 
apoptosis using immunohistochemistry, flow cytometry, in vitro migration assays 
and ex vivo wound healing models.  
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iv) Define the molecular mechanisms underlying these BMP effects by 
performing microarray analyses of wound-induced gene expression in K14-
caSmad1 mice and the effect of BMPR gene silencing on in vitro human and 
mouse keratinocyte migration and proliferation.  
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II. Materials & Methods 
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2.1 Animals and tissue collection 
All animal experimentation was performed under the approval of project licence 
40/2989 at the University of Bradford and the Boston University IACUC 
protocol. Mice had free access to food (standard rodent diet) and water. Animal 
quarters were maintained under continuous 12 hour light-dark cycles, with 
ambient temperature and humidity at 21±1oC and 40-60% respectively. All 
animal handling and experimentation was performed by Dr A Mardaryev and Dr 
M Fessing at the University of Bradford, and Dr A Sharov at Boston University.  
K14-Noggin mice, expressing high levels of the BMP antagonist Noggin under 
the control of a Krt14 promoter (Sharov et al., 2009), were provided by Dr P 
Overbeek (Baylor College of Medicine, USA), whilst K14-caSmad1 mice, 
expressing a constitutively active form of the downstream BMP signalling 
component Smad1, were provided by Dr A Sharov (Boston University, USA). 
TG mice were generated on a Friend Virus B-Type (FVB) background using a 
TG construct containing human Krt14 promoter, human growth hormone poly-A 
sequence (hGHpA) or SV40 polyadenylation signal (SV40pA) (Sharov et al., 
2009; Tucker et al., 2004) and either mouse Noggin cDNA (Figure 2.1a) or 
FLAG-tagged human cDNA encoding phospho-mimetic activated Smad1 
(Figure 2.1b) (Fuentealba et al., 2007). K14-Noggin genotype was confirmed 
by Western blot detection of the 64 kDa Noggin protein in the skin of 9-week-old 
TG mice and the demonstration of transgene expression in the basal layer of 
the epidermis and ORS using in situ hybridization (for genotypic confirmation, 
see Sharov et al., 2009); these experiments were performed by Dr A Mardaryev 
prior to the current PhD project commencing. K14-caSmad1 mice were 
provided by Dr A Sharov at Boston University, and genotype was confirmed by 
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Western blot detection of FLAG-tag expression in dorsal skin samples with actin 
utilised as a positive control. FVB littermates were used as controls.  
 
Figure 2.1 – Transgenic mouse constructs. (a) K14-Noggin and (b) K14-
caSmad1 construct containing a human keratin-14 (hKeratin 14) promoter. KpnI 
and NotI - DNA restriction enzymes; ATG – translational start codon; hGHpA - 
human growth hormone polyA sequence;   SV40pA - SV40 polyadenylation 
signal; DvD – aspartic acid activation domain. 
 
Full-thickness skin wounds were created in the dorsal skin of 8 week-old TG 
and control mice during the telogen (resting) phase of the hair cycle, when HF 
stem cells are quiescent (n=4-5 mice of each strain per time point); this was 
performed under general anaesthesia and using aseptic techniques by Dr A 
Sharov (Boston University) and Dr A Mardaryev (Bradford University). Briefly, a 
sterile 5mm punch biopsy needle (Miltex Integra) was used to create two full-
thickness wounds on the dorsal surface of the mouse, extending through the 
panniculosus carnosus (Figure 2.2) (Mardaryev et al., 2011; Wong et al., 2011). 
Analgesia was administered during the peri- and post-operative period in 
accordance with Home Office guidelines. Skin samples were collected at days 
3, 5 and 7 post-wounding (only day 3 and 5 post-wounding in TG mice), cut in 
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half with a scalpel blade, frozen in liquid nitrogen and embedded in optimal 
cutting temperature (OCT) media (VWR). Unwounded telogen skin samples, 
except in K14-Noggin mice, which remain in a persistent anagen-like phase 
(Sharov et al., 2009), were used as controls. Skin samples were stored at -80oC 
until required.  
 
Figure 2.2 - Illustration of punch biopsies on the dorsal skin of mice. 
(Wong et al., 2011). 
   
2.2 Isolation and culture of primary mouse keratinocytes 
Primary mouse epidermal keratinocytes (PMEKs) were isolated and cultured as 
previously described (Dlugosz et al., 1995; Lichti et al., 2008). Briefly, neonatal 
mouse pups (P2-4) were euthanized according to Home Office guidelines and 
as detailed in the project licence by Dr A Mardaryev and Dr M Fessing. Killed 
mice were rinsed with deionized water and washed in 70% ethanol twice for 2 
minutes. All subsequent procedures were performed in a laminar-flow cell 
culture hood using sterile dissecting tools. The limbs were removed at the elbow 
and ankle joints; the tail was removed close to the body. An incision was made 
along the dorsal midline, and the skin was dissected from the dorsal and ventral 
surface with toothed forceps. The skin was floated dermis side-down on cold 
0.25% trypsin (Sigma) without EDTA overnight at 4oC.  
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Following trypsin incubation, the dermis and epidermis were separated using 
gentle traction. The epidermis was transferred to a 50ml Falcon tube containing 
Eagle’s minimal essential medium (EMEM) (Lonza) supplemented with 4% 
chelated foetal bovine serum (FBS), 100 units/ml penicillin & 100µg/ml 
streptomycin, 2mM L-glutamine (all from Gibco), 0.05mM calcium chloride, 
0.4µg/ml hydrocortisone, 5µg/ml bovine insulin, 2x10-9M 3,3’,5-triiodo-L-
thyronine (T3), 10-10M cholera toxin (all from Sigma) and 10ng/ml epidermal 
growth factor (EGF) (Invitrogen). The epidermis was minced using sterile 
scissors and a 10ml pipette to release the keratinocytes. The suspension was 
passed through a sterile 70µm nylon filter (BD Biosciences) into a fresh Falcon 
tube to remove cornified sheets.  
Type 1 collagen-coated cell culture plates were prepared by coating the base 
with a solution consisting of Hank’s balanced salt solution (HBSS), 1M HEPES 
pH 6.5 (both from Gibco), 100mg/ml bovine serum albumin (BSA) (Sigma), and 
3mg/ml type 1 collagen (Invitrogen). The excess collagen solution was 
aspirated and the plates dried before plating the PMEKs at the required density 
(following quantification using a haemocytometer) in the EMEM media. PMEKs 
were incubated at 37oC with 5% CO2 for 3 to 5 days before experimentation; 
media was changed every 24 hours.  
 
2.3 Cell line culture 
Immortalised human keratinocytes (HaCaT cells) were utilised for in vitro 
experimentation (Boukamp et al., 1988). HaCaT cells evolved from a long-term 
culture of primary human keratinocytes. These aneuploid cells can be 
considered immortal, with specific stable marker chromosomes, but no 
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tumorigenicity. Even after multiple passages, HaCaT cells retain a remarkable 
capacity for normal differentiation and thus offer a suitable and stable model for 
keratinization studies (Boukamp et al., 1988).  
Briefly, HaCaT cells were cultured in P100 cell culture plates (Corning Life 
Sciences) using Dulbecco’s modified Eagle medium (DMEM), supplemented 
with sterile 10% FBS, 25mM HEPES, 100 units/ml penicillin & 100µg/ml 
streptomycin, 2mM L-glutamine and 100mM sodium pyruvate (all from Gibco). 
Cell media was replaced every 72 hours. Prior to splitting, cells were washed 
with sterile phosphate buffered saline (PBS) prior to the addition of TrypLE 
Express trypsinisation solution (Gibco). Detached cells were transferred to a 
sterile culture dish containing sterile DMEM media (cell culture split ratio 1:10). 
Cells were cultured at 37oC with 5% CO2. 
 
2.4 Cell treatment with BMP-4/7 and Noggin 
Both HaCaT cells and PMEKs were treated with BMP-4/7 and Noggin to 
establish the effects on proliferation and migration. Briefly, cells were seeded at 
the required experiment density in cell culture plates with sterile media. Cells 
were treated with 500ng/ml BMP-4/7 (human heterodimer) (R&D systems), 
300ng/ml mouse noggin homodimer (R&D systems), BMP-4/7 500ng/ml and 
noggin 300ng/ml combination or BSA control. BMP-4/7 or Noggin treatment 
remained in culture media with keratinocytes for 4 hours and cells were 
subsequently analysed for proliferation assay, flow cytometry, transwell assay 
or scratch migration at 24 hours (Sections 2.6, 2.7, 2.8 & 2.10).  
 
80 
 
2.5 Cell transfection 
Constitutively active plasmids and small interfering RNAs (siRNAs) were used 
for transient transfection of both HaCaT keratinocytes and PMEKs. Human and 
mouse smartpool siRNAs directed against BMPR-1A and BMPR-1B, and a non-
targeting control were purchased (Thermo Scientific). Plasmids contained 
constitutively active BMP receptors (BMPR-1A or ALK3QD and BMPR-1B or 
ALK6QD), Smad1 and Smad5 under pCMV promoter were acquired from Prof 
K Funa in Sweden; a pcDNA3 plasmid (empty vector) was used as a negative 
control. Plasmids were mutated to become constitutively active by substituting 
glutamic acid for aspartic acid in the GS domain to mimic phosphorylation by 
BMPR-II (Lin et al., 2002). Keratinocytes were grown in twelve-well culture 
plates for proliferation assay and scratch migration; those for flow cytometry 
were grown in P60 culture plates until 60% confluent; HaCaT cells underwent 
72 hours serum starvation prior to transfection to synchronise cell cycle entry. 
Transfection was performed for 4 hours using Lipofectamine RNAimax/2000 
(Invitrogen) according to the manufacturers’ protocol and incubating with sterile 
antibiotic-free media. All assays were performed in duplicate, and data was 
subsequently pooled for analysis.  
 
2.6 Cell proliferation assay 
To assess cell proliferation, HaCaT cells and PMEKs were cultured in twelve-
well culture plates containing sterile 15 x 15mm coverslips (Menzel Gläser) and 
1ml sterile DMEM/EMEM media respectively; coverslips were type 1 collagen-
coated prior to growing PMEKs.  Cells were seeded at 100,000cells/ml and 
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grown until 40% confluence was achieved. Following intervention (transfection, 
exogenous BMP ligand or Noggin treatment), cells were allowed to proliferate 
for 24 hours prior to fixation. Coverslips were incubated with antibodies directed 
against proliferation markers (Ki67 or phospho-histone H3 (Ser28); pH3 
(Ser28)) (Section 2.12). Cell nuclei were visualized using DAPI (Vector Labs). 
Image analysis was performed using a fluorescent microscope (Nikon Eclipse 
501) and Image Analysis software (Image Pro Express, Media Cybernetics). 
Images of coverslip-mounted cells were taken at x40 magnification (n = 20). 
The percentage of proliferating cells was calculated from the total number of 
cells. Means±SD was calculated from pooled data and statistical analysis 
performed using ANOVA analysis with subsequent unpaired Student’s t-test 
with Bonferroni correction; p<0.05 was deemed significant.   
 
 2.7 Flow cytometric cell cycle analysis  
Flow cytometry is a technique which permits the separation of populations of 
cells into groups with similar characteristics based on antibody binding. The 
cells are labelled with fluorescent-labelled chemical compounds and are 
subsequently passed through a narrow gauge needle to produce a stream of 
liquid. The liquid stream is passed through a scanning laser; several laser 
detectors are aimed at the point where the stream passes through the light 
beam: one is placed in line with the light beam (Forward Scatter/FSC) and 
several perpendicular to it (Side Scatter/SSC). Each cell passing through the 
beam scatters the ray, and fluorescent labels found in the particle or attached to 
the particle may be excited into emitting light at a longer wavelength than the 
light source. This combination of scattered and fluorescent light is picked up by 
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the detectors. FSC correlates with the cell volume and SSC depends on the 
inner complexity of the particle. 7-Aminoactinomycin D (7-AAD) (Applichem) is a 
fluorescent chemical with a strong affinity for DNA (Liu, 1991). Following 
combination with cells, the chemical intercalates with double-stranded DNA. 7-
AAD may be used as a cell cycle marker, as once it is combined with DNA, 
cycle profiles can be generated based on the volume of intracellular DNA. 
To perform flow cytometry, HaCaT keratinocytes and PMEKs were cultured in 
P60 cell culture dishes (Corning Life Sciences). Following intervention 
(siRNA/plasmid transfection, exogenous BMP ligand/antagonist treatment), 
cells were washed with sterile PBS before trypsinisation using TrypLE Express 
(Gibco). Following detachment, cells were centrifuged at 362g for 5 minutes, 
following which the supernatant was removed. Cells were subsequently fixed in 
sterile 70% ethanol for 30 minutes at -20oC and washed twice in sterile PBS, 
before filtering through a 50µm filter (BD Biosciences) and staining with 40µg/ml 
7-AAD for 20 minutes at room temperature in the dark. Cell samples were 
analysed using a CyAn™ ADP Analyser flow cytometer and Summit software, 
version 4.2 (Beckman Coulter).        
 
2.8 Transwell migration assay 
Transwell migration assay was performed as previously described (Merlo et al., 
2009; Yin et al., 2005). Briefly, 1x106 PMEKs were seeded onto 8µm pore size 
type 1 collagen-coated well inserts (Greiner BioOne) and were cultured in the 
upper chamber with 1ml serum-free EMEM media. The lower chamber 
contained 1ml complete EMEM medium supplemented with 4% FBS. Following 
24 hours to permit attachment, PMEKs were either transfected with mouse 
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smartpool siRNAs directed against Bmpr-1A or Bmpr-1B and a non-targeting 
control (Thermo Scientific) using Lipofectamine RNAimax (Invitrogen) according 
to the manufacturers’ protocol, or treated with 500ng/ml recombinant BMP-4/7 
(R&D systems), 300ng/ml noggin (R&D systems), BMP-4/7 500ng/ml and 
noggin 300ng/ml combined or BSA control; all transfection and treatments were 
performed in duplicate. For comparison of K14-caSmad1 and WT PMEK 
migration, newborn mouse skins were harvested and prepared as described in 
section 2.2 and seeded at the same concentration described above onto 
collagen-coated well inserts and allowed to migrate over 48 hours. Transfected, 
treated and TG PMEKs were allowed to migrate over 48 hours through the 
insert membrane, after which cells adherent to the top surface of the membrane 
were removed with a cotton swab; cells that had migrated to the bottom surface 
were fixed in 4% paraformaldehyde (PFA) for 10 minutes and counterstained 
with DAPI (Vector Labs). For analysis, the number of DAPI-positive nuclei of 
migrated PMEKs per x40 microscopic field (10 randomly selected 
fields/transwell from two transwells per group) was counted and compared. 
Means±SD were calculated from pooled data and statistical analysis performed 
using ANOVA analysis with subsequent unpaired Student’s t-test with 
Bonferroni correction; differences were deemed significant if p<0.05.   
 
2.9 Mouse explant migration model 
In vivo wound models in rodent skin are typically hindered by panniculus 
carnosus-mediated wound contraction and epithelial fragility. An ex vivo assay, 
described here, has allowed the quantitative assessment of the epithelialization 
potential of PMEKs (Mazzalupo et al., 2002). Newborn mouse skins were 
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removed as previously described (Section 2.2), but the epidermis and dermis 
were left attached. A sterile 3mm punch biopsy (Miltex Integra) was used to 
remove full-thickness skin explants; these skin discs were placed on individual 
collagen type 1-coated glass coverslips (Menzel Gläser) in 12-well plates 
(Corning Life Sciences). After waiting 5 minutes for the skin to adhere to the 
well base, 200µl of sterile 50:50 DMEM (Gibco):F12 (Invitrogen) media was 
added containing 10% FBS, 100 units/ml penicillin & 100µg/ml streptomycin, 
2mM L-glutamine (all from Gibco), 0.1nM cholera toxin, 0.4µg/ml 
hydrocortisone, 5µg/ml bovine insulin, 5µg/ml bovine holotransferrin, 2nM T3 
(all from Sigma) and 10ng/ml EGF (Invitrogen) to maintain the epidermis at the 
air-liquid interface. Plates were incubated at 37oC with 5% CO2. After 24 hours, 
an additional 1.5ml of media was carefully added to each well to submerge the 
skin specimen; media was changed every 48 hours thereafter. To eliminate 
keratinocyte proliferation, explants were treated with 10µg mitomycin C (MMC), 
a DNA-crosslinking chemotherapeutic agent, for two hours after 24 hours 
incubation. Culture media was subsequently changed, and explants were 
treated daily with 500ng/ml recombinant BMP-4/7 (R&D systems), 300ng/ml 
Noggin (R&D systems), BMP-4/7 500ng/ml and Noggin 300ng/ml combined or 
BSA control; all treatments were performed in triplicate.   
Photographs were taken every 24 hours for 7 days using a light microscope 
(Leitz Labovert) at x4 magnification and a Nikon Coolpix camera. Image 
analysis was performed using the Visicam image analysis software; following 
calibration, measurements were made of the keratinocyte migratory area at the 
daily time points. Means±SD were calculated from pooled data and statistical 
analysis performed using ANOVA analysis with subsequent unpaired Student’s 
t-test with Bonferroni correction; differences were deemed significant if p<0.05.   
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2.10 Scratch migration assay 
The scratch assay represents a simple method of observing cell migration in 
vitro (Liang et al., 2007). The creation of a wound or ‘scratch’ in a confluent cell 
monolayer allows migration of those cells along the edge until cell-cell contact is 
re-established. Thus, the rate of cell migration can be compared between 
groups, for example following transfection, and is thought to resemble in vivo 
cell activity. Briefly, scratch assay was performed in twelve-well culture plates 
(Corning Life Sciences), with each biological group performed in duplicate. Prior 
to commencing, cells were seeded at a density of 100,000cells/well and 
incubated overnight at 37oC with 5% CO2 until adherent. Transfection with 
siRNA or plasmid was performed once cells were at 80% confluence (typically 
24-48 hours following seeding). To inhibit cell proliferation, cells were incubated 
with 10µg MMC for two hours at 37oC. A sterile P200 pipet tip was subsequently 
used to create a scratch across the cell monolayer; cells were washed three 
times with sterile PBS to remove both debris and remaining MMC, before media 
replacement.  
A reference point was made adjacent to the scratch to consistently capture the 
same visual field. Images were photographed using a Leitz Labovert light 
microscope and Nikon Coolpix camera at x4 magnification. Images were taken 
at 0, 12 and 24 hours. Following calibration, analysis was performed using 
ImageJ software (National Institutes of Health), whereby the distance between 
the scratch margins was measured (n = 20) and the percentage closure at time 
points calculated. Means±SD were calculated from pooled data and statistical 
analysis performed using ANOVA analysis with subsequent unpaired Student’s 
t-test with Bonferroni correction; differences were deemed significant if p<0.05.   
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2.11 Human ex vivo wound healing model 
Pre-auricular skin specimens were obtained from healthy patients undergoing 
elective rhytidectomy following informed consent and Ethics Committee 
Approval according to the Helsinki Ethical Guidelines for medical research 
involving human subjects. All surgical and consenting procedures were 
conducted by Professor David Sharpe (Consultant Plastic Surgeon). Under 
sterile conditions, subcutaneous fat was trimmed from the specimens. To 
simulate a partial-thickness cutaneous wound, two parallel incisions were made 
in the skin 1mm apart extending to the mid-dermis and the central strip was 
sharply excised using dissecting scissors to leave a wound of uniform width and 
depth (Rizzo et al., 2012) (Figure 2.3a).  
Punch biopsies with the linear partial-thickness wound in the centre were 
excised using a 5mm punch biopsy (Miltex Integra) (Figure 2.3b-c) and were 
placed onto a 24mm Netwell™ insert (Corning) with 440 µm mesh size 
polyester membrane in a twelve-well culture plate. 1.5ml of DMEM (Invitrogen) 
supplemented with 10% FBS, sodium pyruvate and Primocin antimicrobial 
(InvivoGen) was pipetted into the well base to maintain skin specimens at an 
air–liquid interface. Skin was incubated at 37°C in a humidified atmosphere of 
5% CO2 and culture media was renewed every 24 hours. This method provided 
a wound of uniform depth and width to allow characterisation of human wound 
repair (Figure 2.3d).  
Wounded skin discs were treated with 500ng/ml BMP-4/7 (R&D systems), 
300ng/ml Noggin (R&D systems), combined BMP-4/7 and Noggin or control 
media to ascertain the effect of BMPs on human cutaneous wound repair. 
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Figure 2.3 - Generation of a human ex vivo wound healing model (a-c)  
Partial thickness linear wounds are created and excised from pre-auricular skin 
specimens; (d) Cross-sectional illustration of skin specimen at air-liquid 
interface in tissue culture well; (e) Experiment timeline illustrating days when 
human wounds were treated with BMP ligands or Noggin.  
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Treatment was administered directly to the wound surface daily for 7 days 
(Figure 2.3e); all treatments were performed in duplicate. Samples were 
harvested at day 7 (Figure 2.3e) and were snap-frozen in liquid nitrogen and 
imbedded in OCT media (VWR) for cryo-sectioning. Untreated human ex vivo 
skin discs were harvested on days 0, 1, 3, 5 and 7 to assess wound healing 
dynamics in the absence of exogenous treatment; these samples were snap 
frozen in liquid nitrogen and imbedded in OCT media for cryo-sectioning.  
 
2.12 Immunohistochemistry 
Cryosections measuring 9µm thickness were briefly air-dried, prepared with 
ImmEdge hydrophobic barrier pen (Vector Labs) and fixed in acetone (10 
minutes at -20oC) or 4% PFA (10 minutes at room temperature) depending on 
the primary antibody and manufacturers guidelines. Slides to be stained with 
pH3 underwent additional permeabilization with 100% methanol for 10 minutes 
at -20oC. Sections were incubated in 5% BSA (Sigma) overnight at 4oC in 
conjunction with the primary antibody at the optimised dilution (Table 2.1); 
antibodies directed against intracellular antigens were additionally incubated 
with 0.1% triton X100 (Sigma) and 0.2% saponin (Fluka Biochemika).  
Sections were then incubated with corresponding Alexa-546 or Alexa-555-
labeled antibodies (Invitrogen) for one hour at 37oC. Cell nuclei were visualized 
using DAPI (Vector Labs). Image analysis was performed using a fluorescent 
microscope (Nikon Eclipse 501), EXi aqua digital camera (QImaging) and 
Image Pro Express software (Media Cybernetics).  
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Table 2.1 - Primary human & mouse antibodies with associated dilutions. 
Antigen Host Dilution Manufacturer 
Mouse antigens 
Active Caspase 3 Rabbit 1:200 Abcam 
BMPR-1A Rabbit 1:500 Abcam 
BMPR-1B Goat 1:200 Abcam 
CD4 Rat 1:100 Dako 
Keratin-14 Guinea Pig 1:200 Acris 
Keratin-16 Rabbit 1:100 Epitomics 
Keratin-17 Rabbit 1:5000 Epitomics 
Ki67 Rabbit 1:100 Santa Cruz Biotechnologies 
Phospho-histone H3  
(Ser28) 
Rabbit 1:400 Cell Signalling 
pSmad1/5/8 Rabbit 1:200 Millipore 
Smad1 Rabbit 1:200 Abcam 
Human antigens 
Active Caspase 3 Rabbit 1:200 Abcam 
BMPR-1A Rabbit 1:100 Abcam 
BMPR-1B Goat 1:100 Santa Cruz Biotechnologies 
Keratin-10 Rabbit 1:80 Abcam 
Keratin-17 Rabbit 1:5000 Epitomics 
Ki67 Rabbit 1:500 Abcam 
Phospho-histone H3 
(Ser28) 
Rabbit 1:400 Cell Signalling 
pSmad-1/5/8 Rabbit 1:100 Millipore 
 
2.13 Phalloidin staining 
Alexa Fluor® 488-phalloidin (Invitrogen) was utilised to detect the endogenous 
actin filament network within keratinocytes, which shows substantial re-
organization during migration (Lengsfeld et al., 1974; Meyer et al., 2012; Wulf et 
al., 1979). Mouse skin explants (following the treatments described in Section 
2.9) were washed twice in pre-warmed PBS and then fixed in 3.7% methanol-
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free formaldehyde in PBS for 10 minutes at room temperature. Following 
washing, skin explants were carefully removed from the coverslips leaving only 
the migrated keratinocytes attached. Each coverslip was covered with cold 
acetone and incubated at -200C for 5 minutes. After further washing in PBS, 5µl 
stock Phalloidin (Invitrogen) was diluted in 200µl PBS and incubated with each 
coverslip for 30 minutes at room temperature. Finally, the staining solution was 
washed from the coverslips with PBS and they were mounted using DAPI 
(Vector Labs). 
 
2.14 Alkaline phosphatase staining 
For morphological assessment of skin and wound histology sections, alkaline 
phosphatase (AP) staining was performed. In the skin, AP is strongly expressed 
by fibroblasts within the dermal papilla; hence, this is a useful tool to identify 
follicular development and cycling (Handjiski et al., 1994). 
Cryosections of 9µm thickness were fixed in 4% PFA for 10 minutes at room 
temperature. Following five minutes washing in PBS, slides were incubated in 
developing solution (100mM NaCl, 100mM Tris pH 9.5, 0.005% naphtol-ASBI 
phosphate, 0.5% dimethylformamide (DMF), 4% sodium nitrite, 5% new 
fuchsin) for 15 minutes at room temperature. Slides were washed for a further 
10 minutes in PBS before counter-staining with haematoxylin for 90 seconds 
and mounting. 
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2.15 Quantitative wound histomorphometry 
To measure the surface area of the wound proliferative epithelium between WT, 
K14-Noggin and K14-caSmad1 mice, AP-stained skin sections were analysed 
using the VisiCam (VWR) image analysis software. Following calibration, 
measurements were made of the proliferative epithelial tongue area (µm2) and 
tongue length (µm) at time-matched intervals (days 3 and 5 post-wounding). All 
sections were analysed at x20 magnification.  
To assess cell proliferation and apoptosis, the number of Ki-67 positive, active 
caspase-3 positive and DAPI positive cells was counted along the basal layer of 
the wound epithelial tongue or intact epidermis (n=10 from each strain) at time-
matched intervals (days 3 and 5 post-wounding) using ImageJ software 
(National Institutes of Health) and converted to a percentage. This is an 
established method for the quantitative assessment of both proliferation 
(Antsiferova et al., 2009; Bamberger et al., 2005) and apoptosis (Desmouliere 
et al., 1995) in both intact epidermis and wounds. To assess for differences in 
inflammatory cell infiltrate between the three mouse strains, the number of CD4 
positive cells was counted in 10 microscopic fields (x40 magnification)  of 4-5 
mice per strain around the wound at time-matched intervals (days 3 and 5 post-
wounding) (Mardaryev, 2011). For all quantitative wound measurements, 
means±SD were calculated from pooled data and statistical analysis performed 
using single-factor ANOVA testing with subsequent unpaired Students t-test 
with Bonferroni correction. Differences were deemed significant if p<0.05. 
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2.16 RNA isolation and cDNA synthesis 
WT and TG mouse skin and wounds encased in OCT media blocks were used 
as a source of RNA for complimentary DNA (cDNA) synthesis and quantitative 
PCR. Briefly, 10µm thick cryosections (n= 50) were cut; tissue samples were 
transferred to a sterile Eppendorf tube with 1ml of TRIzol (Invitrogen) reagent 
and stored at -80oC until required. When transfected/treated cells were 
harvested for RNA, 500µl TRIzol was added to each 12-well plate culture well 
and a cell scraper was used to disrupt the adherent cells before transfer to an 
Eppendorf tube. For RNA isolation, samples were defrosted for 5 minutes 
before 100µl bromochloropropane (BCP) was added, mixed and incubated at 
room temperature for 15 minutes. Samples were centrifuged at 12,000xg for 15 
minutes at 4oC, and then the aqueous phase was transferred to a new tube. 
500µl isopropanol and 1µl Glycoblue™ (Ambion) were added and incubated for 
5 minutes at room temperature. Samples were centrifuged at 12,000xg for 8 
minutes to pellet the RNA, before the addition of 75% ethanol and further 
centrifugation at 7500xg for 5 minutes. The supernatant was discarded and the 
RNA pellet was dissolved in sterile Tris-EDTA (TE) buffer. To reduce genomic 
DNA contamination, samples were treated with the Turbo DNA-free™ kit 
(Applied Biosystems) according to the manufacturers’ protocol before 
quantification. Isolated RNA samples were subsequently stored at -800C. 
First-strand cDNA synthesis was performed using the Reverse Transcription 
System (Promega) using random primers, according to the manufacturers’ 
protocol. RNA samples were heated to 70oC for 10 minutes, centrifuged and 
placed on ice. The reaction mixture was added to each RNA sample, and then 
incubated at room temperature for 10 minutes, followed by the following 
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temperatures: heated to 42oC for 15 minutes, 95oC for 5 minutes and 4oC for 5 
minutes. Once synthesised, samples were stored at -20oC until analysed.      
 
2.17 Quantitative real-time PCR (qRT-PCR) analysis   
PCR primers were designed with Beacon Designer software (Premier Biosoft 
International; Table 2.2) and synthesised by Sigma. All primers were optimised 
in conjunction with mouse or human reference cDNA at five temperatures; 
55oC, 57oC, 59oC, 61oC and 63oC. Melting curves were compared to establish 
optimal annealing temperatures for each primer. Reaction mixtures containing 
1x SYBR green master mix (Applied Biosystems), 1µM primers and 10ng cDNA 
were analysed using a StepOnePlus™ real-time PCR system (Applied 
Biosystems); each gene of interest was analysed in duplicate. Amplification was 
performed in the following conditions; initial denaturation (95oC for 20 seconds) 
followed by 40 cycles of denaturation (95oC for 3 seconds), annealing (30 
seconds at optimal temperature for each primer pair) and elongation (95oC for 
15 seconds). Following the amplification, a melting curve was created by 
gradual heating the PCR products from 63oC to 92oC. Expression of a 
housekeeping gene (Gapdh in mice/GAPDH in humans) was used for 
normalization. Differences between samples and controls were calculated using 
the Genex™ database software (Bio-Rad) based on the Ct (Ct) equitation 
method and normalized to Gapdh/GAPDH. Data from duplicates was pooled 
and statistical analysis was performed using unpaired Student's t-test within the 
Genex™ (Bio-Rad) software. 
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Table 2.2 - Mouse and human PCR primer sequences. 
Accession 
number 
Sequence 
definition 
Sense/anti-sense primers 
Mouse 
NM_001177696 Actin-binding LIM 
protein 2 (Ablim2) 
CCTCCTTCCTCTACCTACC 
TTGTCTTCTTCCTGCTGTC 
NM_009758 Bone morphogenetic 
protein receptor 1A 
(Bmpr-1A) 
GTGTAGCCCTTGTGGTAATG 
CCTTCCTGTCCTCTGTGG 
NM_007560 Bone morphogenetic 
protein receptor 1B 
(Bmpr-1B) 
CACGATGATAGAAGAAGATGAC 
TTGAGAGGAGGCAGAGTG 
NM_007561 Bone morphogenetic 
protein receptor 2 
(Bmpr-II) 
GCTCGCAGTGGAAGTGAC 
GTAGGTCTCTTAGGAAGGTTCTG 
NM_007553 Bone morphogenetic 
protein 2 (Bmp-2) 
TTGTATGTGGACTTCAGTGATGT 
AGTTCAGGTGGTCAGCAAGG 
NM_007554 Bone morphogenetic 
protein 4 (Bmp-4) 
GAGGAGGAGGAGGAAGAG 
ATGCTGCTGAGGTTGAAG 
NM_007556 Bone morphogenetic 
protein 6 (Bmp-6) 
GTGACGGCTGCTGAGTTC 
GATTGCTAGTTGCTGTGATGTC 
NM_007557 Bone morphogenetic 
protein 7 (Bmp-7) 
CAGCAGCAGTGACCAGAG 
ACAGTAGTAGGCAGCATAGC 
NM_016674 Claudin 1 (Cldn1) TTCATCCTGGCTTCTCTG 
ATGCCAATTACCATCAAGG 
NM_009902 Claudin 3 (Cldn3) GGCAGTTGATTCCCAGGT 
CCACGCAGTTCATCCACAG 
NM_008125 Gap junction protein 
beta 2 (Gjb2) 
GACCCATTTCGGACCAACC 
CTGGTGGAGTGTTTGTTGAC 
NM_008120 Gap junction protein 
alpha 4 (Gja4) 
GCTATTTAAGGCGTCCTG 
GTTAACCAGATCTTGCCCA 
NM_008084 Glyceraldehyde-3-
phosphate 
dehydrogenase 
(Gapdh) 
CAGTGAGCTTCCGGTTCA 
CTGCACCCAGAAG 
NM_008473 Keratin-1 (Krt1) CATATTAGTAGCAGTCTGA 
TGAAGTCCTCTTTGAAAT 
NM_008470 Keratin-16 (Krt16) GAGATCAAAGACTACAGCCC 
CATTCTCGTACTTGGTCCTG 
NM_010663 Keratin-17 (Krt17) CCGTACCAAGTTTGAGACAG 
TCAATCTGCATCTCCAGGT 
NM_010864 Myosin VA (Myo5a) ATCTCCTGCTACCTATGT 
CCACGAATACTCTGACTT 
NM_008711 Noggin (Nog) CGCCCAGACACTTGATGG 
AAACAGTGCATTACAGGAACC 
NM_011223 Paxillin (Pxn) TACTACTGCAACGGACCCA 
TCGTGGAAGCCTTCTGGAC 
NM_009007 Ras-related C3 
botulinum toxin 
substrate 1 (Rac1) 
GCCTGCTCATCAGTTACAC 
AAGAACACGTCTGTCTGC 
NM_008539 Smad1 AACTGTATGCTGGCTGTATTAC 
GCTTTACGGTATAGTCTACATTTG 
NM_001164041 Smad5 ACCTCCAGTATTAGTGCCTCGTC 
GTGCGGTTCATTGTGGCTCAG 
NM_026473 Tubulin beta 6 class V AATGAGTCATCCTCTAAGA 
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(Tubb6) CGAAGATGAAGTTGTCAG 
Human 
NM_004329 Bone morphogenetic 
protein receptor 1A 
(BMPR-1A) 
CGAAGATATGCGTGAGGTTGTG 
GTGAGTCTGGAGGCTGGATTG 
NM_001203 Bone morphogenetic 
protein receptor 1B 
(BMPR-1B) 
GTTGACATACCACCTAACACTC 
TTCCACTATACCTCCTGATACAC 
NM_002046 Glyceraldehyde-3-
phosphate 
dehydrogenase 
(GAPDH) 
TCTCTGCTCCTCCTGTTC 
ACCAAATCCGTTGACTCC 
NM_000421 Keratin-10 (KRT10) TTCGGGCTCTGGAAGAATCAAAC 
GCAGGATGTTGGCATTATCAGTTG 
NM_000526 Keratin-14 (KRT14) GCCTGTCTGTCTCATCCTC 
CTGAAGCCACCGCCATAG 
NM_005557 Keratin-16 (KRT16) GAACCACGAGGAGGAGGAGATG 
ATTCAGGATGCGGCTCAG 
NM_000427 Loricrin (LOR) ACGGAGGCGAAGGAGTTG 
CCAGGTAGGTTAAGACATGAAGG 
 
2.18 Microarray analysis 
For microarray analysis, total RNA was isolated from flow cytometry-sorted 
dissociated primary epidermal keratinocytes of P20 WT and K14-caSmad1 mice 
using RNeasy kit (Qiagen, UK), and processed for one-round RNA amplification 
using RiboAmp RNA Amplification Kit (Molecular Devices, USA). Gene 
expression array analysis was performed by Mogene LLC (St Louis, MO) using 
44K Whole Mouse Genome 60-mer oligo-microarray (Agilent Technologies).  
Functional annotation of the over- and under-represented genes was performed 
using the NIA Array Analysis software (http://lgsun.grc.nia.nih.gov/ANOVA/), 
and enrichment of the genes in different functional categories was assessed by 
using hypergeometric or Fisher’s exact tests by Dr K Poterlowicz at Bradford 
University. Microarray data have been deposited to the Gene Expression 
Omnibus (Accession Number GSE50578). The inherent advantages of the 
microarray approach include speed, specificity and reproducibility. Furthermore, 
this technique is both highly specific and reproducible. However, there are 
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several disadvantages to this method, including practical limitations in terms of 
affordability and flexibility. Microarray validation were performed by qRT-PCR 
analyses of RNA samples isolated from the epidermis of unwounded telogen 
skin by Dr A Sharov at Boston University. Subsequently, microarray data were 
extrapolated to WT and TG wound epithelium obtained 3 or 5 days after wound 
infliction (Mardaryev et al., 2011). Fold changes were determined as a ratio of 
normalized expression values.  
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III. Results 
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3.1 BMP pathway components display a dynamic expression 
profile during wound healing 
To understand the role of the BMP-Smad pathway in wound repair, the 
expressions of BMP ligands (Bmp-2, Bmp-4, Bmp-6, Bmp-7), their receptors 
(Bmpr-1A, Bmpr-1B, Bmpr-II), intracellular components of the BMP canonical 
pathway (Smad1 and Smad5) and BMP antagonist Noggin were examined by 
qRT-PCR analysis at different stages (days 3 and 5) after application of full-
thickness wounds to whole telogen mouse skin.  
Genex™ software analysis revealed significant (p<0.01) decreases in the 
expression of Bmp-2, Bmp-4, Bmp-6 and Bmp-7 transcripts on days 3 and 5 
after skin injury compared to telogen skin (Figure 3.1). Additionally, there was a 
significant decrease in transcripts for Bmpr-1A (p<0.01) and Bmpr-II (p<0.05), 
as well as the downstream signalling components Smad1 and Smad5 (p<0.01) 
and BMP antagonist Noggin (p<0.001) following skin injury. Interestingly, Bmpr-
1B transcript expression was significantly (p<0.01) increased in response to 
wounding (Figure 3.1).  
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Figure 3.1 - Quantitative RT-PCR of BMP pathway components during skin 
healing. RNA transcripts for Bmp-2, Bmp-4, Bmp-6, Bmp-7, Bmpr-1A, Bmpr-II, 
Smad proteins and Noggin were significantly decreased in response to full-
thickness skin injury; Bmpr-1B transcripts were significantly increased following 
skin injury; *p<0.05, **p<0.01, ***p<0.0001; error bars mean±SD, Students t-
test; sample PCR performed in duplicate, analysed with Genex™ (Bio-Rad) 
software using Ct equitation method .  
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To validate the expression patterns seen, immunofluorescence was employed 
to examine BMP signalling components in telogen skin and wounds at days 3, 5 
and 7 post-injury. In telogen skin, immunofluorescent analysis showed that 
BMPR-1A expression was restricted to the HF bulge (Figure 3.2a; arrowhead), 
which is consistent with previously published data (Botchkarev et al., 2001; 
Kobielak et al., 2003). BMPR-1B expression was found in the basal and 
suprabasal layers of the epidermis (Figure 3.2b; arrowheads) (Hwang et al., 
2001), but was not detected in the HF (Yu et al., 2010b) (data not shown). The 
expression of pSmad-1/5/8, a BMP-specific transcriptional regulator, was seen 
throughout the epidermis in telogen skin, being more prominent in the 
suprabasal layers in telogen skin (Figure 3.2c; arrowheads). 
During wound healing, strikingly different patterns of expression were observed. 
BMPR-1A expression was progressively decreased at day 3 (Figure 3.2d; 
arrows) followed by its disappearance from HFs immediately adjacent to the 
wound bed on day 5 and 7 after injury (Figure 3.2g & j; arrow), while it 
remained present in the bulge of HFs distant from the wound (Figure 3.2d, g’ & 
j’; arrowheads). In contrast, there was prominent expression of both BMPR-1B 
and p-Smad-1/5/8 in the wound epithelial tongue and in the adjacent 
unwounded epidermis at all three time points (Figure 3.2e-f, h-i & k-l; 
arrowed). Interestingly, the wound epithelial expression pattern of Bmpr-1B 
appeared to show cytoplasmic staining in the epithelial tongue keratinocytes 
(Figure 3.2e, h & k; arrowed), as opposed to that expected on the cell 
membrane, which was observed in unwounded epidermis (Figure 3.2b; 
arrowheads). 
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Thus, these data suggest that down-regulation of BMP ligands, Noggin and 
BMPR-1A accompanies wound healing. Additionally, the extensive expression 
of BMPR-1B and pSmad-1/5/8 in the wound epithelium implicates an 
involvement of BMP signalling in the control of skin repair. 
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Figure 3.2 - Expression of BMP pathway components during skin healing. 
BMPR-1A expression is restricted to the telogen HF bulge (a; arrowhead), 
BMPR-1B is seen in the basal and suprabasal epidermal layers (b; 
arrowheads); pSmad-1/5/8 is expressed in the basal and more prominently in 
suprabasal epidermal layers (c; arrowheads). On days 3, 5 and 7 post-
wounding, BMPR-1A expression is low in the HF bulges near the wound (d, g & 
j; arrowed) but remains strongly expressed in those further from the wound (d, 
g’ & j’; arrowhead); there is strong expression of BMPR-1B and pSmad-1/5/8 
in the wound epithelial tongue and the adjacent unwounded epidermis (e-f, h-i 
& k-l; arrows). Abbreviations: HF – hair follicle, SG - sebaceous gland, WE – 
wound epithelium, WM – wound margin, scale bar 100µm. 
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3.2 Histomorphological analysis of wound healing in WT, K14-
caSmad1 and K14-Noggin mouse models 
To elucidate a role for BMP signalling in skin healing, K14-caSmad1 and K14-
Noggin TG mice over-expressing a constitutively active form of Smad1 as a key 
component of the ‘canonical’ Bmp pathway or the BMP antagonist Noggin were 
employed, and a detailed morphological analysis of the wound epithelium was 
conducted. These TG constructs drive high-copy expression of mouse Noggin 
and Smad1 cDNA in Krt14 promoter-active cells. The Krt14 promoter becomes 
fully active by E14.5 in the basal layer of the epidermis and subsequently, in the 
ORS and sebaceous glands of developing HFs; high levels of expression are 
maintained throughout life (Byrne et al., 1994; Sharov et al., 2009; Wang et al., 
1997).  
K14-Noggin genotype was confirmed by Western blot detection of the 64 kDa 
Noggin protein in the skin of 9-week-old TG mice and the demonstration of 
transgene expression in the basal layer of the epidermis and ORS using in situ 
hybridization (for genotypic confirmation, see Sharov et al., 2009); these 
experiments were performed by Dr A Mardaryev prior to the current PhD project 
commencing. K14-caSmad1 mice were provided by Dr A Sharov at Boston 
University, and genotype was confirmed by Western blot detection of FLAG-tag 
expression in dorsal skin samples with actin utilised as a positive control.      
A histomorphological analysis of the wound epithelium was conducted to 
characterise the healing characteristics of TG and WT mice. Evaluation of 
wound epithelial tongue area and length provides information on keratinocyte 
proliferation and migration respectively, and are recognised methods for in vivo 
wound healing assessment (Antsiferova et al., 2009; Chmielowiec et al., 2007). 
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Initial ANOVA analysis illustrated that the area covered by hyper-proliferative 
epithelium was significantly different between the three mouse groups on day 3 
(F (2,24) = 26.6, p<0.001) and day 5 (F (2,24) = 30.9, p<0.001) post-wounding. 
Subsequent Student’s t-test analysis with Bonferroni correction found that in 
K14-caSmad1 mice, the epithelial tongue area was significantly smaller at day 3 
(33.9±10µm2 vs. 75.6±22µm2; p<0.01; Figure 3.3a, b & g) and day 5 
(97.6±21µm2 vs. 209.9±59µm2; p<0.05; Figure 3.3d, e & g) post-wounding than 
that of controls. No significant difference was seen between K14-Noggin and 
WT wound epithelium area at day 3 (111.4±42µm2 vs. 75.6±22µm2; p<0.3; 
Figure 3.3a, c & g); however, there was a significant increase in K14-Noggin 
wound epithelial area at day 5 versus WT (348.9±99µm2 vs. 209.9±59µm2; 
p<0.01; Figure 3.3d, f & g). 
The epithelial tongue length, measured to assess the effects of BMP 
antagonism or constitutive Smad activation on keratinocyte migration, was 
significantly different between the three mouse strains at days 3 (F (2,23) = 
17.13, p<0.001) and day 5 (F (2,25) = 14.6, p<0.001), as assessed by ANOVA 
analysis. Subsequent Student’s t-test analysis with Bonferroni correction 
illustrated that K14-caSmad1 epithelial tongue length was shorter at day 3 
(49.8±12µm vs. 72.4±13µm; p<0.01) and day 5 (84.1±15µm vs. 115.2±21µm; 
p<0.01) compared to controls (Figure 3.3h). No significant difference was seen 
between K14-Noggin and WT tongue length at day 3 (85.7±16µm vs. 
72.4±13µm; p<0.3); however, there was a significant increase in K14-Noggin 
epithelial tongue length at day 5 (190.9±66µm vs. 115.2 ±21µm; p<0.03) 
(Figure 3.3h). 
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Figure 3.3 – Histomorphological analysis of wound epithelium in wild-type 
and transgenic mice following skin injury. (a-f) Haematoxylin-stained 
sections of WT, K14-caSmad1 and K14-Noggin wounds; (g) reduced area of 
wound epithelium in K14-caSmad1 mice on days 3 and 5; K14-Noggin area is 
increased at day 5; (h) significantly reduced wound epithelial tongue length in 
K14-caSmad1 mice on days 3 and 5; K14-Noggin tongue length is significantly 
increased at day 5.  Abbreviations: WE – wound epithelium, GT – granulation 
tissue; scale bar 100µm; error bars mean±SD; *p<0.05; Student’s t-test with 
Bonferroni correction; n = 6 measurements per wound x 4 animals per group. 
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To ascertain whether changes in the dynamics of epithelial repair observed in 
K14-caSmad1 and K14-Noggin mice were associated with altered keratinocyte 
proliferation, a quantitative analysis of Ki-67 positive cells in unwounded 
epidermis and the wound epithelial tongue was performed. Significant 
differences were observed between the three mouse groups in unwounded skin 
(F (2,12) = 36.8, p<0.001) and at days 3 (F (2,9) = 17.1, p<0.001) and 5 (F 
(2,11) = 101, p<0.001) post-wounding using ANOVA analysis. Subsequent 
Student’s t-test analysis with Bonferroni correction showed that in K14-
caSmad1 telogen skin, the epidermis had significantly fewer Ki-67 positive 
keratinocytes (21.4±0.5% vs. 34.8±0.8%; p<0.001) than controls (Figure 3.4a-b 
& g; arrowheads). During healing, there was no difference in K14-caSmad1 
wound proliferation at day 3 (p<0.2; Figure 3.4g), but there was a significantly 
lower proportion of Ki-67 positive keratinocytes in K14-caSmad1 wound 
epithelium on day 5 compared to controls (44±3% vs. 61.5±7%; p<0.03; Figure 
3.4d-e & g). As previously described (Sharov et al., 2009), K14-Noggin mice 
demonstrated a significant increase in the number of Ki67 positive cells in intact 
epidermis (48.4±9% vs. 34.8±0.8%; p<0.02; Figure 3.4a, c & g; arrowheads). 
Furthermore, proliferation was significantly increased in K14-Noggin wounds on 
day 3 (69.3±6% vs. 54.3±3%; p<0.03; Figure 3.4g) and 5 (82.1±2% vs. 
61.5±7%; p<0.03; Figure 3.4d, f & g) wounds versus WTs.  
107 
 
Figure 3.4 – Quantitative analysis of proliferation in the wound epithelium 
of K14-caSmad1, K14-Noggin and wild-type mice. (a-f) Ki-67 positive cells 
(arrowheads) are seen in the basal layer of unwounded skin and in the wound 
epithelium on days 3 and 5 after injury; (g) significant reduction in Ki-67+ cells 
in K14-caSmad1 telogen skin and on day 5 after wounding; increased number 
of proliferating cells in K14-Noggin unwounded skin and days 3 and 5 post-
wounding versus WT controls; dash-dot line – dermal-epidermal junction; 
dashed line – wound margin; abbreviations: GT – granulation tissue; scale bar 
100µm; error bars mean±SD; *p<0.05, **p<0.001; Student’s t-test; n = 6 
measurements per wound x 4 animals per group. 
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As BMP signalling plays key roles in the regulation of cellular apoptosis (Sharov 
et al., 2003; Song et al., 1998; Wach et al., 2001; Yokouchi et al., 1996), the 
expression of active caspase-3 was evaluated in the wound epithelial tongue. 
Apoptosis plays a vital role in the wound healing response and by necessity, 
any increase in a responsive cell population must eventually decrease (Brown 
et al., 1997; Desmouliere et al., 1995; Garbin et al., 1996; Greenhalgh, 1998). 
Indeed, wound-induced apoptosis has been illustrated in neutrophils (Walzog et 
al., 1997), macrophages (Savill et al., 1990; Savill et al., 1992), fibroblasts 
(Green, 1997; Hueber et al., 1997) and keratinocytes (Sung et al., 1997). Once 
cell-specific staining was confirmed (Figure 3.5a-c inset) it was noted that 
there was a significant difference (p<0.001) in apoptosis between the three 
mouse strains when analysed using ANOVA testing. Following Student’s t-test 
with Bonferroni correction, it was noted that K14-caSmad1 mice displayed a 
higher proportion of active caspase-3 positive cells in the wound epithelium at 
both day 3 (18.8±5% vs. 6.1±2%; p<0.03; Figure 3.5a-b & g) and day 5 
(9.9±0.2% vs. 4.7±2%; p<0.03; Figure 3.5d-e & g) versus time-matched 
controls. Conversely, K14-Noggin wounds had consistently fewer apoptotic 
cells, both at day 3 (0.9±1% vs. 6.1±2%; p<0.04; Figure 3.5a, c & g) and day 5 
(1.9±0.6% vs. 4.7±2%; p<0.04; Figure 3.5d, f & g) post-wounding.  
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Figure 3.5 - Quantitative analysis of apoptosis in the wound epithelium of 
K14-caSmad1, K14-Noggin and wild-type mice. (a-f) Apoptotic active 
caspase-3 positive cells (arrowheads) are seen in the wound epithelium on 
days 3 and 5 following injury; inset illustrates cell-specific staining; (g) 
significant increase in caspase 3 positive cells in K14-caSmad1 at day 3 and 
day 5 after wounding; decreased number of apoptotic cells in K14-Noggin 
wounds versus time-matched WT controls; dashed line – wound epithelial 
tongue margin; abbreviations: GT – granulation tissue; scale bar 100µm; error 
bars mean±SD; Student’s t-test with Bonferroni correction; *p<0.05; n = 6 
measurements per wound x 4 animals per group. 
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To establish whether the differences in wound repair seen between the three 
mouse strains were due to alterations in inflammatory cell infiltrate, a 
quantitative analysis of cellular CD4 expression, a surface glycoprotein 
expressed on T-helper cells (Nakayamada et al., 2012), monocytes (Kazazi et 
al., 1989; Ziegler-Heitbrock et al., 2010) and dendritic cells (Vremec et al., 
2000), was performed (Figure 3.6a, arrowed). However, no significant 
difference in the number of CD4 positive cells was seen between all three 
mouse strains at day 3 (p<0.2) or day 5 (p<0.5) post-wounding compared to 
corresponding WT controls (Figure 3.6b), thus suggesting that wound closure 
was not assisted by alterations in inflammatory cell number between mouse 
strains.  
In summary, these data provide evidence that BMP/Smad1 signalling slows 
wound healing by attenuating keratinocyte proliferation and migration and 
augmenting wound epithelial apoptosis, while the BMP antagonist Noggin 
promotes wound repair by stimulating proliferation and migration and 
suppressing apoptosis. 
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Figure 3.6 – Quantification of CD4 positive inflammatory cell infiltrate in 
skin wounds. (a) CD4 positive cells (arrowheads) are seen in the dermis 
adjacent to the wound epithelium on day 5 after injury; (b) there is no significant 
difference in the number of CD4 positive cells observed in day 3 (p 0.2) or day 5 
(p 0.5) skin wounds between the three mouse strains (ANOVA analysis); scale 
bar 100µm; error bars mean±SD; Student’s t-test with Bonferroni correction; n = 
10 counts per wound x 4 animals per group. 
 
 
 
 
 
 
 
 
 
 
 
 
112 
 
3.3 Expression of injury-induced keratins and keratinocyte 
morphology in control and transgenic wounds 
 It is well established that injury-induced skin repair is associated with profound 
changes in cytoskeletal organization. Thus, Krt14, Krt16 and Krt17, whose 
expression is induced in response to wounding (Coulombe, 1997; Paladini et 
al., 1996; Patel et al., 2006) were studied by immunofluorescence. There was 
no difference in the epithelial expression of Krt14 between the three mouse 
strains (Figure 3.7a-f). However, Krt16 and Krt17 expressions were 
dramatically reduced in K14-caSmad1 mouse wounds compared to WT at days 
3 and 5 post-wounding, whilst expression was increased in K14-Noggin wounds 
(Figure 3.8a-f & 3.9a-f).  
Analysis of keratinocyte morphology revealed that the epithelial tongue of WT 
mice contained elongated keratinocytes (Figure 3.8a-b & 3.9a-b; arrows). This 
cellular polarisation is an important characteristic of actively migrating cells in 
the wound epithelial tongue, so that they can re-establish the epidermal barrier 
(Allard and Mogilner, 2013; Driscoll et al., 2012; Meyer et al., 2012). In contrast, 
epithelial cells in K14-caSmad1 mice lacked this polarised appearance and 
were cuboidal in shape (Figure 3.8c-d & 3.9c-d; arrowheads). Conversely, 
K14-Noggin wounds displayed visibly more polarised keratinocytes than in WT 
mice (Figure 3.8e-f & 3.9e-f; arrows) Thus, these data suggested that the 
delayed and enhanced wound healing seen in K14-caSmad1 and K14-Noggin 
mice respectively may also be caused by altered keratinocyte migration. 
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Figure 3.7 – Keratin-14 expression in wild-type and transgenic wounds. 
Krt14 expression was of a similar intensity in WT (a-b), K14-caSmad1 (c-d) and 
K14-Noggin wounds (e-f) at days 3 and 5 post-wounding. Abbreviations: GT – 
granulation tissue; dashed line – wound epithelial tongue; scale bar 100µm; 
arrow denotes direction of keratinocyte polarity and migration to close 
epidermal defect. 
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Figure 3.8 - Keratin-16 expression in WT and TG wounds. (a-f) Krt16 
expression was reduced in K14-caSmad1 and increased in K14-Noggin 
wounds; K14-caSmad1 keratinocytes were cuboidal (arrowheads), while those 
in WT and K14-Noggin mice were polarised (small arrows). Abbreviations: GT 
– granulation tissue; dashed line – wound epithelial tongue; scale bar 100µm; 
large arrow illustrates keratinocyte migratory direction towards wound. 
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Figure 3.9 - Keratin-17 expression in WT and TG wounds. (a-f) Krt17 
expression was visibly reduced in K14-caSmad1 and increased in K14-Noggin 
wounds compared to WTs; K14-caSmad1 keratinocytes were cuboidal 
(arrowheads), while those in WT and K14-Noggin mice were notably more 
polarised (small arrows). Dashed line – wound epithelial tongue; scale bar 
100µm; large arrow indicates direction of keratinocyte migration to wound. 
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3.4 Global microarray analysis reveals changes in expression 
of cytoskeletal and cell migration-associated genes in the 
epidermis of K14-caSmad1 mice  
To define the genetic program regulated by Smad1 in epidermal keratinocytes 
and understand the mechanisms underlying the retarded wound healing 
observed in K14-caSmad1 mice, global microarray analyses of flow cytometry-
sorted dissociated primary epidermal keratinocytes isolated from the telogen 
skin of post-natal day 20 WT and K14-caSmad1 mice were performed, as 
previously described (Fessing et al., 2010; Mardaryev et al., 2011). 
Bioinformatic analyses of the microarray data revealed two-fold and higher 
changes in expression of 1697 genes in the epidermis of K14-caSmad1 mice 
compared to WT controls (Figure 3.10). These genes belonged to different 
functional categories and encoded distinct adhesion/extracellular matrix 
molecules, cell cycle/apoptosis regulators, cytoskeletal/cell motility markers, 
metabolic enzymes and signalling/transcription regulators. Among these 
functional categories, significant enrichment (p<0.05) was found for the genes 
that encode cytoskeletal/cell motility-associated markers.  
These included the differentiation-specific cytokeratin Krt1 (Fuchs and Green, 
1980; Moll et al., 2008; Moll et al., 1982), injury-induced cytokeratins Krt16 and 
Krt17 (Coulombe, 1997; Paladini et al., 1996; Patel et al., 2006), Myosin VA 
(Myo5a) (an actin dependent motor protein required for cell motility) (Cao et al., 
2004; Lan et al., 2010; Sloane and Vartanian, 2007),  claudins Cldn1 and Cldn3 
(tight junction proteins involved in cell adhesion and motility) (Webb et al., 
2013), Ras-related C3 botulinum toxin substrate 1 (Rac1) (a GTPase involved 
in regulating motility) (Filic et al., 2012; Fukata et al., 2003), gap junction 
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proteins Gjb2 and Gja4 (transmembrane proteins involved in intercellular 
junction formation) (Scott and Kelsell, 2011; Xu and Nicholson, 2013), actin 
binding LIM protein family member 2 (Ablim2) (a scaffold protein that binds to 
actin) (Barrientos et al., 2007), tubulin beta 6 (Tubb6) (component of 
microtubules needed for migration) (Leandro-Garcia et al., 2010) and paxillin 
(Pxn) (a focal adhesion-associated adaptor protein) (Sattler et al., 2000; Turner, 
1998). 
qRT-PCR validation of microarray data was performed by Dr A Sharov at 
Boston University, which confirmed significant down-regulation of Tubb6, 
Ablim2, Shh and Tgf-α versus WT controls (data not shown). Subsequently, 
total RNA was isolated from snap-frozen samples of full-thickness wounds from 
8-week old WT and K14-caSmad1 mice followed by conversion into cDNA. This 
illustrated that Krt1, Krt16 and Krt17 transcripts were significantly down-
regulated in the wound epithelium of K14-caSmad1 mice compared to WT 
controls (Figure 3.11a-c). Furthermore, transcripts for Myo5a, Ablim2 and 
Tubb6 were significantly more strongly down-regulated in K14-caSmad1 mice in 
response to wounding than in WT controls (Figure 3.11d-f). 
Transcript expression of the cell adhesion proteins Rac1, Cldn3, Gjb2, Gja4 and 
Pxn were significantly down-regulated in K14-caSmad1 wound epithelium 
compared to controls (Figure 3.12a-f). Rac1 and Cldn3 transcripts were up-
regulated in response to wounding in WT mice; conversely in K14-caSmad1 
mice, expression of Rac1 and Cldn1 failed to show a response, whilst Cldn3 
was down-regulated following skin injury (Figure 3.12a-c). Additionally, 
transcripts for Gjb2, Gja4 and Pxn were increased following skin injury in WTs 
(Figure 3.12d-f). However, in K14-caSmad1 wounds, Gjb2 and Pxn failed to 
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show a defined response following wounding, whilst Gja4 transcript expression 
was decreased (Figure 3.12d-f). These data suggest that constitutive activation 
of canonical BMP-Smad signalling in epidermal keratinocytes inhibits wound 
healing, at least in part, via alterations in cytoskeletal organization and cell 
migration.    
 
Figure 3.10 – Functional annotation of up- and down-regulated genes in 
K14-caSmad1 epidermis. (a-b) Analysis of the microarray data showed two-
fold or higher changes in expression of 1697 genes encoding cell adhesion and 
extracellular matrix molecules, cell cycle and apoptosis regulators, cytoskeletal 
and cell motility markers, metabolic enzymes and transcription regulators 
(Figure prepared by Dr K Poterlowicz). 
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Figure 3.11 – Relative expression of cytokeratin, cell motility and 
cytoskeletal organisation genes in K14-caSmad1 versus wild-type full-
thickness skin wounds during healing and in whole telogen skin. (a-f) 
qRT-PCR: transcripts for Krt1, Krt16 and Krt17 were significantly down-
regulated in the wound epithelium of K14-caSmad1 mice compared to WT 
controls; transcripts for Myo5a, Ablim2 and Tubb6 were significantly more 
strongly down-regulated in K14-caSmad1 mice in response to wounding than in 
WT controls. Abbreviations: Tel – telogen; D3/5 – day 3/5; error bars mean±SD; 
*p<0.01, **p<0.0001; Student’s t-test; PCR samples performed in duplicate, 
analysed using Genex™ (Bio-Rad) software using Ct equitation method. 
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Figure 3.12 – Relative expression of cell adhesion genes in K14-caSmad1 
versus wild-type full-thickness skin wounds during healing and in whole 
telogen skin. (a-f) qRT-PCR: transcripts for Rac1, Cldn3, Gjb2, Gja4 and Pxn 
were significantly down-regulated in K14-caSmad1 wounds compared to 
controls; in TG skin, Rac1, Cldn1 Gjb2 and Pxn failed to show a defined 
response to skin injury, whilst Cldn3 and Gja4 expression was decreased. 
Abbreviations: Tel – telogen; D3/5 – day 3/5; error bars mean±SD; *p<0.05, 
**p<0.001; Student’s t-test; PCR samples performed in duplicate, analysed 
using Genex™ (Bio-Rad) software using Ct equitation method. 
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3.5 BMP signalling suppresses in vitro human and mouse 
keratinocyte proliferation  
To establish whether BMP signalling is capable of influencing proliferation, 
HaCaT keratinocytes and PMEKs were treated with BMP-4/7, BMP antagonist 
Noggin or a combination of both BMP-4/7 and Noggin and stained for a marker 
of proliferation (Ki67 antigen) (Figure 3.13a & 3.14a).   
ANOVA analysis confirmed that there was a significant difference between 
treatment groups in both HaCaT (p<0.001) keratinocytes and PMEKs (p<0.01). 
Subsequent Student’s t-test evaluation with Bonferroni correction identified that 
BMP-4/7 treatment suppressed proliferation both in HaCaT keratinocytes 
(51.3±7.4% vs. 42.6±5.6%; p<0.04; Figure 3.13a-b) and PMEKs (46.3±7.5% 
versus 32.3±11.1%; p<0.04; Figure 3.14a-b) compared to BSA-treated 
controls, suggesting that BMP ligands negatively regulate cellular proliferation. 
However, this negative effect was negated when Noggin was co-administered 
with BMP-4/7, returning the number of proliferating cells to that seen in the 
control group (Figure 3.13b). Interestingly, treatment with Noggin alone 
significantly increased the number of proliferating HaCaT cells (61.1±5.5% vs. 
51.3±7.4%; p<0.04; Figure 3.13b) and PMEKs (61±8% vs. 46.3±7.5%; p<0.04; 
Figure 3.14b) versus BSA-treated controls.  
To confirm these results, flow cytometry of HaCaT keratinocytes was performed 
following treatment with BMP-4/7, Noggin or a combination of both (Figure 
3.13c-d). As seen with Ki67 staining, BMP-4/7 treatment increased the 
proportion of cells in resting G0/G1 phases (54% vs. 47%) compared to BSA-
treated controls.  
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Noggin negated this effect when cells were exposed to both treatments, whilst 
solo Noggin treatment increased the proportion of S phase cells (30% vs. 17%) 
and reduced the proportion of quiescent G0/G1 cells compared to controls (33% 
vs. 47%) (Figure 3.13c-d). The sub G1 (apoptotic) population was lower in the 
BMP-4/7 treated group compared to other treatments. However, this effect may 
be due to subtle alterations in the population gating during the experiment. 
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Figure 3.13 – HaCaT keratinocyte proliferation in response to BMP 
pathway modulation. (a-b) BMP significantly reduced HaCaT cell proliferation 
as assessed by Ki67 staining; Noggin increases keratinocyte proliferation; (c) 
Flow cytometry of HaCaT keratinocytes following treatment. BMP-4/7 increased 
G0/G1 phase cells whilst Noggin increased those in S phase; (d) Flow cytometry 
data. Percentages correspond to keratinocytes in discrete cell cycle phases 
determined by flow cytometry. BMP-4/7 treatment increases the percentage of 
cells in G0/G1, whilst Noggin increases the proportion of cells in G2/M phases; 
error bars mean±SD; Student’s t-test with Bonferroni correction; *p<0.04; n = 20 
measurements per group. 
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Figure 3.14 – Primary mouse keratinocyte proliferation in response to 
BMP pathway modulation. (a) PMEK proliferation assessed by Ki67 
immunostaining and expression of positive green (Ki67 positive) nuclei as a 
percentage; (b) Exogenous BMP-4/7 significantly suppressed proliferation 
whilst it was significantly increased by Noggin treatment; error bars mean±SD; 
*p<0.04; Student’s t-test with Bonferroni correction; n = 20 measurements per 
group.  
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To further establish the negative effect of BMP signalling on proliferation, 
HaCaT keratinocytes were transfected with vectors containing one of the 
constitutively active BMP receptors (pALK3QD or pALK6QD), constitutively 
active down-stream Smad signalling components (pCMVSmad1 or 
pCMVSmad5) or an empty control plasmid (pCDNA) (Ishida, 2000). Cells were 
stained with pH3 (Ser28) antibody and the positive proliferating cells 
subsequently counted. Cell transfection with all vectors resulted in a 
significantly decreased number of pH3-positive proliferating cells compared to 
controls (Figure 3.15a-b). ANOVA testing confirmed that there was a significant 
(F (4,45) = 13.2, p<0.001) difference between the groups following plasmid 
transfection and proliferation assessment. Subsequent Student’s t-test analysis 
with Bonferroni correction identified that proliferation was decreased following 
transfection with pALK3/pCMVSmad5 (2.3±1.7% vs. 5.5±1.5%; p<0.001), 
pALK6/pCMVSmad1 (1.7±2% vs. 5.5±1.5%; p<0.001) and pALK6/pCMVSmad5 
(2.7±1.4% vs. 5.5±1.5%; p<0.001) compared to controls. Furthermore, the 
combined transfection with pALK3QD and pCMVSmad1 vectors resulted in a 
significantly greater decrease in pH3 expression than with other plasmids 
(5.5±1.5% vs. 0.65±1%; p<0.0001) (Figure 3.15b).  
To confirm these results, flow cytometry of HaCaT cells was performed 
following transfection with these plasmids (Figure 3.16a-b). As seen with pH3 
(Ser28) staining, transfection with all vectors resulted in a suppression of 
proliferation and indeed, a varying degree of apoptosis (sub G1 population), 
particularly following Smad5 transfection. The proportion of cells in G0/G1 was 
increased and in G2/M was decreased following transfection with 
pALK3/pCMVSmad1, pALK3/pCMVSmad5, pALK6/pCMVSmad1 and 
pALK6/pCMVSmad5 compared to controls (Figure 3.16a-b). These results 
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suggest that constitutive activation of BMP signalling, and in particular BMPR-
1A in conjunction with Smad1, results in attenuation of keratinocyte proliferation 
in vitro.   
 
Figure 3.15 – Proliferation after constitutive activation of BMP-Smad 
pathway in HaCaT keratinocytes. (a) Immunofluorescent staining of 
phosphor-histone H3 (ser28) as a marker of proliferation following constitutively 
activating BMPR plasmid transfection; (b) Constitutive activation of BMPRs and 
Smad proteins using plasmids significantly reduced HaCaT cell proliferation as 
assessed by phospho-histone H3 (ser28) staining; error bars mean±SD; 
*p<0.001; **p<0.0001; Student’s t-test with Bonferroni correction; n = 20 
measurements per group.  
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Figure 3.16 – Flow cytometric analysis of HaCaT keratinocytes following 
constitutive BMPR and Smad protein activation. (a-b) Numbers correspond 
to percentage of keratinocytes in discrete cell cycle phases determined by flow 
cytometry. Constitutive activation of BMPR-1A (pALK3) or BMPR-1B (pALK6) in 
combination with Smad1 (pSmad1) or Smad5 (pSmad5) decreased cell 
proliferation and simulated apoptosis (Sub G1 population). In particular, 
transfection of constitutively active pSmad5 increased the apoptotic Sub G1 
population.  
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To further delineate the effect of differential BMPRs on keratinocyte 
proliferation, PMEKs and HaCaT keratinocytes were transfected with siRNA 
directed against BMPR-1A or BMPR-1B and once gene silencing was 
confirmed (Figure 3.17a-b & Figure 3.18a-b), cells were harvested for flow 
cytometry to ascertain the effects of individual BMPRs on cell cycle progression 
(Figure 3.17c-d & Figure 3.18c-d).  
HaCaT cells transfected with BMPR-1A siRNA displayed a marginal decrease 
in the percentage of cells in G0/G1 phase compared to control (49% vs. 54%)  
and an increased proportion of cells in the S and G2M phases compared to 
control (20 and 27% vs. 19 and 25%). No effect was seen following BMPR-1B 
siRNA (Figure 3.17c-d). BMPR silencing in PMEKs showed similar results; 
Bmpr-1A silencing increased the percentage of cells in G2M compared to 
control (21% vs. 17%), whilst no effect was seen following Bmpr-1B silencing in 
PMEKs (Figure 3.18c-d). Thus, silencing of BMPR-1A caused a marginal 
increase in proliferation in both human and mouse keratinocytes, whilst BMPR-
1B had no effect. 
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Figure 3.17 – HaCaT keratinocyte BMPR silencing and flow cytometry. (a-
b) Confirmation of significant BMPR silencing following siRNA transfection prior 
to flow cytometry; (c-d) Flow cytometry data; numbers correspond to 
percentage of keratinocytes in discrete cell cycle phases determined by flow 
cytometry. BMPR-1A silencing stimulates a marginal increase in the proportion 
of proliferating cells in G2/M phases, whilst BMPR-1B silencing has no effect. 
Error bars mean±SD; *p<0.04, **p<0.001; Student’s t-test; PCR samples 
performed in triplicate, analysed using Genex™ (Bio-Rad) software. 
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Figure 3.18 – Primary mouse keratinocyte BMPR silencing & flow 
cytometry. (a-b) Confirmation of significant BMPR silencing following siRNA 
transfection; (c-d) Numbers correspond to percentage of keratinocytes in cell 
cycle phases determined by flow cytometry. Bmpr-1A silencing stimulates a 
marginal increase in the proportion of proliferating cells in G2/M phases; Bmpr-
1B silencing has no effect. Error bars mean±SD; *p<0.02, **p<0.001; Student’s 
t-test; PCR performed in triplicate, analysed using Genex™ (Bio-Rad) software. 
131 
 
3.6 BMP signalling slows in vitro and ex vivo keratinocyte 
migration 
Keratinocyte migration forms a fundamental part of cutaneous wound healing 
and to ascertain the effect of BMP signalling on in vitro migration, ‘scratch’ 
(Figure 3.19a-b) and transwell assays (Figure 3.19c-d) were employed using 
HaCaT keratinocytes and PMEKs respectively. In scratch assay, BMP-4/7 
significantly inhibited HaCaT keratinocyte migration compared to controls (24 
hour closure 32.1±19% vs. 22.6±9%; p<0.04) (Figure 3.19a-b). However, 
Noggin negated this BMP-induced effect when cells were treated with it in 
combination with BMP-4/7, returning migration rates back to that seen in the 
control group (43.1±17% vs. 32.1±19%; p 0.08). Interestingly when used alone, 
Noggin accelerated migration, significantly exceeding that seen in controls 
(51.8±11% vs. 32.1±19%; p<0.001) (Figure 3.19a-b).   
To confirm the inhibitory effects of BMP on cell migration seen in scratch assay, 
transwell assay with PMEKs was used (Merlo et al., 2009; Yin et al., 2005) 
(Figure 3.19c-d). BMP treatment significantly slowed (p<0.001) PMEK 
migration compared to control keratinocytes, and this effect was negated when 
BMPs were co-administered with their antagonist Noggin. Consistent with 
scratch assay, Noggin treatment significantly (p<0.04) accelerated migration 
compared to controls (Figure 3.19d). Furthermore, transwell assay was 
repeated using K14-caSmad1 PMEKs versus WT PMEKs (Figure 3.20), in 
which WT PMEKs migrated significantly (p<0.0001) faster than TG 
keratinocytes. Taken together, this suggests that BMP signalling indeed 
suppresses keratinocyte migration, whereas BMP antagonist Noggin promotes 
cell migration. 
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Figure 3.19 – Keratinocyte migration following modulation of BMP 
signalling. (a-b) Scratch migration assay; (c-d) Transwell assay; BMPs 
significantly attenuate keratinocyte migration; Noggin significantly accelerates 
cell movement. Error bars mean±SD; *p<0.05; **p<0.001; Student’s t-test with 
Bonferroni correction; n = 20 measurements per group. 
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Figure 3.20 – Transwell migration assay of wild-type and K14-caSmad1 
primary mouse keratinocytes. At 48 hours, migration was significantly 
reduced in K14-caSmad1 keratinocytes compared to WT counterparts. Error 
bars mean±SD; **p<0.0001; Student’s t-test with Bonferroni correction; n = 20 
measurements per group.  
 
To elucidate the effects of BMP signalling on keratinocyte migration in an ex 
vivo setting, mouse skin explants (Mazzalupo et al., 2002) were treated with 
Bmp-4/7, Noggin or their combination, and cell migratory area from the explants 
was measured at days 3, 5 and 7. Keratinocyte migration was significantly 
retarded by BMP-4/7 treatment at both day 5 (p<0.02) and day 7 (p<0.03) 
compared to control explants (Figure 3.21a-b). Noggin negated this BMP-
induced inhibition of migration when explants were exposed to both treatments 
and restored keratinocyte movement back to that seen in controls (Figure 
3.21a-b). When Noggin was administered alone, keratinocyte migration was 
significantly increased at days 5 (p<0.01) and 7 (p<0.05) compared to controls, 
suggesting that antagonism of BMP signalling accelerated cell migration in this 
model (Figure 3.21a-b). Thus, the ex vivo data supported that seen in vitro 
using HaCaT keratinocytes and PMEKs (Figure 3.19). 
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Figure 3.21 – Ex vivo mouse skin explant migration on type 1 collagen-
coated plates in response to BMP signalling pathway modulation. (a) 
Mouse skin explants following 7 days of treatment – the border of keratinocyte 
migration is marked by a dotted line; (b) Area of keratinocyte migration from the 
skin explants; BMP-4/7 significantly slowed ex vivo migration at days 5 and 7; 
Noggin in combination with BMP-4/7 negated this effect; Keratinocyte migration 
was significantly enhanced at days 5 and 7 when explants were treated with 
Noggin alone; Error bars mean±SD; *p<0.05; **p<0.01; Student’s t-test with 
Bonferroni correction; all treatments performed in triplicate. 
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To evaluate PMEK morphology following 7 days of BMP-4/7 or Noggin 
treatment, migrating keratinocytes from skin explants were stained with Alexa 
Fluor® 488-phalloidin to detect the endogenous actin filament network 
(Lengsfeld et al., 1974; Meyer et al., 2012; Wulf et al., 1979). In the control 
group, the majority of migrating keratinocytes displayed an elongated 
appearance with actin fibres seen across the cell body (Figure 3.22a). In 
marked contrast, the majority of cells migrating from BMP-4/7-treated explants 
had acquired a spherical shape (Figure 3.22b; arrowheads), and did not show 
a defined actin fibre network. In the samples co-treated with BMP-4/7 and 
Noggin, cell morphology was similar to that seen in control cells (Figure 3.22c). 
However, notably more polarised cell shapes were observed in Noggin-treated 
samples versus the control (Figure 3.22d), which may reflect the accelerated 
migration observed in explant migration assay (Figure 3.21). Thus, this data 
asserts that BMP signalling negatively regulates keratinocyte migration during 
wound repair.  
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Figure 3.22 – Phalloidin staining of endogenous actin filaments in mouse 
keratinocytes cultured on type 1 collagen-coated plates following BMP-4/7 
and/or Noggin treatment. (a) Control keratinocytes were elongated with actin 
fibres visible across the cell body; (b) BMP-4/7-treated keratinocytes were 
spherical and lacked defined actin fibres (arrowheads); (c) Cell morphology 
was restored to that seen in controls when keratinocytes were treated with both 
Noggin and BMP-4/7; (d) Noggin alone increased cell polarity and actin 
formation; scale bar 100µm. 
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3.7 BMP receptors differentially modulate keratinocyte 
migration in vitro  
To define the role that individual BMPRs play in keratinocyte migration, HaCaT 
keratinocytes were transfected with vectors containing one of the constitutively 
active BMP receptors (pALK3QD or pALK6QD), constitutively active down-
stream Smad signalling components (pCMVSmad1 or pCMVSmad5) or an 
empty control plasmid (pCDNA) (Ishida et al., 2000) (Figure 3.23a-b). Plasmid 
transfection resulted in significant (p<0.0001) slowing of migration at 12 and 24 
hours in all groups compared to controls (Figure 3.23b). There was, however, 
no discernible or statistical difference seen between the four BMPR/Smad 
protein groups, suggesting that global activation of the BMP-Smad pathway 
attenuates keratinocyte migration.    
Similarly, the effect of BMPR silencing on cell migration was examined in both 
HaCaT keratinocytes and PMEKs. In HaCaT cells, BMPR-1A silencing had no 
effect on migration, and the percentage wound closure at 24 hours was 
comparable to that seen in controls (56±6% vs. 59±6%; p 0.26; Figure 3.24a-
b). In contrast, BMPR-1B silencing significantly accelerated keratinocyte 
migration at both 12 hours (42±9% vs. 32±5%; p<0.01) and 24 hours (71±5% 
vs. 59±6%; p<0.01) compared to controls (Figure 3.24a-b). To confirm the 
results seen with HaCaT keratinocytes, BMPRs were silenced in PMEKs and 
transwell assay was performed (Figure 3.24c-d). In this model, silencing of 
Bmpr-1B significantly increased keratinocyte migration (194±23 PMEKs per 
microscopic field vs. 118±19 PMEKs per microscopic field; p<0.001); no effect 
was seen following Bmpr-1A silencing (109±14 PMEKs per microscopic field vs. 
118±19 PMEKs per microscopic field; p<0.2). 
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Figure 3.23 - Migration in response to constitutive activation of BMP-Smad 
pathway in HaCaT keratinocytes. (a-b) Constitutive activation of either 
BMPR-1A (pALK3) or BMPR-1B (pALK6) in combination with Smad1 or Smad5 
significantly slowed keratinocyte migration compared to empty vector controls 
(pCDNA); no significant difference was found between each treatment group. 
Error bars mean±SD; *p<0.0001; Student’s t-test with Bonferroni correction; n = 
20 measurements per group.  
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Figure 3.24 – Assessment of keratinocyte migration using scratch and 
transwell assays following BMPR silencing. (a-b) Scratch migration assay 
using HaCaT keratinocytes; BMPR-1B silencing significantly (p<0.01) 
accelerated scratch closure at 12 and 24 hours; (c) Photomicrograph images of 
migratory PMEKs following Bmpr silencing and transwell assay; (d) Bmpr-1B 
silencing significantly (p<0.001) increased PMEK migration in transwell assay. 
Error bars mean±SD; *p<0.01; **p<0.001; Student’s t-test with Bonferroni 
correction; n = 20 measurements per group in each experiment.  
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3.8 BMPR-1B signalling regulates expression of migration-
related genes   
In order to delineate which genes may be responsible for the Bmpr-1B-
mediated acceleration in migration, Bmpr-1B-silenced PMEKs were processed 
for qRT-PCR. Following confirmation of significant (p<0.001) Bmpr-1B silencing 
(Figure 3.25), increased transcript expression of Myo5a (p<0.02), Krt16 
(p<0.01) and Krt17 (p<0.001) was observed in Bmpr-1B-silenced keratinocytes 
compared to controls, all of which are involved in cell migration (Coulombe, 
1997; Paladini et al., 1996; Patel et al., 2006; Cao et al., 2004; Lan et al., 2010; 
Sloane and Vartanian, 2007). This suggests that BMP signalling can potentially 
delay re-epithelialization by inhibiting keratinocyte migration through BMPR-1B.  
 
Figure 3.25 – Bmpr-1B silencing increases migratory gene expression in 
primary mouse epidermal keratinocytes. Bmpr-1B was significantly down-
regulated in transfected PMEKs prior to further PCR analysis; Bmpr-1B 
silencing up-regulated transcript expression of Krt16, Krt17 and Myo5a, all of 
which are involved in keratinocyte migration and wound healing. Error bars 
mean±SD; *p<0.02; **p<0.01; ***p<0.001; Student’s t-test; PCR performed in 
duplicate.  
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3.9 Human skin heals and exhibits differentiation markers when 
cultured ex vivo at an air-liquid interface  
In order to establish the effect of BMP ligands and antagonists on human skin 
repair, an ex vivo wound healing model was designed (Section 2.10). Control 
wounds were cultured and harvested at days 1, 3 and 5 and stained with 
haematoxylin and AP (Figure 3.26). Wound histology demonstrated the 
presence of an epithelial tongue within 24 hours of injury (Figure 3.26; arrows), 
which progressively elongated across the exposed wound bed at day 3 (Figure 
3.26; arrows). By day 5, the wound was successfully closed, with evidence of a 
hyperproliferative epidermis and a contour defect due to dermal injury in the 
original wound location (Figure 3.26).  
To further delineate the dynamics of ex vivo human skin healing, Ki67 (Figure 
3.27a-d) and active caspase 3 (Figure 3.27e-h) immunostaining was performed 
to quantify proliferation and apoptosis in healing wounds. Initial ANOVA 
analysis indicated a significant difference in proliferation between time points (F 
(4,17) = 7.04, p<0.001). Proliferating Ki67+ keratinocytes were evident 
throughout the migrating epithelial tongue (Figure 3.27a-c), with a significantly 
increased proportion of positive cells detected at day 5 post-wounding 
(58.5±10% vs. 23.6±9%; p<0.05; Student’s t-test; Figure 3.27d) versus 
unwounded skin. Apoptotic cells detected by active caspase 3 were also seen 
in healing human wounds, with initial ANOVA testing indicating a significant 
difference between time points (F (4,21) = 19.8, p<0.001). Subsequent 
Student’s t-test analysis illustrated that apoptosis was significantly (p<0.001) 
increased on days 1 (4.4±0.9%), 3 (10.2±3%), 5 (18±4%) and 7 (14.7±4%) 
post-wounding versus unwounded skin (Figure 3.27e-h).  
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Figure 3.26 – Haematoxylin and alkaline phosphatase staining of human 
skin ex vivo wound healing model demonstrating healing over 5 days. A 
migrating epithelial tongue is visible on day 1 post-wounding, and is more 
pronounced at day 3. The wound is re-epithelialized at day 5, with evidence of a 
hyperproliferative epithelium and contour defect. Abbreviations: HF - hair 
follicle. 
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Figure 3.27 – Proliferation and apoptosis in human wound healing. (a-d) 
Proliferating cells seen in the wound tongue were significantly increased at day 
5 post-wounding; (e-h) Apoptotic cells were significantly increased on days 1, 3, 
5 and 7. *p<0.05; **p<0.001; error bars mean±SD; Student’s t-test with 
Bonferroni correction; n = 10 measurements per time point; scale bar 100µm. 
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To visualise the expression of differentiation-dependent and injury-induced 
keratins, ex vivo human skin wounds were stained for Krt10 (Fuchs and Green, 
1980; Moll et al., 2008; Moll et al., 1982) and Krt17 (Coulombe, 1997; Paladini 
et al., 1996; Patel et al., 2006) respectively. Expression of Krt10, which is a 
marker of terminal keratinocyte differentiation in the suprabasal epidermis 
(Fuchs and Green, 1980; Moll et al., 2008; Moll et al., 1982), was high in 
unwounded skin (Figure 3.28a). However, during day 3 of wound healing 
(Figure 3.28b) it was absent from the tip of the epithelial tongue, which contains 
relatively undifferentiated keratinocytes, whilst it remained highly expressed in 
the remainder of the migrating tongue. At day 5 post-wounding, Krt10 was 
highly expressed in the newly repaired epidermis as the keratinocytes 
differentiated (Figure 3.28c). As anticipated, Krt17 expression was absent in 
unwounded human skin samples (Figure 3.28d), but was dramatically 
increased at days 3 and 5 post-wounding (Figure 3.28e-f), illustrating that Krt17 
expression is induced following skin injury.  
Thus, these data illustrate that human wounds heal when cultured appropriately 
ex vivo and demonstrate proliferation, apoptosis, differentiation and inducible 
keratin expression during the repair process.  
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Figure 3.28 – Expression of Krt10 and Krt17 in healing human wounds.  (a-
c) Krt10 was highly expressed in unwounded suprabasal epidermis, but absent 
from the tip of the migrating epithelial tongue. However, it was highly expressed 
in the newly re-epithelialized epidermis; (d-f) Krt17 expression was absent from 
unwounded human skin but was strongly induced at days 3 and 5 post-
wounding. Dash-dot line – dermal-epidermal junction; dash line – wound 
epithelial tongue; scale bars 100µm. 
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3.10 BMP signalling components are expressed in healing 
human skin 
To begin to understand the involvement of BMP signalling in human skin repair, 
the expression of BMPR-1A, BMPR-1B and the downstream signalling 
component pSmad-1/5/8 were studied in unwounded human skin samples and 
ex vivo wounds at days 3 and 7 post-injury (Figures 3.29 & 3.30).  
A positive control illustrated that BMPR-1A was expressed in the HF bulge in 
unwounded human skin (Figure 3.29a; arrowed) but not in the wound 
epithelium (Figure 3.29b-c). Due to an absence of terminal hair in the skin 
specimens used for the ex vivo wound healing model, HF bulge-specific 
staining of BMPR-1A was not observed during wound healing.  
In unwounded skin, BMPR-1B was prominently expressed in the suprabasal 
epidermis (Figure 3.30a). Interestingly, BMPR-1B was expressed in the 
elongating epithelial tongue at day 3 post-wounding (Figure 3.30b), and was 
present in the newly re-epithelialized epidermis at day 7 (Figure 3.30c). P-
Smad-1/5/8 was prominently expressed throughout the unwounded epidermis 
(Figure 3.30d), as well as the migrating epithelial tongue at both days 3 and 7 
(Figure 3.30e-f; arrowheads), suggesting the involvement of BMP signalling in 
the skin healing response.  
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Figure 3.29 – Expression of BMPR-1A in the human hair follicle and during 
skin healing. (a) Positive control demonstrating BMPR-1A localisation to the 
HF bulge in an unwounded human HF skin sample (arrowed); (b-c) BMPR-1A 
is not expressed in the epithelial tongue during wound healing. Dashed line – 
wound epithelial tongue; scale bars 100µm. 
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Figure 3.30 – Expression of BMPR-1B and pSmad-1/5/8 in unwounded 
human skin and during healing. (a) BMPR-1B is expressed in the suprabasal 
layers of unwounded epidermis and is also seen in the (b) migrating epithelial 
tongue and (c) re-epithelialized epidermis; (d) pSmad-1/5/8 is expressed 
throughout the unwounded epidermis and the epithelial tongue at  day 3 (e; 
arrowheads) and day 7 (f; arrowheads) post wounding. Dash-dot line - 
dermal-epidermal junction; scale bars 100µm. 
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3.11 BMPs impair human wound closure by suppressing 
keratinocyte proliferation and potentiating apoptosis 
To characterise healing following BMP-4/7 or Noggin treatment, skin was 
harvested after 7 days treatment and a detailed morphological wound analysis 
performed (Figure 3.31a-e). Initial ANOVA analysis suggested a significant 
difference in wound healing between the four treatment groups (F (3,20) = 42.7, 
p<0.001). Subsequent Student’s t-test analysis illustrated that both untreated 
(control) (Figure 3.31a) and Noggin-treated (Figure 3.31d) wounds achieved 
100% closure following 7 days treatment (Figure 3.31e). In contrast, wound 
closure was significantly reduced in BMP-4/7-treated samples compared to 
controls (64±0.7% vs. 100%; p<0.01; Figure 3.31b). The combination of Noggin 
with BMP-4/7 increased wound closure compared to BMP-4/7 alone (88±12%; 
p<0.04; Figure 3.31c), negating the BMP-induced retardation of epidermal 
closure. To determine whether the impaired healing seen following treatment 
was due to alterations in proliferation or apoptosis, a quantitative analysis of 
epithelial tongue Ki67 and active caspase 3 positive cells was performed. Initial 
ANOVA analysis suggested a significant difference in proliferation (F (3,19) = 
15, p<0.001) between groups. Subsequent Student’s t-test analysis 
demonstrated that BMP-induced retardation of healing was associated with 
significantly reduced proliferation compared to controls (28±8% vs. 51±4%; 
p<0.01; Figure 3.32a-b & e; arrowed). However, Noggin negated this inhibitory 
effect of BMP-4/7 and proliferation was significantly increased in the skin co-
treated with Noggin and BMP-4/7 compared to BMP-4/7 alone (38±6% vs. 
28±8%; p<0.03) (Figure 3.32b-c & e; arrowed). Wounds treated solely with 
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Noggin did not display a significant increase in proliferation versus control 
(52±10% vs. 51±4%; p<0.8) (Figure 3.32d-e; arrowed).  
 
Figure 3.31 – Wound closure in human skin following BMP-4/7 or Noggin 
treatment. (a-d) Haematoxylin and AP-stained wound sections following 7 days 
of treatment - note evidence of incomplete epidermal closure in both BMP-4/7 
and BMP-4/7+Noggin treated wounds; (e) BMP-4/7 treatment significantly 
impaired wound closure, whilst combining Noggin with BMP-4/7 partially 
negated this effect; Noggin and control wounds were both completely healed at 
7 days. Error bars mean±SD; *p<0.04; **p<0.01; Student’s t-test with Bonferroni 
correction; n = 10 measurements per group; scale bars 100µm. 
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Figure 3.32 – Keratinocyte proliferation in human wounds following BMP 
pathway modulation. (a-d) Ki67 positive proliferating keratinocytes seen in the 
wound epithelial tongue of ex vivo human wounds following 7 days BMP-4/7 
and/or Noggin treatment; (e) BMP-4/7 significantly reduced the percentage of 
proliferating cells in the wound epithelium; Noggin negated this BMP-induced 
negative effect when wounds were treated with a combination of these agents; 
error bars mean±SD; *p<0.03; **p<0.001; Student’s t-test with Bonferroni 
correction; n = 10 measurements per group; scale bars 100µm. 
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Initial ANOVA analysis suggested a significant difference in apoptosis (F (3,17) 
= 25.2, p<0.001) between the four treatment groups. BMP-4/7 treatment 
significantly increased apoptosis in the wound bed compared to controls, as 
evidenced by active caspase 3 expression (13±2% vs. 9±1%; p<0.04; Figure 
3.33a-b & e; arrowed). In contrast, Noggin significantly reduced the proportion 
of apoptotic cells compared to control samples (3±0.7% vs. 9±1%; p<0.01; 
Figure 3.33d-e; arrowed). Apoptosis was also significantly reduced in wounds 
co-treated with Noggin and BMP-4/7 compared to BMP-4/7 treatment alone 
(8±3% vs. 13±2%; p<0.04; Figure 3.33c & e; arrowed). Combined, these data 
suggest that BMPs suppress keratinocyte proliferation and stimulate 
keratinocyte apoptosis in an ex vivo wound human wound healing model, 
effects which are overcome by antagonising BMP activity with Noggin. 
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Figure 3.33 - Keratinocyte apoptosis in human wounds following BMP 
pathway modulation. (a-d) Active caspase 3 positive apoptotic keratinocytes 
seen in the wound epithelial tongue of ex vivo human wounds following 7 days 
BMP-4/7 and/or Noggin treatment; (e) BMP-4/7 significantly increased 
apoptosis in the wound epithelium; Noggin negated this BMP-induced effect 
when wounds were treated with a combination of these agents; Noggin 
significantly reduced apoptosis when administered to wounds alone; error bars 
mean±SD; *p<0.04; **p<0.001; Student’s t-test with Bonferroni correction; n = 
10 measurements per group; scale bars 100µm. 
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3.12 Modulation of BMP activity in human ex vivo wounds 
alters the expression of genes involved in epidermal 
differentiation 
To further define the effects of BMP pathway modulation on wound healing and 
epidermal differentiation, mRNA transcript expression of genes involved in 
keratin reorganisation and epidermal cornification were determined by qRT-
PCR and compared following BMP-4/7 and/or Noggin treatment in human ex 
vivo wounds (Figure 3.34a-e). These genes included KRT14 (keratin 
expressed in mitotically-active basal layer keratinocytes) (Moll et al., 2008), 
KRT10 (differentiation-keratin expressed in the suprabasal epidermis) (Moll et 
al., 2008), KRT16 (injury-induced keratin) (Coulombe, 1997; Moll et al., 2008), 
and the predominant protein of the cornified cell envelope, loricrin (LOR) 
(Nemes and Steinert, 1999).  
BMP-4/7 treatment significantly (p<0.001) reduced LOR transcript expression 
and significantly (p<0.05) increased KRT10 expression (Figure 3.34a & d). 
Conversely, transcript expression of KRT10 (p<0.001), KRT14 (p<0.001), 
KRT16 (p<0.05) and LOR (p<0.001) (Figure 3.34a-d) were significantly up-
regulated following BMP antagonism with Noggin. Treatment with combined 
BMP-4/7 and Noggin significantly reduced expression of LOR (p<0.001) and 
KRT10 (p<0.01) compared to controls (Figure 3.34a & d). 
In conclusion, antagonism of BMP activity using Noggin increases proliferation- 
and differentiation-related keratin transcript expression, together with cornified 
cell envelope protein transcripts. This effect correlates with the accelerated 
wound repair seen in Noggin-treated ex vivo human wounds.   
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Figure 3.34 – Relative mRNA transcript expression of keratins and loricrin 
after 7 days of BMP pathway modulation in human ex vivo wounds. BMP-
4/7 treatment reduced LOR expression and increased KRT10 expression. 
Noggin increased KRT10, KRT14, KRT16 and LOR expression. Combined 
BMP-4/7 and Noggin treatment reduced expression of LOR and KRT10 versus 
controls. Error bars mean±SD; *p<0.05; **p<0.01; ***p<0.001; Student’s t-test; 
PCR samples performed in duplicate; analysed using Genex™ (Bio-Rad) 
software using Ct equitation method. 
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IV. Discussion 
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4.1 BMP signalling components are differentially expressed in 
the early stages of wound healing  
BMP signalling is involved in the regulation of a large number of biological 
processes including proliferation, differentiation, cell fate decision and apoptosis 
both in embryonic development and postnatal tissue remodelling (Botchkarev, 
2003; Botchkarev and Sharov, 2004; Kimura et al., 2000; Miyazono et al., 2010; 
Walsh et al., 2010). However, the role of BMP signalling cascades in cutaneous 
wound healing remains relatively unexplored. 
To begin to understand the role of BMP signalling in this process, the mRNA 
expression of BMP-Smad ‘canonical’ pathway components was examined in 
detail using qRT-PCR in 8 week-old WT telogen skin, and at days 3 and 5 post-
wounding. This revealed an almost global suppression of the BMP axis in 
response to skin injury (Mathura et al., 2000), with significantly decreased 
transcript expression of Bmp ligands, Bmpr-1A, Bmpr-II, Smad1, Smad5 and 
Noggin. Interestingly, Bmpr-1B expression was significantly increased following 
wounding.  
These data are supported by previous observations that BMP ligands are down-
regulated following injury. Indeed, both BMP-2 and -4 have been shown to be 
down-regulated in retinal epithelium in response to hypoxia-induced ischaemic 
retinopathy (Mathura et al., 2000). Furthermore, transcript expression of BMP-2, 
-4 and -7 have been shown to decline following skin injury, showing recovery 
towards the end of the proliferative phase of wound healing (Wankell et al., 
2001). 
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The immunofluorescent expression pattern of BMPRs observed in telogen skin 
was consistent with that previously described, with BMPR-1A localised to the 
HF bulge (Blanpain and Fuchs, 2006) and BMPR-1B in the suprabasal 
epidermis (Hwang et al., 2001; Sharov et al., 2003; Yu et al., 2010b), where 
they were both co-localised with the downstream signalling component pSmad-
1/5/8. The prominent expression of BMPR-1A was consistent with its role in 
maintaining stem cell quiescence in conjunction with BMP ligands (Blanpain 
and Fuchs, 2006; Blanpain et al., 2004; Fuchs, 2008; Kobielak et al., 2007; 
Zhang et al., 2006), whilst the suprabasal localisation of BMPR-1B correlated 
with its role in the control of cell differentiation of epidermal layers (Botchkarev 
and Sharov, 2004; Fessing et al., 2010; Pardali et al., 2005; Plikus et al., 2008). 
Skin injury induced a localised down-regulation of bulge BMPR-1A expression 
in those HFs immediately adjacent to the wound, suggesting a decrease in 
BMP-mediated inhibition of stem cell activity. Together with the qRT-PCR data, 
this suggests that down-regulation of both BMP ligands and BMPR-1A may 
potentially facilitate an increase in stimulatory (Wnt) signalling and subsequent 
HF stem cell activity, which accompanies wound healing (Botchkarev et al., 
1999; Cotsarelis, 2006; Hwang et al., 2001; Ito and Cotsarelis, 2008; Ito et al., 
2005; Kobielak et al., 2003; Plikus et al., 2008; Sharov et al., 2009; Wong and 
Reiter, 2011; Zhang et al., 2006). Further studies including stem cell lineage 
tracing in K14-Noggin and K14-caSmad1 mice would be useful to substantiate 
this theory.  
Furthermore, the extensive expression of BMPR-1B and pSmad-1/5/8 in the 
wound epithelium implicates an involvement of this receptor in the control of 
skin repair, together with the dynamic expression profile observed in qRT-PCR. 
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Interestingly, the wound epithelial expression pattern of BMPR-1B appeared to 
show cytoplasmic staining in the epithelial tongue keratinocytes, as opposed to 
that expected on the cell membrane, which was seen in unwounded epidermis. 
Intracellular localisation of both BMPR-1A and BMPR-1B has been described in 
human osteoblasts (Singhatanadgit et al., 2008), with BMPR-1B in particular 
found in the peri-nuclear region. This suggests that in the absence of an 
appropriate ligand, BMPR-1B undergoes internalisation; alternatively, 
intracellular BMPR-1B may represent newly synthesised receptors prior to their 
transport to the cell surface (Singhatanadgit et al., 2008) to play roles in wound 
repair and keratinocyte differentiation. Certainly, BMPR-1B is thought to 
modulate keratinocyte differentiation (Plikus et al., 2004), though BMP-
treatment has failed to illustrate changes in epidermal differentiation markers 
such as involucrin, loricrin or suprabasal keratins (Fessing et al., 2010), but 
follicular differentiation markers have been demonstrated (Sharov et al., 2006).   
The expression patterns seen in murine skin were complemented by those seen 
during human ex vivo skin repair. As expected, BMPR-1B and pSmad-1/5/8 
were prominently expressed in human suprabasal epidermis (Hwang et al., 
2001; Sharov et al., 2003; Yu et al., 2010b) and the migrating epithelial tongue. 
However, due to an absence of terminal hair in the skin specimen analysed, HF 
bulge-specific staining of this BMPR in relation to human skin wounding was not 
observed. Thus, the expression patterns observed in both murine and human 
skin illustrate the highly conserved nature of this signalling cascade. 
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4.2 BMP pathway modulation influences wound repair 
Two TG mouse models were employed to elucidate the role of BMP signalling 
on in vivo wound repair, these being the K14-caSmad1 and K14-Noggin 
models. Using these mice, a comprehensive histomorphological analysis of the 
wound epithelium was conducted, to establish the effect that constitutive BMP 
activation or antagonism has on skin repair. These data were supplemented 
with ex vivo human wound healing models and in vitro characterisation of BMP 
effects on HaCaT keratinocyte and PMEK proliferation. 
 
 4.2.1 In vivo alteration of BMP activity alters keratinocyte 
proliferation and apoptosis 
The K14-caSmad1 mouse model provided in vivo evidence that constitutive 
BMP signal activation delays wound healing by suppressing keratinocyte 
proliferation and potentiating apoptosis (Kimura et al., 2000). These data are 
consistent with previous studies showing that other components of the TGF-β 
signalling pathways, such as Smad2, Smad3 and Smad4 negatively regulate 
skin repair through alterations in proliferation (Ashcroft et al., 1999; Flanders et 
al., 2003; Hosokawa et al., 2005; Owens et al., 2010; Tomikawa et al., 2012; 
Yang et al., 2012). Furthermore, these data strongly support a role for BMP 
signalling in cutaneous wound repair, as Smad1 is specific to the BMP-Smad 
‘canonical’ pathway (Botchkarev, 2003; Botchkarev and Sharov, 2004; Sieber et 
al., 2009).  
Wound histomorphometry in K14-Noggin mice was markedly different from that 
seen in K14-caSmad1 mice, as the wound epithelial tongue area was 
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significantly larger and demonstrated increased proliferation and reduced 
apoptosis. These results fit with previous reports, whereby over-expression of 
the BMP antagonist Noggin results in epidermal hyperplasia due to 
hyperproliferation (Sharov et al., 2009), suppresses apoptosis (Sharov et al., 
2003) and prolongs anagen follicle growth (Plikus et al., 2004; Sharov et al., 
2006), whilst exogenous Noggin treatment stimulates epidermal proliferation 
(Botchkarev et al., 1999). Furthermore, Noggin has been shown to suppress 
apoptosis in other tissues, including teeth (Nadiri et al., 2007), the hard palate 
(He et al., 2010) and during limb development, where Noggin over-expression 
induces syndactyly (fused digits) (Guha et al., 2002).  
The role of BMP signalling in apoptosis has been illustrated in a number of 
studies (Sharov et al., 2003; Song et al., 1998; Trousse et al., 2001; Wach et 
al., 2001; Yokouchi et al., 1996), all of which support the results seen in the 
K14-caSmad1 model. Indeed, Smad2, -3 and -4 have previously been shown to 
induce apoptosis (Fujita et al., 2012; Yanagisawa et al., 1998; Yu et al., 2008) 
potentially in collaboration with p53 (Brash, 2006; Wang et al., 2006a). The 
differential apoptotic effect seen in K14-caSmad1 and K14-Noggin wounds may 
be due to the modulation of apoptosis regulators including cyclin-dependent 
kinase inhibitor p21 (Chang et al., 2009; Fessing et al., 2011; Franzen and 
Heldin, 2001; Jernvall et al., 1998; Sharov et al., 2006), the transcriptional 
activator Stat3 (Kawamura et al., 2000; Ying et al., 2003) or caspase-8 (Borrelli 
et al., 2009; Lagna et al., 2006). Additionally, the tumour suppressor p53 has 
been shown to interact with Smad1 (Chau et al., 2012) to induce DNA-binding 
protein inhibitor Id-1 and therefore regulate proliferation (Liu et al., 2013). 
Furthermore, BMP-treated pulmonary cells have been shown to express 
diminished levels of the anti-apoptotic factor Bcl-2 (Buckley et al., 2004), 
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supporting its possible involvement in this process. Combined, these results 
suggest that Smad1 has an important function in regulating epidermal 
homeostasis during skin repair, and may potentiate apoptosis through a variety 
of potential mechanisms. 
It has previously been shown that activation of BMP signalling slows 
keratinocyte proliferation (Ahmed et al., 2011; Blessing et al., 1996; D'Souza et 
al., 2001; Drozdoff et al., 1994; Kaiser et al., 1998; Mathura et al., 2000; 
McDonnell et al., 2001; Park and Morasso, 2002), whilst targeted over-
expression of BMP ligands results in a resistance to chemical-induced skin 
carcinogenesis (Blessing et al., 1995; Wach et al., 2001). Conversely, chemical-
induced carcinogenesis is accompanied by a down-regulation of both Smad1 
and Smad5 proteins (He et al., 2001), signifying their importance in regulating 
proliferation. Aside from the potential apoptotic targets described, studies have 
illustrated a number of regulatory pathways and transcription factors which may 
act as BMP targets to control epidermal proliferation during skin healing. These 
include Wnt (Di Pasquale and Brivanlou, 2009; Ishitani et al., 1999; Kamiya et 
al., 2008; Lintern et al., 2009; Piccolo et al., 1999; Sharov et al., 2009) and Shh 
(Laurikkala et al., 2003; Sharov et al., 2009; Zuniga et al., 1999), both of which 
are up-regulated in response to Noggin, and c-myc, which is downstream of 
BMP-Smad signalling (Holien et al., 2012; Kowalik, 2002; Seoane et al., 2001; 
Yagi et al., 2002).  Additionally, p63 has also been shown to be extensively 
expressed in the wound margin and epithelial tongue (Kurokawa et al., 2006), 
and represses transcription of Smad7 and activate BMP-7, thereby potentiating 
BMP signalling (De Rosa et al., 2009). A number of important growth factors 
have also been demonstrated to interact with BMP signalling, including EGF 
(Kretzschmar et al., 1997), GM-CSF (Montenegro et al., 2009), NGF (Schnitzler 
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et al., 2010), HGF (Gupta et al., 2000; Tsai et al., 2012) and vasoactive 
intestinal peptide (Pitts et al., 2001), suggesting a role.  
A quantitative analysis of CD4 positive cells in all three mouse strains was 
conducted to ensure that the differences seen in wound repair were not due to 
variations in inflammatory cell infiltrate (Mardaryev et al., 2011). This confirmed 
that there was no difference in CD4 positive cell numbers between the three 
groups.  Thus, the in vivo models provide strong evidence that Smad1, a crucial 
downstream regulator of the BMP-Smad pathway (Botchkarev and Sharov, 
2004), slows wound healing by attenuating keratinocyte proliferation and 
migration and augmenting wound epithelial apoptosis. Conversely, the BMP 
antagonist Noggin accelerates skin repair by augmenting epithelial tongue 
proliferation and suppressing apoptosis. In conjunction with the down-regulation 
of BMP ligands observed in WT mice, it is possible that if BMPs act as growth-
regulators in the skin, then their down-regulation may be part of the healing 
response, thereby allowing positive growth regulators to stimulate proliferation 
(Mathura et al., 2000).  
As alluded to before, BMPs influence angiogenesis which forms a vital part of 
skin repair. Different BMP ligands act as either pro or anti-angiogenic (David et 
al., 2009; Ramoshebi and Ripamonti, 2000; Sieber et al., 2009), whilst deletion 
of BMP-Smad down-stream components lead to defects in vasculogenesis and 
vessel wall anatomy (David et al., 2009; Gallione et al., 2006; Huang et al., 
2009; Morrell, 2006; Shintani et al., 2009; Yang et al., 1999). In particular, the 
BMP-7 component of the heterodimer used in this study (BMP-4/7) has been 
illustrated to be pro-angiogenic (David et al., 2009). Further studies to ascertain 
the effect of BMP-Smad pathway modulation on angiogenesis in K14-caSmad1 
164 
 
and K14-Noggin mice would be both novel and useful to further understand the 
role of BMPs on this vital part of skin repair.  
Fibrosis and scarring form an inevitable conclusion of cutaneous wounding and 
at its extreme, may develop into a hypertrophic or even a keloid scar. The TGF-
β family (Cowin et al., 2001), and in particular, BMPs are involved in the 
processes of late wound repair and cutaneous remodelling (Botchkarev, 2003). 
Foetal mammals heal wounds through the second trimester with no evidence of 
scarring (Stelnicki et al., 1998b), but when BMP-2 is applied to foetal wound 
beds, there is marked dermal and epidermal thickening, together with the 
deposition of irregular collagen bundles due to enhanced fibroblast activity 
(Stelnicki et al., 1998b). Similar results are found in the cornea; up-regulation of 
BMP-6 is associated with increased conjunctival scar tissue (Andreev et al., 
2006). In contrast, over-expression of the weak BMP antagonist follistatin 
reduces the volume of granulation tissue, delays re-epithelialization and 
reduces scarring (Wankell et al., 2001). Thus, antagonism of BMP ligands 
impedes scar tissue formation (Wankell et al., 2001). Whilst not performed in 
this study, examination of collagen fibrils in the two TG models used would 
provide some insight into the effect of BMP-pathway activation/antagonism on 
scar tissue formation. This would be relatively easy to perform using Picrosirius 
Red dye (Junqueira et al., 1979; Puchtler et al., 1973).     
A further facet of wound repair that would benefit investigation following BMP 
pathway modulation is inflammation. The TGF-β family as a whole is well 
established to play roles in immune suppression and T-cell regulation (Bierie 
and Moses, 2010). Indeed, absence of TGF-β1 leads to a propensity to develop 
autoimmune diseases due to T-cell over-activity (Gorelik and Flavell, 2000; 
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Kulkarni et al., 1993; Kulkarni and Karlsson, 1993), potentially due to the loss of 
p21Cip1 and p27Kip1 cell cycle regulators (Wolfraim et al., 2004). The present 
study suggested that BMP pathway modulation had no effect on the number of 
CD4 positive cells seen in the local wound environment. However, whilst this 
may be the case, further studies to establish T-cell activity rather than 
population size following BMP or Noggin treatment, as well as on other 
inflammatory cells, may be beneficial. Certainly, BMP signalling has been 
illustrated to stimulate both IL-2 and T-cell activity, whilst antagonism of the 
BMP axis using dorsomorphin and Noggin suppresses interleukin secretion and 
T-cell function (Cejalvo et al., 2007; Yoshioka et al., 2012). Furthermore, BMP 
signalling has been illustrated to play vital roles in natural killer cell (Hidalgo et 
al., 2012) B-cell (Passa et al., 2011) and T-cell development (Hager-
Theodorides et al., 2002; Varas et al., 2009). Thus, local antagonism of BMPs 
using Noggin may reduce local inflammatory cell infiltrate and could increase 
the propensity to develop subsequent wound infection. This represents an 
interesting area for future study.  
 
4.2.2 BMP pathways affect human skin repair by influencing 
keratinocyte proliferation, apoptosis and differentiation 
The ex vivo skin healing model was a useful model to study the effects of BMPs 
on human skin repair. When cultured correctly, these wounds re-stratified the 
epidermis and exhibited evidence of keratinocyte proliferation, keratin induction, 
epidermal differentiation and apoptosis (Rizzo et al., 2012).  Furthermore, this 
model demonstrated that BMP treatment inhibits epidermal closure, whilst 
Noggin accelerates skin repair. Clearly, these results support our in vivo data 
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and further suggest that the effects of this signalling cascade are highly 
conserved between murine and human skin.  
Interestingly, BMP pathway modulation led to a change in expression of 
keratins and loricrin, a constituting protein of the cell envelope (Hitomi, 2005; 
Hoffjan and Stemmler, 2007; Koch et al., 2000). BMP antagonism with Noggin 
dramatically increased transcript expression of KRT10, KRT14, KRT16 and 
loricrin (LOR). This effect could be explained by the accelerated wound healing 
dynamics observed in the Noggin-treated wounds, as Krt14 is expressed by 
proliferating basal epidermal keratinocytes (Moll et al., 1982), whilst Krt16 is 
injury-induced (Coulombe, 1997; Moll et al., 2008). Furthermore, the increased 
expression of KRT10 and LOR, both of which signify epidermal differentiation 
(Hitomi, 2005; Hoffjan and Stemmler, 2007; Koch et al., 2000; Moll et al., 2008; 
Nemes and Steinert, 1999), may be due to accelerated closure after Noggin 
treatment, as the epidermis re-stratified ahead of other treatment groups.  
Yu et al. (2010b) examined the expression of fillagrin in the stratum granulosum 
following BMP treatment, finding it to be reduced, whilst Sharov et al. (2003) 
found that Noggin overexpression attenuated involucrin and loricrin expression. 
GATA3 (a transcriptional regulator of EDC gene expression) may also play 
roles in this process, as it is expressed in the epidermis (Chikh et al., 2007; 
Kaufman et al., 2003) and displays a dynamic expression profile during skin 
morphogenesis (Sellheyer and Krahl, 2010), which is akin to wound healing 
(Martin and Parkhurst, 2004). Furthermore, a relationship between GATA3 and 
BMP signalling has been demonstrated in tissue development (Bonilla-Claudio 
et al., 2012). 
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Whilst some studies have been successful in identifying the effects of BMPs on 
epidermal differentiation, others have not. Fessing et al. (2010) and Gosselet et 
al. (2007) failed to show an effect of BMPs on suprabasal keratin or loricrin 
expression, potentially due to the presence of EGF in culture media. However, 
this was absent from the culture media for this experiment, and an increase in 
KRT10 and decrease in LOR expression was observed after BMP-4/7 
application. Thus, it appears that antagonism of BMP signalling increases 
keratin and differentiation marker expression in this human skin healing model.  
 
4.2.3 BMP signalling pathway modulation affects keratinocyte 
proliferation in vitro 
Whilst in vivo and ex vivo models clearly demonstrated the negative effect of 
BMP pathway signalling on epidermal proliferation and apoptosis (Plikus et al., 
2004; Sharov et al., 2009), it was important to demonstrate this in vitro using 
two keratinocyte sources. Treatment of HaCaT cells and PMEKs with BMP-4/7 
inhibited proliferation, as evidenced by Ki67 proliferation marker 
immunostaining. Furthermore, flow cytometry of HaCaT keratinocytes 
demonstrated a reduction in those undergoing mitosis. Clearly, the presence of 
BMP-4/7 suppresses active keratinocyte proliferation, and tends to induce cell 
cycle arrest, complimenting data that has been shown before (Ahmed et al., 
2011; Blessing et al., 1996; D'Souza et al., 2001; Drozdoff et al., 1994; Kaiser et 
al., 1998; Mathura et al., 2000; McDonnell et al., 2001; Park and Morasso, 
2002; Sharov et al., 2006). Furthermore, the anti-proliferative effect of the BMP 
pathway has been illustrated in numerous cancers, including osteosarcoma (Lv 
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et al., 2013), breast carcinoma (Chen et al., 2012; Wang et al., 2011; Ye et al., 
2013) and gastric carcinoma (Zhang et al., 2012). 
This suppressive effect was negated when BMP-4/7 was antagonised by 
Noggin, which is known to inhibit BMP-4 and -7 with high specificity (Botchkarev 
et al., 1999; Botchkarev, 2003; Krause et al., 2011). When administered alone, 
Noggin stimulated proliferation compared to controls. This, of course, is in 
keeping with previous observations (Botchkarev et al., 1999; Plikus et al., 2004; 
Sharov et al., 2006; Sharov et al., 2009), which describe epidermal hyperplasia 
in response to Noggin, both in K14-Noggin mice and ex vivo organ culture.  
To define the effect that specific BMPRs play in keratinocyte proliferation, 
keratinocytes were transfected with siRNA and QD plasmids for flow cytometry 
analysis. BMPR-1B silencing in both PMEKs and HaCaT cells had no definable 
effect on proliferation, whilst BMPR-1A silencing resulted in a minimal increase 
in cellular mitosis compared to controls. This failure to exert a dramatic effect on 
proliferation can perhaps in hindsight be anticipated for two reasons. Ideally, the 
time following siRNA transfection until analysis would have been 72 hours to 
permit full gene knockdown (Dalby et al., 2004; Zhao et al., 2008). This was 
limited to 48 hours due to the rapid rate of HaCaT cell growth and the relative 
fragility and susceptibility of PMEKs to cell death. Furthermore, HaCaT 
keratinocytes are immortalised and less likely to display any further increase in 
proliferative potential.  
Transfection of cells with constitutively active plasmids globally reduced 
proliferation, supporting previous evidence of the inhibitory action of BMP 
signalling. However, constitutive activation of BMPR-1A in conjunction with 
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Smad1 had the most notable effect with a four percent reduction in G2/M cells 
versus control.  
Taken together, these data suggest that BMPR-1A could possibly play a role in 
modulating keratinocyte proliferation, as has been suggested (Yamaguchi et al., 
1999; Panchision et al., 2001; Plikus et al., 2004), and supports a theory that 
BMPR-1A down-regulation in HFs may permit increased stem cell activity 
through stimulatory Wnt signalling (Sharov et al., 2009), resulting in progeny 
proliferation to close the skin defect. However, further data are required to fully 
understand the role of BMPR-1A in wound healing. Certainly, BMPs have been 
shown to induce cell cycle inhibitor activity, including p21Cip1 (Pardali et al., 
2005) and p27Kip1 (Sharov et al., 2006), further reinforcing this argument.  
These data, therefore, would be in keeping with the model described by Sharov 
et al. (2006).  
 
4.3 BMP pathway modulation affects keratin gene & protein 
expression 
Examination of the expression pattern of Krt16 and Krt17, which are induced in 
response to wounding (Coulombe, 1997; Paladini et al., 1996; Patel et al., 
2006) revealed significant differences between our TG models and WT mice. 
qRT-PCR illustrated dramatic down-regulation of Krt16 and Krt17 in K14-
caSmad1 mice compared to WT controls. Furthermore, immunostaining showed 
that both Krt16 and Krt17 were intensely reduced in K14-caSmad1 mouse 
wounds compared to WT controls whilst they were increased in K14-Noggin 
wounds. Analysis of keratinocyte morphology also revealed that the epithelial 
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tongue of WT and K14-Noggin mice contained polarised keratinocytes (Allard 
and Mogilner, 2013; Driscoll et al., 2012; Meyer et al., 2012). In contrast, K14-
caSmad1 wound epithelial keratinocytes had a cuboidal appearance, 
suggesting that the delayed wound healing observed in these mice may also be 
caused by impaired keratinocyte migration. 
The importance of both Krt16 and Krt17 in skin repair is well documented, as 
activated keratinocytes reorganise the intracellular keratin network in order to 
migrate (Wawersik et al., 2001). In particular, Krt16 and Krt17 are induced in 
activated keratinocytes (Machesney et al., 1998; Mansbridge and Knapp, 1987; 
McGowan and Coulombe, 1998; Paladini et al., 1996; Takahashi et al., 1998; 
Wawersik and Coulombe, 2000; Wawersik et al., 2001), principally in the 
migrating epithelial tongue (Wawersik et al., 2001). Deficiency of both Krt16 
(Wawersik et al., 2001) and Krt17 (Mazzalupo et al., 2003) is associated with 
impaired keratinocyte migration (Trost et al., 2010) and wound closure.  
A link between TGF-β family members and keratins has previously been 
illustrated, after Hosokawa et al. (2005) and Tomikawa et al. (2012) noted that 
over-expression of Smad2 inhibits Krt16 expression. Furthermore, knock-out of 
Smad4 leads to up-regulation of Krt17 expression (Yang et al., 2012). However, 
these Smads do not form part of the BMP-Smad pathway. Thus, the in vivo 
models utilised here provide strong and novel evidence that the BMP-Smad 
signalling pathway slows epithelial repair by altering the expression of specific 
keratin proteins. 
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4.4 Constitutive BMP activation in K14-caSmad1 epidermis 
down-regulates the expression of genes encoding cytoskeletal 
and migration-associated markers 
By employing a microarray approach, genome-wide gene expression profiles 
were compared between K14-caSmad1 and WT epidermis (deposited to the 
Gene Expression Omnibus - Accession Number GSE50578) and subsequently 
extrapolated to full thickness skin wounds. The microarray and qRT-PCR 
analyses demonstrated two-fold and higher changes in expression of 1697 
genes in the epidermis of TG versus WT mice. These encoded distinct 
cytoskeletal and cell motility-associated proteins, including keratins (Krt1, Krt10, 
Krt16 and Krt17) (Coulombe, 1997; Fuchs and Green, 1980; Moll et al., 2008; 
Moll et al., 1982; Paladini et al., 1996; Patel et al., 2006), Myo5a (Cao et al., 
2004; Lan et al., 2010; Sloane and Vartanian, 2007),  Cldn1 and Cldn3 (Webb 
et al., 2013), Rac1 (Filic et al., 2012; Fukata et al., 2003; Tscharntke et al., 
2007), Gjb2 and Gja4 (Xu and Nicholson, 2013; Scott and Kelsell, 2011), 
Ablim2 (Barrientos et al., 2007), Tubb6 (Brieher, 2013; Leandro-Garcia et al., 
2010) and Pxn (Ishibe et al., 2004; Meyer et al., 2012; Sattler et al., 2000; 
Turner, 1998). It is unlikely that all of these genes are direct targets of BMP 
signalling, as those genes representing direct targets for the BMP pathway may 
in turn regulate transcription of other indirect targets or interfere with 
components of other signalling pathways. However, the changes in transcription 
activity observed are likely to contribute to the retardation of wound healing 
observed in K14-caSmad1 mice.  
Previous microarray data (Fessing et al., 2010; Sharov et al., 2006) has 
illustrated a number of target genes involved in migration that are influenced by 
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BMP signalling. BMP-4/7 treatment of PMEKs has been shown to affect 
expression of MMP-3 and 10 (Fessing et al., 2010), both of which play 
important roles in matrix degradation during wound healing. Indeed, Smad4 
knock-out has been shown to increase MMP levels, potentially impacting on 
migration and wound remodelling (Owens et al., 2010). Additionally, periostin, a 
ligand known to support integrin-mediated epithelial cell migration (Gillan et al., 
2002), is down-regulated in both keratinocytes and fibroblasts (Fessing et al., 
2010). Hyaluronan synthase 1 (HAS1), an extracellular matrix polysaccharide 
required for migration and vessel ingrowth, is up-regulated in fibroblasts but not 
keratinocytes following BMP-4/7 treatment (Fessing et al., 2010).  
Importantly, the K14-caSmad1 epidermis showed a marked decrease in the 
expression of migration-related genes, some of which have been described to 
play direct roles in epidermal repair (Castilho et al., 2010; Hosokawa et al., 
2005; Mazzalupo et al., 2003; McGowan and Coulombe, 1998; Moll et al., 2008; 
Paladini et al., 1996; Patel et al., 2006; Tomic-Canic et al., 1998; Tscharntke et 
al., 2007; Wawersik and Coulombe, 2000; Wawersik et al., 2001). In 
conjunction with the in vivo data, which showed that the epithelial tongue was 
shorter and contained fewer polarised migratory keratinocytes in K14-caSmad1 
mice (Kurosaka and Kashina, 2008), this suggests that Smad1 constitutive 
activation slows keratinocyte migration.  
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4.5 BMP pathway modulation alters keratinocyte migration 
through BMPR-1B signalling 
Utilisation of ‘scratch’, transwell and ex vivo migration assays allowed the 
effects of BMPs and their antagonists on HaCaT keratinocyte and PMEK 
migration to be studied. In all of these models, BMP-4/7 consistently slowed 
keratinocyte migration, whilst Noggin treatment had a stimulatory effect and 
accelerated migration in excess of that seen in controls. Transwell assay also 
demonstrated that constitutive BMP pathway activation in K14-caSmad1 
keratinocytes slowed migration when studied in vitro (Ashcroft et al., 1999; 
Flanders et al., 2003; Hosokawa et al., 2005; Owens et al., 2010; Tomikawa et 
al., 2012; Yang et al., 2012).  
These data are consistent with previous results showing the inhibitory effects of 
the TGF-β family on cell migration during skin repair (Ashcroft et al., 1999; 
Hosokawa et al., 2005; Tsuboi et al., 1992), as well as with data demonstrating 
that Smad2 (Hosokawa et al., 2005), Smad3 (Ashcroft et al., 1999; Flanders et 
al., 2003) and Smad4 (Yang et al., 2012) inhibit cell movement in other models. 
Furthermore, these results suggest that BMP signalling negatively regulates 
keratinocyte migration (Ahmed et al., 2011).  
Consistent with these data, BMP-treated PMEKs lacked the defined cytoplasmic 
actin filament network required for movement, while Noggin-treated 
keratinocytes displayed an elongated polarised shape with endogenous actin 
filaments visible (Allard and Mogilner, 2013; Firat-Karalar and Welch, 2011; 
Fletcher and Mullins, 2010; Kurosaka and Kashina, 2008; Reymann et al., 
2012). Combined with microarray and qRT-PCR data, these results suggest 
that BMP signalling attenuates keratinocyte movement through alterations in 
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different proteins involved in varying facets of migration, including actin and 
myosin binding, adhesion, microtubule formation and cytoskeletal organisation. 
Thus, down-regulation of these protein groups may lead to the alterations in 
keratinocyte shape observed.  
Besides the direct effect of BMP ligands on migration, BMPR-1B silencing also 
consistently accelerated wound closure, though no discernible difference could 
be seen when QD plasmid transfection was performed to activate BMPR-1A or 
BMPR-1B. This may be due to the fact that constitutive activation of the BMP 
axis potentiates apoptosis (Sharov et al., 2003; Song et al., 1998; Wach et al., 
2001; Yokouchi et al., 1996), thus promoting global keratinocyte death and 
failing to illustrate a subtle distinction between BMPR-1A or BMPR-1B activation 
on keratinocyte migration. Furthermore, BMPR-1B knockdown in keratinocytes 
caused increased expression of Krt16, Krt17 (Hosokawa et al., 2005; 
Mazzalupo et al., 2003; McGowan and Coulombe, 1998; Moll et al., 2008; 
Paladini et al., 1996; Patel et al., 2006; Tomic-Canic et al., 1998; Wawersik and 
Coulombe, 2000; Wawersik et al., 2001) and Myo5a, an actin-dependent 
molecular motor involved in cell motility and metastasis (Cao et al., 2004; 
Eppinga et al., 2008; Kurosaka and Kashina, 2008; Lan et al., 2010).  
Previous studies have found BMPR-1B expression on endothelial cell filopodial 
tips (Pi et al., 2007; Sieber et al., 2009) and retinal axons (Liu et al., 2003; 
Yamauchi et al., 2008), where they have been suggested to play a role in cell 
guidance. Furthermore, Ror2, a BMPR-1B co-receptor (Sammar et al., 2004), 
has been shown to interact with Filamin A in filopodia and influence Wnt5a-
induced cell motility (Nishita et al., 2006; Sammar et al., 2009; Sieber et al., 
2009). In summation, this suggests that BMP signalling can cause delayed re-
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epithelialization by inhibiting keratinocyte cytoskeletal organization and 
migration, effects which are mediated, at least in part, through BMPR-1B. 
 
4.5.1 Model illustrating the involvement of BMP signalling in 
cutaneous wound repair 
Taken together, these data support a concept that the BMP signalling pathway 
is intrinsically involved in the negative regulation of cutaneous wound repair. 
Our data provides compelling evidence that BMPs negate keratinocyte 
proliferation, augment apoptosis and modulate keratinocyte migration through 
specific BMPRs (Figure 4.1). Thus, transient antagonism of BMP activity using 
specific BMP antagonists may provide a new set of tools to aid wound 
management in the future.  
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Figure 4.1 – Response of BMP pathway components to skin injury. The 
scheme illustrates the sequential reaction of the BMP pathway to tissue 
damage and potential downstream mechanisms.  
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Conclusions 
 
Based on the data shown, the following conclusions can be drawn: 
o Epidermal wounding results in marked alterations in BMPR expression and 
localisation in murine and human wounds, together with down-regulation of 
BMP ligands and Smad canonical pathway components.  
 
o Noggin over-expression in the epidermis and hair follicle stimulates 
keratinocyte proliferation and migration, and suppresses apoptosis in the 
wound epithelium. In contrast, potentiation of Smad1 activity in the 
epidermis and hair follicle inhibits keratinocyte proliferation and migration, 
and increases apoptosis.  
 
o Smad1 over-expression leads to marked alterations in gene expression 
programmes in keratinocytes, and is accompanied by altered expression of 
genes encoding selected migratory proteins (Krt1, Krt16, Krt17, Myo5a, 
Cldn1, Cldn3, Rac1, Gjb2, Gja4, Ablim2, Tubb6 and Pxn). These pathways 
are likely to contribute to the impaired healing response seen following 
Smad1 constitutive activation.   
 
o BMP treatment negatively regulates keratinocyte proliferation; this effect 
may be co-ordinated through BMPR-1A. However, BMP antagonists 
stimulate keratinocyte proliferation.  
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o BMP signalling negatively regulates keratinocyte migration, migratory gene 
expression and alters keratinocyte morphology, potentially through BMPR-
1B. Modulation of the BMP pathway with antagonists triggers keratinocyte 
polarisation and accelerates migration. 
 
o BMP treatment slows human wound repair through the same effects on 
keratinocyte proliferation, apoptosis and migration seen in murine skin. 
Modulation of BMP signalling using Noggin accelerates human skin healing 
and increases epidermal differentiation marker expression.  
 
o Taken together, global suppression of the BMP axis may facilitate 
keratinocyte migration and proliferation to close an epidermal defect 
following skin injury. Use of BMP antagonists may represent a novel 
therapeutic approach for the treatment of chronic wounds in the future. 
    
 
 
 
 
 
 
 
179 
 
Future Work 
 
To further elucidate the role of BMP signalling cascades in cutaneous wound 
repair, the following studies may be useful:  
 
o Genome wide gene expression profiling of proliferation, migration and 
differentiation markers in Alk3 (Bmpr-1A) and Alk6 (Bmpr-1B) homozygous 
mice to establish specific receptor targets.  
 
o Chromatin immunoprecipitation sequencing and reporter assay analyses to 
define the complete set of the downstream target genes that are regulated 
by the BMP-Smad pathway in keratinocytes during wound healing.  
 
o Design and use of small molecule inhibitors of BMP signalling as a novel 
approach for the treatment of chronic wounds. 
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